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A B S T R A C T
Background
The diagnosis of glaucoma is traditionally based on the finding of optic nerve head (ONH) damage assessed subjectively by oph-
thalmoscopy or photography or by corresponding damage to the visual field assessed by automated perimetry, or both. Diagnostic
assessments are usually required when ophthalmologists or primary eye care professionals find elevated intraocular pressure (IOP) or a
suspect appearance of the ONH. Imaging tests such as confocal scanning laser ophthalmoscopy (HRT), optical coherence tomography
(OCT) and scanning laser polarimetry (SLP, as used by the GDx instrument), provide an objective measure of the structural changes
of retinal nerve fibre layer (RNFL) thickness and ONH parameters occurring in glaucoma.
Objectives
To determine the diagnostic accuracy of HRT, OCT and GDx for diagnosing manifest glaucoma by detecting ONH and RNFL
damage.
Search methods
We searched several databases for this review. The most recent searches were on 19 February 2015.
Selection criteria
We included prospective and retrospective cohort studies and case-control studies that evaluated the accuracy of OCT, HRT or the
GDx for diagnosing glaucoma. We excluded population-based screening studies, since we planned to consider studies on self-referred
people or participants in whom a risk factor for glaucoma had already been identified in primary care, such as elevated IOP or a family
history of glaucoma. We only considered recent commercial versions of the tests: spectral domain OCT, HRT III and GDx VCC or
ECC.
1Optic nerve head and fibre layer imaging for diagnosing glaucoma (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Data collection and analysis
We adopted standard Cochrane methods. We fitted a hierarchical summary ROC (HSROC) model using the METADAS macro in
SAS software. After studies were selected, we decided to use 2 x 2 data at 0.95 specificity or closer in meta-analyses, since this was the
most commonly-reported level.
Main results
We included 106 studies in this review, which analysed 16,260 eyes (8353 cases, 7907 controls) in total. Forty studies (5574 participants)
assessed GDx, 18 studies (3550 participants) HRT, and 63 (9390 participants) OCT, with 12 of these studies comparing two or three
tests. Regarding study quality, a case-control design in 103 studies raised concerns as it can overestimate accuracy and reduce the
applicability of the results to daily practice. Twenty-four studies were sponsored by the manufacturer, and in 15 the potential conflict
of interest was unclear.
Comparisons made within each test were more reliable than those between tests, as they were mostly based on direct comparisons within
each study.The Nerve Fibre Indicator yielded the highest accuracy (estimate, 95% confidence interval (CI)) among GDx parameters
(sensitivity: 0.67, 0.55 to 0.77; specificity: 0.94, 0.92 to 0.95). For HRTmeasures, the Vertical Cup/Disc (C/D) ratio (sensitivity: 0.72,
0.60 to 0.68; specificity: 0.94, 0.92 to 0.95) was no different from other parameters. With OCT, the accuracy of average RNFL retinal
thickness was similar to the inferior sector (0.72, 0.65 to 0.77; specificity: 0.93, 0.92 to 0.95) and, in different studies, to the vertical
C/D ratio.
Comparing the parameters with the highest diagnostic odds ratio (DOR) for each device in a single HSROC model, the performance
of GDx, HRT and OCT was remarkably similar. At a sensitivity of 0.70 and a high specificity close to 0.95 as in most of these studies,
in 1000 people referred by primary eye care, of whom 200 have manifest glaucoma, such as in those who have already undergone
some functional or anatomic testing by optometrists, the best measures of GDx, HRT and OCT would miss about 60 cases out of the
200 patients with glaucoma, and would incorrectly refer 50 out of 800 patients without glaucoma. If prevalence were 5%, e.g. such as
in people referred only because of family history of glaucoma, the corresponding figures would be 15 patients missed out of 50 with
manifest glaucoma, avoiding referral of about 890 out of 950 non-glaucomatous people.
Heterogeneity investigations found that sensitivity estimate was higher for studies with more severe glaucoma, expressed as worse
average mean deviation (MD): 0.79 (0.74 to 0.83) for MD < -6 db versus 0.64 (0.60 to 0.69) for MD ≥ -6 db, at a similar summary
specificity (0.93, 95% CI 0.92 to 0.94 and, respectively, 0.94; 95% CI 0.93 to 0.95; P < 0.0001 for the difference in relative DOR).
Authors’ conclusions
The accuracy of imaging tests for detecting manifest glaucoma was variable across studies, but overall similar for different devices.
Accuracy may have been overestimated due to the case-control design, which is a serious limitation of the current evidence base.
We recommend that further diagnostic accuracy studies are carried out on patients selected consecutively at a defined step of the clinical
pathway, providing a description of risk factors leading to referral and bearing in mind the consequences of false positives and false
negatives in the setting in which the diagnostic question is made. Future research should report accuracy for each threshold of these
continuous measures, or publish raw data.
P L A I N L A N G U A G E S U M M A R Y
Tests for imaging the optic nerve and its fibres for diagnosing glaucoma
Review question
We reviewed the evidence about the accuracy of confocal scanning laser ophthalmoscopy (commercially available as the Heidelberg
Retinal Tomogram (HRT)), optical coherence tomography (OCT) and scanning laser polarimetry (as used by the GDx device) for
diagnosing glaucoma in people who are at risk. These tests can measure the structure of the optic nerve head or measure the thickness
of the nerve’s fibres, or both.
Background
Glaucoma is a progressive neurodegenerative disease that affects the optic nerve, with corresponding damage to the visual field. The
course of the disease can be slowed or halted by reducing intraocular pressure with eye drops or surgery.
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Study characteristics
We found 106 studies, mostly assessing a single device, which analysed 16,260 eyes (8353 cases, 7907 controls). Forty studies (5574
participants) assessed GDx, 18 studies (3550 participants) HRT, and 63 (9390 patients) OCT. Twenty-four studies were sponsored by
themanufacturer, and in 15 the study funding was unclear. The final diagnosis of glaucoma had to be confirmed by clinical examination,
including visual field testing or clinical optic nerve examination or both. However, we could not find studies comparing two tests, the
most robust way to test these instruments, and including a series of consecutive patients at risk as seen in routine care, as we had hoped.
Rather, we found studies assessing the performance of a single test in people without glaucoma as opposed to its performance in people
with a previous diagnosis of glaucoma. The study search is current to 19 February 2015.
Key results
The performance of all devices was very variable across studies, but overall similar. In 1000 people referred by primary eye care, of whom
200 (20%) have manifest glaucoma, such as in those who have already undergone some functional or anatomic testing by optometrists,
the best measures of GDx, HRT and OCT would miss about 60 cases out of the 200 patients with glaucoma (sensitivity 70%), and
would incorrectly refer 50 out of 800 patients without glaucoma (at specificity 95%). If prevalence were 5%, for example, in people
referred only because of family history of glaucoma, the corresponding figures would be 15 patients missed out of 50 with manifest
glaucoma, avoiding referral of about 890 out of 950 non-glaucomatous people.
The tests were better at detecting more severe glaucoma compared to early glaucoma.
Quality of the evidence
The selection of two well-defined groups of healthy and glaucoma eyes in nearly all studies, rather than the use of these imaging tests
in a series of patients at risk of glaucoma as in the real world, may overestimate the accuracy of these devices compared to what could
be achieved in daily practice.
B A C K G R O U N D
Target condition being diagnosed
Glaucoma is a group of progressive optic neuropathies that have in
common a slow progressive degeneration of retinal ganglion cells
and their axons, resulting in a distinct appearance of the optic disc
and retinal nerve fibre layer (RNFL) and a concomitant pattern
of visual loss (Weinreb 2004).
Without adequate treatment, glaucoma can progress to visual dis-
ability and eventual blindness (Quigley 2006). Vision loss caused
by glaucoma is irreversible, and glaucoma is the second leading
cause of blindness in the world. It is estimated that glaucoma af-
fects more than 66 million individuals worldwide with at least
eight million bilaterally blind.
The overall risk of developing glaucoma increases with the num-
ber and strength of risk factors. It increases substantially with the
level of intraocular pressure (IOP) elevation and with increasing
age (OHTS 2002). Other strong risk factors include some visual
field (VF) abnormalities seen in otherwise usual baseline visual
field examinations, high myopia and family history of glaucoma.
Recently, a thin cornea and a vertical or horizontal cup-to-disc ra-
tio of greater than 0.4 (as determined from stereoscopic disc pho-
tographs) have been added to the list of risk factors for developing
glaucoma (Coleman 2008; OHTS 2002 ).
Disease progression rates in primary open angle glaucoma, the
most common form of glaucoma in Europe, differ strongly be-
tween patients from rapid to very slow. Many patients show no
or only small deterioration, even after years of follow-up (EMGT
1999; Wilson 2002). Most cases of glaucoma are not discovered
until visionhas already beenpermanently lost because clinical signs
of early glaucoma are subtle, even to an eye specialist (Weinreb
2004). In most cases, the loss of vision caused by glaucoma can be
limited or prevented by currently available therapies if the disease
is identified in its early stages (AGIS 1994; CIGTS 1999; EMGT
1999).
The goal of glaucoma treatment is to maintain the visual func-
tion and related quality of life at a sustainable cost (EGS 2008
Guidelines). Currently, the only approach proven to be efficient
in preserving visual function is lowering the IOP (AGIS 1994;
CIGTS 1999; EMGT 1999; OHTS 2002). It has been estimated
that each single mmHg of pressure reduction obtained with treat-
ment accounts for a 10% to 19% reduction of risk of progression
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(Chauhan 2008; EMGT 1999).
The diagnosis of glaucoma is traditionally based on the finding
of visual field damage with automated perimetry, glaucomatous
damage to the optic nerve head (ONH), or both (EGS 2008
Guidelines). Diagnostic assessments are usually required when
ophthalmologists or primary care physicians find an elevated IOP
or a suspected anomaly of the optic nerve head such as a large cup/
disc ratio or a focal rim notch.
Visual field damage is commonly assessed with automated perime-
try. A variety of visual field scoring systems or algorithms have
been adopted in cohort studies to diagnose the presence of glau-
coma (AGIS 1994; Brusini 2006b; CIGTS 1999; EMGT 1999;
Mills 2006; Spaeth 2006). However, no scoring system has yet
been accepted as a reference standard. Furthermore, visual field
examination is not completely reliable and repeated testing may
be needed to diagnose cases with modest damage (Katz 1995; Spry
2003). Moreover, ONH deterioration is thought to precede visual
field damage; there is evidence that about 40% of nerve fibres may
be lost before impairment of visual function (Sommer 1991). The
main pathological ONH changes are progressive neuroretinal rim
thinning and enlargement of the cup/disc ratio, or a definite disc
cupping inmore severe cases (Spaeth 2006). Optic disc assessment
is usually based on fundus biomicroscopy or photography. A dis-
advantage of direct optic disc evaluation with biomicroscopy or
photography is that these methods, especially biomicroscopy, rely
on the ability and experience of the physician who is perform-
ing the assessment, and therefore lead to considerable variation
amongst assessments (Abrams 1994). Imaging methods provide
more reliable and quantitative results. In clinical practice, imaging
investigations might contribute to standardising the diagnosis of
glaucoma and improvement of follow-up.
Even though ONH and RNFL imaging is already a well-estab-
lished alternative to biomicroscopy or photography for the evalu-
ation of ONH appearance, no method has yet been recognised as
optimal.
Index test(s)
Clinical ONH and RNFL assessment is limited by poor repro-
ducibility and by a wide variation in the normal anatomy of these
structures between individuals (Lichter 1976). Confocal scan-
ning laser ophthalmoscopy, commercially available as the Heidel-
berg Retinal Tomogram (HRT), optical coherence tomography
(OCT) and scanning laser polarimetry (SLP), commercially avail-
able as GDx, are relatively new techniques for the measurement of
the structural changes of the optic nerve and RNFL (Mai 2007;
Medeiros 2004; Oddone 2008; Strouthidis 2008).
These devices allow measurement of RNFL thickness as well as
various morphological optic disc parameters.
HRT:HRT uses a diode laser (670 nm) to scan the retinal surface
at multiple consecutive parallel focal planes. The pixel with the
highest reflectivity on the z-axis across the focal planes for each x,
y location is used to identify the retinal surface and to construct a
topographic image of the ONH. Relative topographic heights are
then calculated from a reference ring placed on the retinal surface
at the periphery of the scanned area.
After image acquisition, the operator using HRT needs to set an
optic disc contour line manually, after which the instrument cal-
culates ONH stereometric parameters. Besides stereometric pa-
rameters, the HRT 3 provides two different classification algo-
rithms of theONHmorphology: theMoorfields Regression Anal-
ysis (MRA), which requires the placement of the contour line; and
themore recent, contour-line independent, Glaucoma Probability
Score (GPS).
GDx: The GDx is a scanning laser polarimeter that measures
RNFL thickness using polarised, near-infrared (780 nm) light.
The GDx measures the RNFL birefringence, which is correlated
to the RNFL thickness. The cornea and lens are also birefringent
structures which affect the total retardation measured, thus the
GDx measures and individually compensates for the anterior seg-
ment (cornea and lens), isolating the signal from the RNFL. In-
dividual anterior segment compensation late-generation models
result in more accurate RNFL measures.
OCT:Optical coherence tomography (OCT) is a high-resolution
imaging device that uses low coherent light from a broadband light
source produced from a super-luminescent diode to acquire in
vivo images of the retina. Optical coherence tomography applies
the principle of interferometry to interpret reflectance data from a
series of multiple side-by-side A-scans combined to form a cross-
sectional image.
Classification algorithms are implemented in HRT, GDx and
OCT, based on normative databases to discriminate between nor-
mal and diseased eyes. It has been estimated that the availability of
imaging devices for the diagnosis and management of glaucoma
ranges from12.5% for theGDx to 43.9% for theHRTand 45.2%
for the OCT in hospital practice in the UK (Gordon-Bennet
2008). It is likely that these figures are lower in primary care services
and in low- andmiddle-income countries. As technology advances,
different versions of glaucoma imaging devices have been released
in the market in the last 10 years with improvements in terms of
resolution, accuracy, reproducibility and availability of normative
databases. In this review, we consider only versions equipped with
normative databases, thus providing classifications, and versions
with latest, mature technology (Spectral Domain OCT devices,
HRT 3 and GDx VCC or ECC).
A health technology assessment (HTA) conducted in 2005 found
poor performance of both HRT and GDx in cross-sectional and
longitudinal groups of patients suspected of glaucomatous visual
field loss (Kwartz 2005). However, the assessment was based on
the results of a single clinical study and did not include a system-
atic review of the literature. Moreover, the GDx and HRT ver-
sions considered are no longer available. More recently, Burr 2007
assessed the HRT II, an older model not included in our review,
and yielded meta-analytic estimates of sensitivity and specificity
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of 86% and 89% in three studies using a common cut-off.
Clinical pathway
We expect that ONH and RNFL imaging is used in people who
have already been tested by means of clinical examination at pri-
mary care level, including ONH clinical assessment, IOP mea-
surement and even visual field testing. Thus, these devices will
generally be used as an add-on test. Patients may be screened for
or suspected of having glaucoma for several reasons. Apart from
population-based screening programmes, which are still uncom-
mon (Heijl 2013), people may refer themselves to optometrists,
orthoptists or ophthalmologists, depending on the setting, for re-
fractive error or routine eye check. In the USA and Canada, re-
ferrals to glaucoma specialists are made both by ophthalmologists
and optometrists (Cheng 2014). Those with a family history of
glaucoma may know that they are particularly at risk and seek pe-
riodic consultation. An eye care professional will prescribe further
tests for glaucoma in the presence of ocular hypertension (above 21
mmHg) orONHchanges at fundus examination. Visual field test-
ing is needed to confirm manifest or perimetric glaucoma, but it
has to be interpreted by an experienced professional in the context
of a full eye examination. After visual field testing, an examination
by an ophthalmologist is the gold standard for manifest glaucoma,
whereas suspected glaucoma may require longitudinal follow-up
demonstrating either changes to the visual field or ONH or both.
Furthermore, there are glaucoma specialists or ophthalmologists
with greater experience in glaucoma, to whom other ophthalmol-
ogists may refer difficult cases.
Prior test(s)
Ratnarajan 2013 has recently reported on suspected glaucoma re-
ferral patterns by optometrists with or without special interest in
glaucoma in the UK. They concluded that a referral for suspected
glaucoma is based characteristically on nding an elevated IOP, an
abnormal optic disc appearance, an abnormal visual field, or a
combination of these. The frequency of manifest glaucoma was
about 5% to 15% when elevated IOP was the main reason for
referral, and rose to 20% to 30%, the higher figure being detected
by optometrists with special interest in glaucoma, when optic disc
anomalies were also considered.
Role of index test(s)
How ONH and RNFL imaging could affect glaucoma referrals
and diagnosis in real-world clinical settings is unclear, according
to the studies we retrieved to prepare this review. Even among
general ophthalmologists, the value of ONH and RNFL imaging
may be enhanced by the large variability in diagnostic accuracy
among clinicians, and the often moderate intra-observer agree-
ment between clinicians in a large study of 243 ophthalmologists
in 11 European countries (Reus 2010), which makes an objective
and reproducible measure attractive. Reus 2010 also found that
common imaging devices outperform most clinicians in classify-
ing optic discs. An objective test providing continuous anatomi-
cal measures may therefore considerably improve clinical perfor-
mance, as also found by Andersson 2011.
Alternative test(s)
A previous systematic review has examined a range of tests that
can be used for the screening of glaucoma, as well as in diagnostic
settings (Burr 2007; Mowatt 2008). However, our review focuses
on studies of patients referred from primary care or self-referred
patients, or studies of patients already followed in secondary- or
tertiary-care glaucoma clinics.We considered the three tests (GDx,
HRT,OCT) as equally relevant andno further test as a comparator.
Rationale
Imaging of the ONH and of the RNFL is increasingly used as an
objective tool to diagnose glaucomatous disc and RNFL changes.
Each imaging device provides several continuous parameters and
classification algorithms characterised by a broad spectrum of sen-
sitivity and specificity. We therefore deemed a systematic assess-
ment of the diagnostic accuracy of new imaging methods for the
diagnosis of glaucoma to be useful.
O B J E C T I V E S
• To determine the diagnostic accuracy of HRT, OCT and
GDx for diagnosing manifest glaucoma by detecting ONH and
RNFL damage.
Secondary objectives
• To determine which morphometric measure or diagnostic
algorithm yields the highest diagnostic accuracy within each
device.
• To compare the relative diagnostic accuracy of the three
devices.
• To explore potential causes of heterogeneity of diagnostic
performance across studies.
We planned to investigate the following sources of clinical hetero-
geneity:
A. Heterogeneity related to the choice of reference standard: type
of reference standard (optic disc assessment, visual field, or both);
definitions of visual field damage.
B. Heterogeneity related to characteristics of the study population:
severity of glaucoma.
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C. Heterogeneity related to issues of methodological quality.
As we expected a large number of included studies to be case-con-
trol, we considered a particular type of bias resembling incorpo-
ration bias for these studies. Usually the investigator assessing the
presence of glaucoma does not rely exclusively on valid perimetric
criteria to allocate patients to the glaucoma group, but also on op-
tic disc appearance such as cupping. Diseased patients may have
larger cups than expected, thus enhancing the ability of imaging
methods to detect disease based on disc morphology algorithms.
For this reason, we investigated heterogeneity between case-con-
trol studies using visual field only versus case-control studies us-
ing visual field plus optic disc as a reference standard. We consid-
ered visual field alone the preferred, unbiased reference standard
method (Garway-Heath 1998).
We originally planned to investigate heterogeneity based on spe-
cific methodological issues of included studies (Appendix 1): in-
clusion of a representative spectrum of patients; reporting of un-
interpretable results; choice of unit of analysis. However, we then
adopted QUADAS 2 and used its domains for heterogeneity in-
vestigation.
Finally, we planned an exploratory subgroup analysis based on the
overall level of missing data, regardless of their cause (including
withdrawals and any patients whomay have been excluded because
of uninterpretable index test results), using the median level of
missing data across studies to define better versus worse quality,
as well as a level of 10% missing data for the same purpose. We
planned further subgroup analyses to investigate the contribution
of studies that did not report anymissing data but did not explicitly
state that there were no missing data.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We planned to include all prospective and retrospective cohort
studies and case-control studies that evaluate the accuracy ofOCT,
HRT or the GDx for diagnosing glaucoma. We included both sin-
gle studies assessing each imaging method and comparative stud-
ies assessing more than one imaging method in the same patient
population. We included only studies that provide data to allow
calculation of sensitivity and specificity estimates.
A first draft of this reviewwas submitted based on a literature search
conducted until 15 June 2013, which identified a large number of
case-control studies. During the revision of the final version of this
review,we updated the search to 15February 2015 and found some
additional case-control studies. We decided not to include these
additional case-control studies, as they are known to be prone to
methodological biases and unlikely to change the current evidence
base. Future updates of this review should only focus on studies
where the patient population is enrolled consecutively, with the
same set of inclusion criteria, such as referable patients identified
in primary care.
We applied no language restriction to the inclusion criteria of the
studies.
Participants
The tests on which this review focuses have not been extensively
studied in population-based screening studies, which should be
the subject of a future Cochrane review on screening tests for glau-
coma. The published protocol for this review stated we would in-
clude glaucoma suspects, but did not fully specify the professional
and clinical pathway stage at which such a question is made. Fram-
ing the question in a well-defined pathay is also difficult due to
variation of eye care pattens in different health care settings. In ret-
rospect, the findings of this review could be used in an add-on set-
ting which could be a primary care, or a triage setting when some-
body has already been referred fromprimary care to secondary care
as suspect glaucoma and needs triage by a non glaucoma specialist
Index tests
We assessed the following imaging devices: confocal scanning laser
ophthalmoscopy (HRT); optical coherence tomography (OCT);
and scanning laser polarimetry (GDx). For each test we extracted
and analysed all parameters which can be obtained with standard
commercial software and are measuring RNFL orONHmorphol-
ogy.
During the review process, we decided to extract OCT measures
that are not related to RNFL and ONHmorphology, but to mac-
ular cell layers affected by glaucoma, such as ganglion cell complex
(GCC) and ganglion cell inner plexiform layer (GCIPL), as these
parameters have gained popularity in recent years.
Target conditions
The target condition of interest was manifest glaucoma.
Reference standards
There is no universally-accepted reference standard for the diag-
nosis of manifest glaucoma. Both optic disc and visual field dam-
age are used to diagnose the presence of glaucoma. Several systems
have been proposed to score visual field and optic disc damage
and have been tested in multicentre randomised controlled trials
(RCTs) (AGIS 1994; CIGTS 1999; EMGT 1999). While we ac-
cepted any diagnosis of glaucoma given by the study investigators,
we conducted subgroup analyses to assess whether differences be-
tween studies could be explained by the choice of the reference
standard.
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Search methods for identification of studies
Electronic searches
We searched the Database of Abstracts of Reviews of Effects
(DARE), theHealth Technology Assessment Database (HTA) and
the NHS Economic Evaluation Database (NHSEED) (Cochrane
Library 2015, Issue 1), Ovid MEDLINE, Ovid MEDLINE
In-Process and Other Non-Indexed Citations, Ovid MED-
LINE Daily, Ovid OLDMEDLINE (January 1946 to February
2015), EMBASE (January 1950 to February 2015), MEDION
(www.mediondatabase.nl/) (2002 to 2012, database archived in
2012) and the Aggressive Research Intelligence Facility database
(ARIF) (147.188.28.230/rmwp) We did not use any date or lan-
guage restrictions in the electronic searches for studies. We last
searched the electronic databases on 19 February 2015.
See: Appendices for details of search strategies for the Cochrane
Library (Appendix 3), MEDLINE (Appendix 4), EMBASE (Ap-
pendix 4), MEDION (Appendix 5) and ARIF (Appendix 6).
Searching other resources
We handsearched the reference lists of the included studies for
further relevant studies.
Data collection and analysis
Selection of studies
Pairs of review authors (MM, EL, GV, SF) independently ex-
amined the titles and abstracts of all citations identified by the
electronic searches. We classified the abstracts as (a) definitely in-
cluded, (b) unsure or (c) definitely excluded. We obtained and
re-assessed full-text copies of those classified as (a) definitely in-
cluded and (b) unsure. We subsequently classified the studies as
(1) included, (2) awaiting assessment or (3) excluded. Because of
the huge volume of identified evidence, we did not contact the
authors of studies classified as awaiting assessment for further clar-
ification, but we planned to re-assess the studies if further infor-
mation should become available. Due to the large number of re-
trieved and assessed full-text papers, we chose not to list all studies
classified by the two review authors as (3) excluded in the ’Char-
acteristics of excluded studies’ table.We are happy to provide a list
of these studies upon request. We assessed all studies identified as
(1) included for methodological quality and data extraction. The
review authors were not masked to the names of study authors
and institutions. We resolved any disagreement between the two
review authors by discussion or by referral to a third review author
(GV).
Data extraction and management
Pairs of review authors (SF, EL,MM, SN) independently extracted
the following information from each included study: the number
of true positives (TP), i.e. patients categorised as diseased by both
the reference and index test; the number of false negatives (FN),
i.e. patients categorised as diseased by the reference test, but as
non-diseased by the index test; the number of true negatives (TN),
i.e. patients categorised as non-diseased by both the reference and
index tests; the number of false positives (FP), i.e. patients cate-
gorised as non-diseased by the reference test, but as diseased by
the index test; the number of patients with uninterpretable index
test results; the number of patients for whom the assessment of
both eyes was included in the statistical analyses; the number with
missing data (patients who were not included in the analyses).
We summarised the Characteristics of included studies using the
items shown in Appendix 7.
Assessment of methodological quality
Pairs of review authors (SF, EL, MM, SN) independently as-
sessed the methodological quality of included studies using the
QUADAS 2 checklist (Appendix 8), which has recently replaced
the original QUADAS checklist (Whiting 2003) (Appendix 1).
We also followed the recommendations provided in Chapter 9 of
the Cochrane Handbook for Systematic Reviews of Diagnostic Test
Accuracy (Reitsma 2009). We resolved any disagreement by dis-
cussion or by referral to a third author (GV).
Statistical analysis and data synthesis
For each imaging test we extracted indices of diagnostic perfor-
mance or derived them from the data reported in each primary
study. Where possible we recorded the number of true positive
cases, false positive cases, false negative cases and true negative
cases by 2 x 2 contingency tables, where the columns reveal the
true status (diseased or not diseased) of the condition under in-
vestigation and the rows show the dichotomised index test results.
From the 2 x 2 tables we calculated: sensitivity (the proportion
of diseased people correctly diagnosed) and specificity (the pro-
portion of non-diseased people incorrectly diagnosed) with 95%
confidence intervals. Initially, we explored heterogeneity by visual
inspection of the forest plots of pairs of sensitivity and specificity,
and of plotted data on a receiver operating characteristic (ROC)
plot (sensitivity on the vertical axis and (1 - specificity) on the
horizontal axis).
We had planned to conduct meta-analyses of correlated pairs of
sensitivity and specificity using the hierarchical summary ROC
(HSROC) model (Rutter 1995; Rutter 2001). However, when
we had completed the data extraction, we noticed that studies
compared several measures of each device and presented data at
fixed levels of specificity (such as 0.80, 0.90 and 0.95), without
reporting any cut-off used, sometimes presenting sensitivity at
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more than one specificity level.We extracted all data and presented
them in forest plots regardless of the specificity level chosen by
the study authors. Thereafter, we decided to use 2 x 2 data at
0.95 specificity or closer in meta-analyses, since this was the most
commonly reported level and because ONH and RNFL imaging
tests might have a role as a triage test when the target condition
is manifest glaucoma, especially in primary care settings, which is
then confirmed by an ophthalmologist by means of clinical and
visual field examination.
Because of the data structure, we expected and found little varia-
tion in specificity. Thus, we deviated from the protocol and fitted
a bivariate model using the METADAS macro in SAS (Takwoingi
2008), focusing on summary sensitivity when reporting data, de-
spite the fact that thresholds were not reported. Harbord 2007 has
shown that the bivariate (Reitsma 2005) and the HSROC models
are mathematically equivalent and, as a result, METADAS simul-
taneously derives pooled sensitivity and specificity.
Because of the large number of test parameters, we faced the is-
sue of conducting a huge number of comparisons and decided to
limit multiple testing by adopting the following strategy: first, we
considered that direct comparisons are more reliable than indi-
rect comparisons in diagnostic accuracy studies (Takwoingi 2013).
Nearly all studies included a single device, but compared several
parameters within the same imaging device, making within-test
comparisonsmore robust thanbetween-test comparisons.Weused
a covariate coding for each test parameter in the bivariate model
and, given limited variation of specificity, we reported the signif-
icance of testing for the sensitivity of each parameter versus that
with the highest sensitivity. We conducted such comparisons in-
cluding two parameters at a time, to avoid problems with missing
data for other parameters. In order to conduct indirect compar-
isons between tests, but still reducing the amount of significance
testing, we included in the analysis the parameters with the two
highest levels of sensitivity within each test and again compared
them to that with the best sensitivity among all.
Investigations of heterogeneity
We had planned to use forest plots to look for evidence of hetero-
geneity within sensitivity and within specificity, and ROC plots
to look for evidence of a threshold effect and heterogeneity due to
differences in accuracy.
Although we planned to incorporate covariates in the hierarchical
model to examine the effect of potential sources of heterogeneity
on threshold parameters, accuracy parameters or both, we adopted
a bivariate regression model and focused on reporting sensitivity,
as there was minimal variation in specificity as explained above.
Sensitivity analyses
Weplanned to undertake sensitivity analyses for individual quality
items, in particular for ’Type of study design’ by omitting case-
control studies. However, as nearly all the included studies were
case-control we did not perform this analysis.
Assessment of reporting bias
We had planned to assess publication bias using funnel plots dis-
playing lnDOR on the x-axis and 1/ESS½ (where ESS is the effec-
tive sample size) on the y-axis, as recommended by Deeks 2005,
provided that 10 or more studies are included in the analyses. We
decided not to conduct these analyses in the review phase.
R E S U L T S
Results of the search
Weupdated the searches used for this review inFebruary 2015.The
electronic searches yielded a total of 9332 records (Figure 1). Af-
ter deduplication we screened 7306 reports, of which we consid-
ered 6883 records not to be relevant, based on title and abstract,
because of incorrect target condition, index test, participants, or
study design. In total we screened 423 full-text reports of studies,
of which we excluded 317 for one or more of the following rea-
sons, mainly because they evaluated an old test version or did not
provide suitable data (references available upon request). Finally,
we identified 106 relevant studies with a total of 16,260 eyes. One
hundred-and-three studies were case-control studies, one study
was a consecutive cohort study and the study design was unclear
for the remaining two studies. The sample size ranged from 61
to 435 patients (median 143). Most studies were conducted in
Asia (44), followed by Europe (31), North America (24), South
America (2) and Oceania (1). Four studies did not report suffi-
cient information to determine study setting. Almost all studies
enrolled one eye per person (90 studies, 85%).
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Figure 1. Flow diagram.
Forty studies (5574 patients) assessed GDx, 18 studies (3550 pa-
tients) HRT, and 63 (9390 patients) OCT. Twelve of these studies
compared two or three tests. Sixty-seven studies used VF damage
plus ONH glaucomatous optic neuropathy as the reference stan-
dard; the remaining 37 studies relied on either VFdamage only (29
studies) or ONH/RNFL damage only (10 studies) as definition
criteria for confirming glaucoma. There was limited opportunity
to explore the variability of controls regarding risk factors for glau-
coma, as well as to investigate subgroups of severity of glaucoma
based on studies’ inclusion criteria of cases. We therefore used the
study average mean deviation (MD) for this purpose, with values
ranging from -0.16 db to -11.4 db.
Methodological quality of included studies
We present a summary of methodological quality assessment in
Figure 2. The main quality issue was the case-control design (103
studies) or unclear design (two studies) of all included studies
except one. This led to a high risk of bias for the Patient Selection
domain inQUADAS 2, and raised concerns about the applicability
of our findings to clinical practice, particularly when the purpose
is to triage patients to be referred to glaucoma centres.
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Figure 2. Risk of bias and applicability concerns graph: review authors’ judgements about each domain
presented as percentages across included studies
There were some concerns about the conduct of the index test.
In fact, we assumed that the use of fixed specificities equalled
threshold prespecification in all but one study (Chen 2008).
Quality of images, whichwe chose as an additional signalling ques-
tion because it is known to affect the accuracy of RNFL thick-
ness (Rao 2013), was assessed and used in 99 out of 106 studies.
Conflict of interest was of high concern in 24 studies, of unclear
concern in 15 studies, and of no concern in 67 studies.
Reference standard was rated as good when visual field only was
used to detect the presence of glaucoma (27 studies). As reported
below, confirmation of glaucoma using visual field testing means
that the patient’s function is affected, which is more relevant, and
also explores a different dimension compared to that assessed by
ONH/RNFL imaging tests. Masking of reference test to index test
results was unclear (75 studies) or not adopted (one study), with
only 30 studies reporting its masked interpretation with respect
to index test results.
With regard to the Flow and Timing domain, 101 out of 106
studies used the same reference standard for all patients and 59
studies excluded fewer than 10% of the patients from the analyses;
we judged the remaining studies to be at unclear or high risk of
bias. However, exclusions were often due to poor-quality images,
which we considered a good quality criterion for the assessment of
the Index test domain. For this reason, we decided not to carry out
sensitivity analyses on this issue, as its interpretation would have
been difficult. Finally, adopting a strict criterion of less than one
month between index and reference tests, we classified 28 studies
at high risk of bias, and most of the remaining at unclear risk of
bias.
Findings
One hundred-and-six studies reported sensitivity values of several
parameters at given specificity values, mainly at approximately
0.80, 0.90 and 0.95. Our revised analysis plan was to present the
accuracy of all reported parameters for each test (Table 1), and then
compare parameters to that with the best diagnostic odds ratio
(DOR) (Table 2). Because ONH parameters obtained with OCT
were reported in a substantially smaller set of studies compared
with RNFL parameters, we present them separately to maintain
the validity of within-test comparisons.
Finally, macular/GCC and GCIPL parameters have increasingly
been investigated as OCT-based parameters for detecting glau-
coma, but were not among the structural dimensions we origi-
nally planned to investigate in this review (i.e. ONH and RNFL).
Nonetheless, 32 studies assessed these new measures, and we re-
port on them separately without carrying out any statistical testing
on the differences versus other parameters (Table 3).
Accuracy of test parameters and within-test
comparisons
Table 1 presents the accuracy of all parameters of each test. Sensi-
tivities were very heterogenous, as seen in forest plots, while speci-
ficities were above 0.80 by design. Statistical modelling of relative
DOR within each instrument is shown in Table 2, where sensi-
tivity and specificity may slightly differ from Table 1 due the in-
troduction of covariates and the assumption of parallel HSROC
curves in the model to assist interpretability.
GDx
Forty studies (5574 participants) investigated GDx, with each
parameter assessed in 30 to 35 studies, indicating that most of
them carried out direct comparisons (Table 1). Point estimates of
summary sensitivity varied between 0.61 (for superior and infe-
rior RNFL thickness; temporal superior nasal inferior temporal
(TSNIT) average) and 0.76 nerve fibre indicator (NFI). There
was minimal variation in specificity (0.92 to 0.93) across these
parameters, as expected, due to the design of the included studies
and our data extraction strategy.
The DOR of the NFI was significantly better than that of other
parameters (Table 2).
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HRT
Eighteen studies (3550 participants) investigated HRT (Table
1). Eight studies obtained MRA, but only two of these reported
other measures. Comparing MRA to other HRT parameters was
therefore basedmostly on indirect comparisons. TheMRAhad the
highest sensitivity (0.69), with theVertical C/D ratio as the second
best (0.67). However, the specificity was better for the Vertical
C/D ratio (0.94 versus 0.89), suggesting threshold effects. For
other parameters, sensitivity varied between 0.32 (Cup volume)
and 0.58 (Frederick S. Mikelberg (FSM) discriminant function)
and specificity was 0.94 to 0.95 for all parameters.
When we compared overall accuracy using DOR, we found no
significant differences between the Vertical C/D ratio and the best
four parameters, including MRA (Table 2).
OCT
Sixty-three studies (9390 participants) assessed OCT (Table 1).
Of these, 57 assessed mean RNFL thickness, 45 and 43 assessed
the inferior and superior sectors respectively, which are believed
to be clinically more informative than temporal and nasal sectors
(assessed in 30 studies each). Point estimates of sensitivity varied
between 0.29 (nasal) and 0.72 (inferior) with modest variation in
specificity (0.93 to 0.94).
The DOR of the average RNFL thickness was not significantly
better than the inferior sector, whereas it was better than the su-
perior, nasal and temporal parameters (Table 2).
OtherONHparameterswere evaluated in four to 17 studies, yield-
ing sensitivities between 0.16 (Disc area) and 0.72 (Vertical C/D
area ratio) and specificities between 0.92 and 0.95. The Vertical
C/D ratio was no better than the C/DAreaRatio, but was superior
to all other parameters (Table 2).
Alternative data extraction at the lowest reported specificity
Table 4 presents diagnostic accuracy obtained by extraction data at
the lowest rather than the highest reported specificity. The pooled
specificity of the best-performing parameters of GDx and OCT
decreased to 0.86 to 0.87, and sensitivity increased to about 0.80.
Comparisons of parameters between tests
Overall comparisons
We focused on the parameter with the highest DOR for GDx,
HRT, and separately for RNFL and ONH measures of OCT,
in single parameter analyses as estimated in Table 1. These were
compared including a covariate in the HSROC model: pooled
estimates of sensitivity/specificity andDORwere almost identical,
(Figure 3; Table 5).
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Figure 3. Summary ROC Plot of tests with data extracted at the highest specificity in case of multiple study
measures for the same parameter: 2 GDx: NFI, 4 GDx: TSNIT average, 5 OCT: mean RNFL thickness, 6 OCT:
RNFL at inferior quadrant, 13 HRT: vertical C-D ratio, 17 HRT: MRA, 39 OCT: ONH C/D area ratio, 41 OCT:
ONH C/D vertical ratio.
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Direct comparisons
We compared the best parameter for each test by restricting the
analysis to direct comparisons. However, direct comparisons of the
best-performing parameters were sufficient for meta-analysis only
for GDx NFI versus OCT RNFL average (eight studies, Figure
4). The DOR of OCT RNFL average (75.92; 95% CI 44.25
to 130.28) was non-significantly superior to that of GDx NFI
(relative DOR: 0.68; 95% CI 0.38 to 1.21; P = 0.190).
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Figure 4. Summary ROC Plot of tests: 47 Direct comparison: GDx NFI, 48 Direct comparison: OCT RNFL
average.
14Optic nerve head and fibre layer imaging for diagnosing glaucoma (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Accuracy of GCC/GCIPL OCT parameters
Table 3 shows the summary sensitivity and specificity for all GCC/
GCIPL parameters with any of three different OCT tests in up to
35 studies for each parameter. Sensitivities and specificities were
in the range of those observed for ONH and RNFL parameters.
However, we did not compare these parameters formally, since this
was not an aim of our review.
Heterogeneity investigation and effect of
methodological quality
We restricted these analyses to the best parameter identified in
indirect comparisons (NFI for GDx, vertical C/D ratio for HRT,
and mean RNFL thickness for OCT) using all available studies,
given the similar accuracy of performance. We present the results
of these analyses in Table 6.
The main finding was the lower sensitivity estimated for detecting
milder glaucoma cases (MD better than -6 Db, 65 studies, 9720
patients: 0.64; 95% CI 0.60 to 0.69), as compared to more severe
glaucoma cases (MD -6 Db or worse: 49 studies, 7,598 patients:
0.79; 95% CI 0.74 to 0.83) at about the same specificity (0.93,
95%CI 0.92 to 0.94 and, respectively, 0.94; 95% CI 0.93 to 0.95;
P <0.0001 for the difference in relative DOR).
We found no significant difference in sensitivity when adopting a
functional reference standard, such as the visual field, as compared
to a combination of anatomic and functional reference standards.
All studies were at high risk of bias for the Patient Selection do-
main, which could not be used as a covariate. We found no dif-
ference in accuracy for the domains Index Test, Reference Test or
Flow and Timing, as seen in Table 6.
Interpretation of findings
Because the performance of GDx, HRT andOCTwas remarkably
similar comparing the parameterswith the highestDOR in a single
HSROCmodel, we applied our accuracy estimates to the following
scenarios (Summary of findings). Based on Ratnarajan 2013, who
recently investigated glaucoma referral patterns by optometrists
with or without special interest in glaucoma in UK, referrals by
optometrists with no special interest in glaucoma are diagnosed
manifest glaucoma in 3.5% when elevated IOP is the reason for
referral, up to about 20% when anomalies of disc and IOP or
disc and visual field are reasons for referral. The corresponding
figures for optometrists with an interest in glaucoma are about
15% and 30%. Though people finally diagnosed with suspect
glaucomawould bemore than twice asmany as thosewithmanifest
glaucoma among primary care referrals, investigating the accuracy
of imaging devices for diagnosis of suspect glaucoma is outside the
scope of our review. Therefore, we present two referral scenarios,
one with a low prevalence of manifest glaucoma (5%) and another
with a high prevalence (20%), In both scenarios we also assume a
sensitivity of 0.70 and a high specificity close to 0.95 as in most
of these studies.
If 50 out of 1000 referrals have manifest glaucoma, for example
for people who are found elevated IOP or a family history of
glaucoma in a non-specialised primary care setting, these tests
would correctly identify about 35 glaucomatous patients and miss
15 out of the 50 patients, while avoiding referral of about 890 out
of 950 non-glaucomatous people.
Assuming 200 of 1000 referrals are finally found manifest glau-
coma, e.g. on the basis of prior testing such as combined disc and
visual field assessment in specialised primary care, these tests would
correctly identify about 140 glaucomatous patients and miss 60
out of the 200, while avoiding referral of about 750 out of 800
non-glaucomatous patients.
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Summary of findings
What is the accuracy of GDx, HRT and OCT for diagnosing manifest glaucoma?
Patients/
population
Patients with manifest glaucoma compared to healthy controls
Prior testing Unclear (case-control design and insufficient reporting for nearly all studies)
Settings Studies carried out at glaucoma clinics
Index test Scanning Laser Polarimetry (GDx), Heidelberg Retina Tomograph II (HRT), Optical Coherence Tomography (OCT)
Importance Objective and reproducible test
Reference stan-
dard
Clinical assessment of visual field or optic nerve head or both
Studies Case-control design for all studies
Quality and
Comments
Case-control design overestimates accuracy and makes inference difficult
Test parameter N. studies (par-
ticipants)
Sensitivity
(95% CI)
Specificity
(95% CI)
Implications in 1000 patients referred from primary care for clinician’s assessment
Manifest glaucoma prevalence 5%
50 cases out of 1000 referrals
Manifest glaucoma prevalence 20%
200 cases out of 1000 referrals
Glaucoma de-
tected
Missed Referred, but no
glaucoma
Glaucoma
detected
Missed Referred, but no glaucoma
GDx NFI 35 (4958) 0.76
(0.70 to 0.81)
0.92 (0.90 to 0.
94)
38 12 76 152 64 48
HRT vertical C/D
ratio
8 (1849) 0.67 (0.55 to 0.
77)
0.94 (0.92 to 0.
95)
34 16 57 134 66 48
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OCT C/D vertical
ratio
15 (2389) 0.72 (0.60 to 0.
81)
0.94 (0.92 to 0.
95)
36 14 57 144 56 48
OCT RNFL mean
thickness
57 (8223) 0.72
(0.65 to 0.77)
0.93 (0.92 to 0.
95)
36 14 67 140 56 56
Heterogeneity investigation: sensitivity was better for detecting more severe glaucoma cases (MD≥ 6 db: 0.79, 95% CI 0.74 to 0.83) as compared to milder cases (MD <6 db: 0.64,
95% CI 0.60 to 0.69, P = <0.0001) at a specificity of 0.04 (95% CI 0.93 to 0.95) and 0.93 (95% CI 0.92 to 0.94) respectively.
CAUTION: The results on this table should not be interpreted in isolation from the results of the individual included studies contributing to each summary test accuracy measure. These are
reported in the main body of the text of the review
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D I S C U S S I O N
Summary of main results
This review evaluates the accuracy of GDx, HRT and OCT used
for imaging the ONH and RNFL for the diagnosis of manifest
glaucoma. Considering the use of these devices as stand-alone tests
to inform decision making, the findings of this review could be
used in an add-on setting which could be a primary care, or a triage
setting when somebody has already been referred from primary
care to secondary care as suspect glaucoma and needs triage by a
non glaucoma specialist.
All 106 included studies used several types of parameters for a
single test, with the large majority reporting sensitivities at ap-
proximate fixed and high specificity levels, mostly at 0.95. Hence,
comparisons between different types of parameters within each
test were based largely on direct comparisons. We found that NFI
was the most accurate parameter for GDx, whereas for OCT the
sensitivity of mean RNFL thickness was not significantly different
from that of the inferior sector, but was better than the other sec-
tors. With regard to HRT, we did not observe differences among
vertical C/D ratio, C/D area ratio, MRA and FSM or Reinhard
O.W. Burk (RB) discriminant functions, but the vertical C/D ra-
tio was superior to all other cup and rim morphological parame-
ters.
The heterogeneity of sensitivity estimates between studies, assessed
in forest plots, was large for most devices and parameters at all
specificity levels, potentiallymaking indirect comparisons between
tests unreliable (Takwoingi 2013). Nonetheless, the performance
of the best parameter of each test was remarkably similar.
The main limitation of this assessment, despite the large number
of studies on the use of GDx, HRT and OCT for detecting man-
ifest glaucoma, was the case-control design of nearly all included
studies. Case-control studies are likely to overestimate diagnostic
accuracy due to the sharp separation of themeasurements between
cases and controls, unless a nested design is used. Furthermore,
the applicability of the findings to patients referred to glaucoma
specialists by primary eye-care professionals may be limited.
Strengths and weaknesses of the review
The strength of this review is in the systematic assessment of a
considerable number of studies, including double data extraction
and quality assessment according to recommended standards (
QUADAS 2).
A weakness of this review is that we did not provide an explicit
description of the potential clinical pathways in the original pro-
tocol. However, for themanagement of glaucoma, the mapping of
clinical pathways is a complex and difficult process and is likely to
be setting-specific at least at a country/local level. Consequently,
the unclear applicability of our findings can also be the result of the
differences in the care pathway of patients with glaucoma among
different countries, unless such pathways are actively monitored
(Ratnarajan 2013). Overall, we find the methodology for such re-
views has evolved during the process, particularly the importance
of specifying the clinical context in which the review is set.
Comparison with other reviews
We found other relevant reviews of diagnostic accuracy studies.
Recent narrative reviews have supported the use of ONH and
RNFL imaging for detecting glaucoma. Two reviews (Bussel 2013;
Sung 2011) focused on the role of spectral-domainOCTfor the di-
agnosis and management of glaucoma. They observed that RNFL
measurement is the most accurate parameter for the detection of
glaucoma, but ONH and segmentedmacular analyses have shown
in many studies a diagnostic capability overlapping and compara-
ble to that of RNFL peripapillary analysis. Bussel 2013 also high-
lighted a number of limitations of the available evidence, which
influence applicability of findings, and concluded that OCT is a
valuable tool for glaucoma diagnosis and detection of progression,
but that it lacks the necessary diagnostic performance for general
population glaucoma screening. These reviews did not include a
systematic search of evidence, nor did they carry out a meta-anal-
ysis.
Burr 2007 and Mowatt 2008 published different version of a sys-
tematic review of tests for screening and diagnosing glaucoma.
Burr 2007 also assessed the cost effectiveness of screening pro-
grammes and considered three test categories:
• tests for intraocular pressure measurement: contact and
non-contact tonometry;
• tests for structural optic nerve damage: optic disc
assessment by means of ophthalmoscopy or photography, RNFL
photography, and tests for quantitative analysis of the optic nerve
head and RNFL also included by us, such as HRT, GDx and
OCT;
• visual function tests: frequency doubling technology
(FDT), motion detection technology, oculokinetic perimetry,
short-wavelength automated perimetry, standard automated
perimetry.
Among imaging tests, HRT II, an older model not included in our
review, yieldedmeta-analytic estimates of sensitivity and specificity
of 0.86 and 0.89 in three studies using a common cut-off. It is
difficult to compare these results with those of our review, because
we included different test models and far more studies.
In a systematic comparative effectiveness review searching for stud-
ies up to June 2011, Ervin 2012 investigated the diagnostic per-
formance of a similar set of optic nerve structure and function tests
for screening of glaucoma, including 17 studies on HRT II, 11
studies on HRT III, 47 studies on different OCT models and 27
studies on different GDx devices. They found sensitivity estimates
of 0.68 and 0.72 at a fixed specificity of 92%, for the best HRT III
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parameters GPS andMRA, respectively. Sensitivity and specificity
estimates for OCT average RNFL thickness ranged from 0.24 to
0.96 and from 0.66 to 1.00, respectively. For the NFI of GDx-
VCC, sensitivity estimates ranged from 0.28 to 0.99 at specificity
levels between 0.53 and 0.95. The authors concluded that “the
ability of these devices to identify glaucoma in a screening setting
is not well understood [...] due to the lack of a single diagnostic
standard for glaucoma and the high degree of variability in the
design and conduct of largely cross-sectional studies of diagnostic
accuracy”.
Ervin 2012 also included studies assessing older imaging test mod-
els and studies conducted in population-based or screening set-
tings. For population-based studies, Ervin 2012 retrieved two
HRT II studies, and no OCT or GDx studies up to June 2011.
In addition, we found two population-based studies using more
recent imaging tests. However, the estimates in these studies were
imprecise, since Kamdeu 2011 identified four cases of manifest
glaucoma in 197 screened patients, and Bengtsson 2012 identified
five cases in 170 screened patients.
Bussel 2013 conducted anarrative reviewof spectral-domainOCT
studies and reported seven selected studies on glaucoma detection,
and six studies on glaucoma progression. They concluded that
RNFL remains the dominant parameter for glaucoma diagnosis
and detection of progression, but thatOCT still currently lacks the
diagnostic performance for glaucoma screening. Burr 2014 pub-
lished a modelling study that found that a randomised glaucoma
screening trial would not be cost-effective in the UK scenario, but
they used conventional tests such as tonometry, visual field, and
photography, and not OCT.Meier 2014 remarked that to date the
US Food and Drug Administration has not cleared or approved
an OCT device for glaucoma diagnosis and screening.
We did not include screening studies in our review. Interestingly,
Li 2013 reported on the use of GDx-VCC in a community-based
study on volunteer participants with risk factors for glaucoma.
They found that the best-performing parameter was the GDxNFI
using a cut-off of 35 with a sensitivity of 75% (95% CI 19.4 to
99.4) at a specificity of 95% (95% CI 91.3 to 97.3), and con-
cluded that theGDx-VCC has inadequate sensitivity for screening
of definitive glaucoma. Springelkamp 2014 published the results
of the population-based Rotterdam study, which detected 41 glau-
coma cases with no known glaucoma risk factor and 1081 controls
after excluding 96 patients with risk factors. Mean RGCL thick-
ness in the inferior half of the macular region showed the highest
sensitivity (53.7%; 95% CI 38.7 to 68.0%) at 97.5% specificity.
The mean thickness of the peripapillary RNFL had a sensitivity
of 24.4% (95% CI 13.7 to 39.5%).
Our review focused on RNFL and ONH parameters, but there
has been an increasing interest in GCC/GCIPL parameters using
OCT,in recent years. We did not formally compare such param-
eters to RNFL and ONH parameters, but overall found similar
ranges of sensitivity when they were reported. Lee 2014 observed
that GCC may be less sensitive than RNFL parameters to optic
disc torsion.
Finally, newer OCT with better tissue penetration, such as the
swept-source OCT, are being used to select new imaging param-
eters by detecting the posterior border of the sclera and lamina
cribrosa, which we have not included in our review.
Applicability of findings to the review question
When we planned this review, we were aware of potential vari-
ability in care pathways across settings and healthcare systems.
We intended to support decisions about patients referred by
optometrists and primary eye care professionals (Cheng 2014;
Ratnarajan 2013). Studies considered in this review should have
included consecutive participants at risk of glaucoma identified by
primary eye care professionals, using these devices in an add-on
setting, which could be optometrists in primary care, or a triage
setting when somebody has already been referred from primary
care to secondary care as suspect glaucoma and needs triage by
a non glaucoma specialist. However, we ended in including al-
most only case-control studies including healthy participants and
glaucoma patients identified a priori, which not only overestimate
accuracy, but also makes it difficult to translate study results to a
specific setting.
How ONH and RNFL imaging could affect glaucoma referrals
and diagnosis in different real-world clinical settings is still un-
clear. Even among general ophthalmologists, the value of ONH
and RNFL imaging may be enhanced by the large variability in
diagnostic accuracy among clinicians. In fact, a large study includ-
ing 243 ophthalmologists in 11 European countries (Reus 2010)
found onlymoderate intra-observer agreement between clinicians,
which makes the use of imaging tests attractive, since they provide
an objective and reproducible anatomic measure.
Another applicability issue of the included studies relates to their
estimate of sensitivity at fixed specificity (e.g. 95%). Although
this makes the comparison of several measures easier, the lack of
a definite measurement cut-off makes inference more difficult for
users. Morevoer, overall accuracy at high sensitivity, rather than
high specificity, was not available in studies. However, since the
standard of care is referral of all patients with glaucoma risk factors
in primary eye care, achieving a high sensitivity to avoid missing
patients with glaucoma may be a better strategy, provided that
the burden of referrals is reduced. As an example, OCT has been
used to limit referrals in a UK screening programme of people
with diabetes who were screen-positive for diabetic maculopathy
on fundus photographs, ruling out diabetic macular oedema when
OCTmacular retinal thickness is normal (Olson 2013). Although
assessing accuracy is a useful step of diagnostic test investigation,
mapping patient flow during the whole clinical pathway is neces-
sary to implement screening programmes in public health.
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A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Despite the large number of studies exploring the use of imag-
ing tests for detecting manifest glaucoma, their accuracy has been
studied only partially. The accuracy of these tests varied across
studies and was suboptimal in many, despite the fact that it may
have been overestimated due to the case-control design. As a con-
sequence of these limitations, the studies included in this review
should be considered exploratory, and our results would only in-
directly inform clinical decisions on referrals in primary eye care
settings.
The findings of this review indicate that the best parameters for
diagnosing glaucoma in a triage setting are NFI for GDx, average
or inferior sector RNFL thickness for OCT, and the vertical C/D
ratio or some others for HRT. Although the studies had various
methodological shortcomings, we consider these findings useful
and reliable because they are mostly based on direct comparisons.
On the other hand, comparisons among tests were hampered by
the presence of heterogeneity and the lack of direct comparisons.
Overall, the accuracy of the best parameters of GDx, HRT and
OCT was remarkably similar.
The implications of using our estimates for clinical decision mak-
ing is highly dependent on the care pathway and the diagnostic
alternatives available, which goes beyond the scope of this review.
Implications for research
Further case-control studies are not useful in this research field.
Given the limitations we found, we suggest the following improve-
ments for studies assessing the accuracy of imaging devices for the
diagnosis of manifest glaucoma, which should:
• include consecutive patients based on a single set of
inclusion/exclusion criteria;
• be conducted in a specific clinical setting;
• clearly specify the clinical decision problem (in order to
render the care pathway explicit);
• report relevant information both on patients’ prior clinical
assessments and on reasons for referral;
• present sensitivity/specificity estimates and counts in 2 x 2
tables at relevant cut-off values of each test parameter which is
obtained as a continuous measure;
• discuss the potential consequences for false positives (over-
referrals) and false negatives (under-referrals), adopting the new
test as compared to existing practice.
Combination of imaging test results with clinical information,
such as IOP, age, family history, etc., should also be considered
in future research. We need reviews of studies on the ability of
longitudinal ONH changes, detected by means of imaging tests
(Mansoori 2011), to detect perimetric glaucoma progression.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Akashi 2013
Study characteristics
Patient sampling Observational cross-sectional study in which Japanese glaucomatous and normal people were en-
rolled. If eligible, both eyes of the same patients were included in the study
Patient characteristics and set-
ting
Sample size: 232 participant enrolled, 145 glaucoma (75 of whom considered as early glaucoma)
and 87 controls
Age: all glaucoma patients mean ± SD, 47.6 ± 9.4 years; early glaucoma patients mean ± SD, 48.3
± 10.6 years; controls 43.5 ± 12.8 years
Sex: 102 men (68 glaucoma, 34 controls) and 130 women (77 glaucoma, 53 controls)
Ethnicity: Japanese.
Country: Japan.
Setting: Kobe University Hospital.
Ocular comorbidities: Patient with BCVA worse than 20/40, spherical refraction < -6 D, a cylin-
der correction > ±3 D were not included. Patients with any previous ocular surgery, VF loss due
to vitreoretinal diseases, and optic nerve or RNFL abnormality unrelated to glaucomatous optic
neuropathy, were excluded
Spectrum of glaucoma severity: the mean ± SD MD on the VF test were -7.12 ± 6.62 dB for
glaucoma. According to Anderson and Patella’s classification, patient with MD > -6 were considered
as early glaucoma
Control participants: IOP ≤ 21 mmHg and reliable VF test result with no abnormal finding
suggestive of glaucoma
Index tests Optical coherence tomography: Cirrus HD-OCT (software version 6.1.0.96; Carl Zeiss Meditec)
. The optic disc cube protocol 200 x 200 and macular cube 200 x 200 protocols were used. Images
with signal strength < 6 were excluded
Optical coherence tomography: RTVue-100 (software version 4.0.5.39; Optovue, Inc., Fremont,
CA, USA). TheONHmap and GCC protocols were used. Only images with a signal strength index
> 30 were accepted
Optical coherence tomography: 3D OCT-2000 (software version 8.00; Topcon, Inc., Tokyo,
Japan). The 3D 7 x 7 mm scan disc and 3D macular protocols were used. Images with a quality
factor < 60 were excluded
No authors had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: eyes with glaucomatous optic nerve appearance (defined as neuroretinal rim
damage, an increased cup-to-disc ratio, rim thinning, and notches with or without RNFL defects)
and glaucomatous VF defects (defined as 2+ contiguous points with a PSD sensitivity loss of P <
0.01, 3+ contiguous points with sensitivity loss of P < 0.05 not crossing the horizontal meridian
line, or a 10-dB difference across the nasal horizontal midline at 2+ adjacent locations, and GHT
outside normal limit)
Visual field testing: Humphrey Field Analyzer, 30-2 SITA standard programme (Carl Zeiss
Meditec)
Optic disc evaluation: no details were reported.
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Akashi 2013 (Continued)
Flow and timing Index tests and reference standard were performed within 6 months
No patients were reported by the authors as excluded from the analysis
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
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Akashi 2013 (Continued)
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Aptel 2010
Study characteristics
Patient sampling Prospective investigation conducted in a French university-affiliated glaucoma centre. 166 patients
were initially screened. One eye from each of 120 patients were finally included in the analysis: 40
with glaucoma, 40 with suspected glaucoma, and 40 healthy participants
Patient characteristics and set-
ting
Sample size: 166 patients initially screened, 120 eyes of 120 patients included in the analysis (40
glaucoma, 40 suspected glaucoma, 40 controls)
Age: glaucoma patients mean ± SD, 63.4 ± 11.2 years; suspected glaucoma 61.7 ± 12.7 years;
controls 60.9 ± 13.1
Sex: 46 men (14 glaucoma, 15 suspected glaucoma, 17 controls) and 74 women (26 glaucoma, 25
suspected glaucoma, 23 controls)
Ocular comorbidities: no retinal disease, BCVA < 20/40, SE < -6 or > +3 D, non-glaucomatous
optic neuropathy or intraocular surgery except for uncomplicated cataract surgery
Setting: French university-affiliated glaucoma centre.
Country: France.
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -9.88 ± 6.93 dB
and 4.42 ± 4.85 dB for glaucoma, -1.73 ± 2.16 dB and 2.06 ± 0.54 dB for suspected glaucoma
Control participants: IOP < 22 mmHg, normal optic disc appearance and no repeatable abnormal
SAP results
Index tests Scanning laser polarimetry: GDx VCC, software version 5.5.0 (Carl Zeiss Meditec, Inc.). Only
well-focused, well-centred images with a quality scan score >8 were used
Optical coherence tomography: Cirrus OCT, software version 3.0 (Carl Zeiss Meditec, Inc,
Dublin, California, USA). Imaging was performed using the 200 x 200 protocol optic disc cube.
Only well-focused, well-centred images, without eye movement and with a signal strength of 7/10
or more, were used
The authors indicate no financial conflict of interest.
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Aptel 2010 (Continued)
Target condition and reference
standard(s)
Manifest glaucoma: abnormal SAP result (GHT and PSD outside 95% of normal limits), and
optic nerve damage (asymmetric cup-to-disc ratio > 0.2, rim thinning, notching, excavation, or
RNFL defect)
Suspected glaucoma: glaucomatous optic nerve damage (asymmetric cup-to-disc ratio > 0.2, rim
thinning, notching, excavation, or retinal nerve fibre layer defect) without repeatable abnormal SAP
results
Visual field testing: Humphrey Field Analyzer, 24-2 SITA-standard strategy (Zeiss-Humphrey
Systems, Dublin, CA, USA)
Optic disc evaluation: dilated fundus was examined by indirect ophthalmoscopy.
Flow and timing Time interval between reference standard and index tests was not reported. 14 patients were excluded
from the analysis for poor OCT quality criteria, 23 for poor GDx VCC quality criteria, and 28 for
poor VF quality or reliability criteria
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
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Aptel 2010 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
Arintawati 2013
Study characteristics
Patient sampling Retrospective study in which new glaucoma and glaucoma-suspect patients, referred to the Depart-
ment of Ophthalmology, between March 2008 and April 2011, were recruited. 164 patients were
studied. 261 eyes were included in the analysis
Patient characteristics and set-
ting
Sample size: 261 eyes included in the analysis (80 advanced glaucoma, 81 early glaucoma, 32
preperimetric glaucoma and 68 controls)
Age: glaucoma mean ± SD, 61.49 ± 14.21 years (advanced glaucoma 64.56 ± 10.89; early glaucoma
60.16 ± 16.77; preperimetric glaucoma 58.94 ± 12.15 years); controls 59.65 ± 16.88 years
Sex: 113 men and 150 women
Ethnicity: not specified.
Setting: Department of Ophthalmology, Hiroshima University Hospital.
Country: Japan.
Ocular comorbidities:patient with refractive errors (spherical equivalent) > +3.00 D or < 7.00 D,
and those with retinal disease that could cause VF defects or optic disc abnormalities were excluded
Spectrum of glaucoma severity: The mean ± SD mean deviation and PSD on the VF test were -
6.05 ± 6.22 and 6.57 ± 4.88 for glaucoma group overall (-0.11 ± 1.55 and 1.58 ± 0.31 respectively
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Arintawati 2013 (Continued)
for the preperimetric eyes, -2.68 ± 1.79 and 4.03 ± 2.57 respectively for the early glaucoma, -11.99
± 5.29 and 11.26 ± 3.47 respectively for advanced glaucoma)
Control participants: IOP < 22 mmHg, normal optic disc appearance, and normal ophthalmo-
logical findings
Index tests RTVue Fourier-domain OCT system (OptovueInc., Fremont, CA, USA); software version 4.0.5.
100). Imagingwas performed usingGCC andRNFL3.45mode analysis. Images withmisalignment
of the surface detection algorithm, or decentration of the measurement circle and the signal strength
index < 40, were excluded
The authors indicate no financial conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: VF defects (defined as the pattern deviation plot with more than 3 contiguous
points with P < 0.05 and at least 1 with P < 0.01 level on the same side of the horizontal meridian
and GHt outside the normal limit) and glaucomatous optic disc appearance (neuroretinal rim loss,
notching, focal thinning of the nerve fibre layer, disc haemorrhages, or vertical elongation of the
optic cup)
Preperimetric Glaucoma: glaucomatous optic disc appearance but normal VF results
Visual field test: Humphrey Field Analyzer (Carl Zeiss Meditec, Dublin, CA, USA); 24-2 SITA-
standard strategy
Optic nerve evaluation: Dilated fundus biomicroscopy.
Flow and timing 164 patients were originally studied. Patients with SD-OCTnot goodwere excluded from this study.
261 eyes were included in the analysis, but details about number of exclusions were not reported
Time interval between reference standard and index tests was not reported
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
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Arintawati 2013 (Continued)
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Did all patients receive a refer-
ence standard
Yes
Badala 2007
Study characteristics
Patient sampling Cases were extracted from the clinical database of the Glaucoma Division at Jules Stein Eye Institute
(University of California, LA) choosing from patients who underwent VF testing and optic disk
imaging with OCT, CSLO, SLP and stereoscopic optic disk photographs at the same visit between
April 1 2003 and April 1 2006. Normal patients were recruited among staff, patients’ spouses, and
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volunteers
Patient characteristics and set-
ting
Sample size: 92 eyes of 92 patients (46 glaucoma, 46 healthy controls).
Age: glaucoma patients mean ± SD, 61.8 ± 9.7 years; controls 58.9 ± 6.8
Sex: 37 men (20 glaucoma, 17 controls) and 55 women (26 glaucoma, 29 controls)
Ethnicity: glaucoma: 31 white, 5 black, 4 Hispanic and 6 Asian. Controls: 25 white, 1 black, 9
Hispanic and 11 Asian
Country: USA.
Ocular comorbidities: no ocular disease other than glaucoma, BCVA < 20/40, SE > ±5 D, and no
history of ocular surgery/trauma
Setting: Glaucoma Division, Jules Stein Eye Institute, University of California, Los Angeles
Spectrum of glaucoma severity:mean ± SDMD and PSD on the VF test were−4.0 ± 2.5 dB and
5.5 ± 2.5 dB. No patients had MD < -8 dB
Control participants: normal optic disc, IOP≤ 21mmHg and a normal SAP (GHTwithin normal
limits and a PSD with a P > 0.05 on 2 consecutive examinations).
Index tests Scanning laser polarimetry: GDx-VCC, software version 5.2.3 (Laser Diagnostic Technologies,
San Diego, CA, USA). The image quality scores were averaged and reported
The authors indicate no financial conflict of interest.
Target condition and reference
standard(s)
Manifest Glaucoma: early defect on SAP (defined as GHT results outside normal limits, a PSD
with P < 0.05 and a MD of more than -8 dB) and open angle by gonioscopy
Visual field testing: Humphrey Field Analyzer, model 750, 24-2 SITA-Standard strategy (Allergan
Humphrey, San Leandro, CA., USA). Only patients with reliable fields (fixation loss rate < 33%;
false-positive and false-negative rates < 20%) were included
Optic disc appearance was not part of the reference standard
Flow and timing Reference standard and imaging tests were performed during the same day
All patients enrolled were included in the analysis.
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
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Badala 2007 (Continued)
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
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Barella 2013
Study characteristics
Patient sampling Observational, case-control study, enrolling 103 eyes of 103 participants (46 control patients and
57 glaucoma). One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 103 eyes of 103 patients (57 glaucoma and 46 controls).
Age: glaucoma mean ± SD, 59.9 ± 9.0 years; controls, 56.5 ± 8.9 years
Sex: 51 men (28 glaucoma, 23 controls) and 52 women (29 glaucoma, 23 controls)
Ethnicity: 78 white (43 glaucoma and 35 controls); 25 African-American (14 glaucoma and 11
controls)
Clinical setting: Glaucoma Service of the University of Campinas (UNICAMP).
Country: Brazil.
Ocular comorbidities: patient with retinal diseases, uveitis, pseudophakia or aphakia, non-glauco-
matous optic neuropathy, and significant cataract were excluded
Spectrum of glaucoma severity: the mean ± SDmean deviation and PSD on the VF test were -4.0
± 2.4 and 4.3 ± 2.4 respectively, for glaucomatous eyes. 86% had early VF damage, 14%, moderate
VF damage
Control participants: IOP ≤ 21 mmHg with no history of elevated IOP or glaucoma cases in the
family and 2 consecutive and reliable normal VFs
Index tests Optical coherence tomography: Cirrus SD-OCT (version 5.1.1.6, Carl Zeiss Meditec Inc.,
Dublin, CA, USA). ONHmodes scan was used to measure RNFL thickness and ONH topography
measurement. Poor-quality images with incorrect identification of the vitreoretinal surface, hori-
zontal eye motion within the measurement circle, and misidentification of Bruch’s membrane, or a
signal strength < 6 were excluded. All images were acquired with undilated pupils by a single, well-
trained ophthalmologist, masked for the diagnosis
No conflicts of interest were reported
Target condition and reference
standard(s)
Manifest glaucoma: IOP measurements > 21 mmHg and a glaucomatous VF defect confirmed in
2 recent and reliable examinations. VF defects were defined as 2 of the following criteria: cluster of
3 points with P < 5% on a pattern deviation map in a single hemifield, including at least 1 point
with P < 1% or GHT outside normal limits, or PSD outside normal limits
Visual field test:Humphrey Field Analyzer II (Carl Zeiss Meditec, Dublin, CA, USA); 24-2 SITA-
standard strategy
Optic nerve appearance: dilated slit lamp fundus examination.
Flow and timing No details reported.
Time interval between reference standard and index tests was not reported
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Barella 2013 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
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Did all patients receive a refer-
ence standard
Yes
Begum 2014a
Study characteristics
Patient sampling Cross-sectional, case-control study of the baseline examinations of participants included in a prospec-
tive longitudinal study (LOGES), enrolling glaucoma, glaucoma suspects and normal controls
Patient characteristics and set-
ting
Sample size: 304 eyes of 174 patients enrolled. 136 eyes of 112 patients included in the analysis
(62 eyes of 46 perimetric glaucoma; 21 eyes of 18 preperimetric glaucoma and 53 eyes of 38 control
patients
Age: perimetric glaucoma median (IQR), 53 (45, 58) years; preperimetric glaucoma median (IQR)
, 47 (36, 60) years; controls, 42 (33, 53) years
Sex: 67 men (34 perimetric glaucoma, 12 preperimetric glaucoma, 21 controls) and 35 women (12
perimetric glaucoma, 6 preperimetric glaucoma, 17 controls)
Ethnicity: Indian
Clinical setting:L V Prasad Eye Institute, Hyderabad,
Country: India
Ocular comorbidities: patient with any media opacities that prevented good quality optic disc
photographs and other imaging tests, and any retinal (including macular) or neurologic disease
other than glaucoma, were excluded
Spectrum of glaucoma severity: the median (IQR) mean deviation and PSD on the VF test were
-1.9 (-2.9, -0.8) and 1.7 (1.3, 1.9) respectively, for preperimetric glaucomatous; -11.4 (-17.5, -4.9)
and 7.6 (4.9, 10.0) respectively, for perimetric glaucoma
Control participants: non-glaucomatous optic discs appearance and normal VF result
Index tests Optical coherence tomography: Cirrus HD-OCT (software version 6.0). Macular cube 200 x
200 and optic disc cube 200 x 200, were the scanning protocol used. Only good-quality scans with
signal strength > 6, absence of motion and blinking artefacts, and segmentation failure were used
for the analysis.
No conflict of interest with manufacturer were reported.
Target condition and reference
standard(s)
Manifest perimetric glaucoma: glaucomatous optic discs (defined as the presence of focal or diffuse
neuroretinal rim thinning, localised notching, or nerve fibre layer defects and glaucomatous) and
glaucomatous VF result (defined as the PSD < 5% and GHT outside normal limits)
Visual field test: Humphrey Field Analyzer, model 750i (Zeiss Humphrey Systems, Dublin, CA,
USA), with the SITA-standard programme. The VFs were considered reliable if the fixation losses,
false-positive and false-negative response rates were < 20%. A single observer masked to the optic
disc classification, SD-OCT findings and the other eye status, graded all VFs
Optic disc evaluation: stereoscopic optic disc photographs using digital fundus camera (FF 450
plus with VISUPAC 4.2.2; Carl Zeiss Meditec Systems GmbH, Pirmasens, Germany). Optic disc
photograph was evaluated independently by 2 experts masked to the clinical details of the patients
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Flow and timing 21 eyes were excluded due to poor disc photographs. 28 eyes due to unreliable VFs were excluded
and 57 eyes were excluded due to poor quality HD-OCT scans. 106 out of 242 eyes (> 10%)
originally considered, were not included in the analysis
VF data of the same imaging day were reported but time interval between all the reference standard
and imaging session are unclearly reported
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
Yes
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of the results of the index tests?
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
Begum 2014b
Study characteristics
Patient sampling Retrospective, cross-sectional study. 295 eyes were randomly selected (after the exclusion of eyes
with poor index or reference-test quality results) from 678 eyes of 382 patients referred for glaucoma
evaluation to a tertiary care clinic
Patient characteristics and set-
ting
Sample size: 295 eyes (68 with perimetric glaucoma, 62 with preperimetric glaucoma and 165
normal control eyes)
Age: perimetric glaucoma median (IQR), 56 (48, 61) years; preperimetric glaucoma median (IQR)
, 54 (41, 62) years; controls, 54 (41, 63) years
Sex: not reported.
Ethnicity: not reported.
Setting: L V Prasad Eye Institute, Banjara Hills, Hyderabad, Andhra Pradesh
Country: India.
Ocular comorbidities: patient with any media opacities that prevented good-quality optic disc
photographs and other imaging tests, and any retinal (including macular) or neurologic disease
other than glaucoma, were excluded
Spectrum of glaucoma severity: the median (IQR) mean deviation and PSD on the VF test were
-9.1 (-14.8, -4.8) and 8.2 (3.7, 10.5) respectively, for perimetric glaucoma, -2.3 (-3.9, -0.9) and 1.
8 (1.5, 2.2) respectively, for preperimetric glaucoma
Control participants: non-glaucomatous optic discs appearance and normal VF result
Index tests Optical coherence tomography: RTVue (Optovue Inc, Fremont, CA, USA), software version 5.
1.0.90. GCC scanning protocol was used for imaging the macula. Only well-centred images with
a signal strength index of ≥ 30 were used for analysis
The authors declared no conflict of interest.
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Target condition and reference
standard(s)
Manifest perimetric glaucoma: glaucomatous optic disc (defined as the presence of focal or diffuse
neuroretinal rim thinning, localised notching, or nerve fibre layer defects and glaucomatous) and
glaucomatous VF result (defined as the PSD < 5% and GHT outside normal limits)
Visual field test: Humphrey Field Analyzer, model 750i (Zeiss Humphrey Systems, Dublin, CA,
USA), with the SITA-standard programme. The VFs were considered reliable if the fixation losses,
false-positive and false-negative response rates were < 20%. A single observer masked to the optic
disc classification, SD-OCT findings and the other eye status, graded all VFs
Optic disc evaluation: stereoscopic optic disc photographs using digital fundus camera (FF 450
plus with VISUPAC 4.2.2; Carl Zeiss Meditec Systems GmbH, Pirmasens, Germany). Optic disc
photograph was evaluated independently by 2 experts masked to the clinical details of the patients
Flow and timing 42 eyes with unreliable VFs, 7 eyes with poor quality disc photographs and 18 eyes with poor OCT
images quality, were excluded from the analysis. So, fewer than 10% of the patients enrolled were
excluded
Index test and reference standard were performed on the same day
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Unclear
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
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DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Benitez-del-Castillo 2011
Study characteristics
Patient sampling Healthy volunteers and patients with glaucoma who met the eligibility criteria were consecutively
enrolled in this prospective, observational case-control study. Normal participants consisted of
volunteers such as office employees and friends or family members of patients with glaucoma
Only one eye per person, selected randomly, was enrolled.
Patient characteristics and set-
ting
Sample size: 117 patients enrolled, 88 eyes of 88 patients included in the analysis (33 glaucoma,
55 controls)
Age: glaucoma patients mean ± SD, 63.8 ± 13.3 years; controls 59.1 ± 7.5
Sex: 45 men (23 glaucoma, 22 controls) and 43 women (10 glaucoma, 33 controls)
Country: Spain.
Ocular comorbidities: No ocular disease other than glaucoma or cataract, BCVA < 20/40, SE < -
7 or > +3 D, neurologic disorders, retinal disease, or intraocular surgery except for uncomplicated
cataract extraction
Setting: Glaucoma Unit, Hospital General del S.A.S. de Jerez.
Spectrum of glaucoma severity: mean (95% CI) MD and PSD on the VF test were -6.69 (-8.07
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to -5.31) dB and 6.22 (4.8 to 7.65) dB respectively. According to Hodapp et al. grading scale, 18
eyes had early disease and 15 eyes moderate
Control participants: IOP ≤ 21 mmHg, normal optic disc appearance and 2 normal SAP results
(define as GHT within normal limits, MD and PSD with P > 5%)
Index tests Scanning laser polarimetry: GDx-VCC and GDx-ECC, software version 5.5.0 (Carl Zeiss
Meditec, Inc.). 3 consecutive scans were obtained with VCC and ECC on the same day by the same
examiner, through undilated pupils. An average of the 3 measurements was used for the analysis.
Images that were obtained during eyemovement were excluded, as well as unfocused, poorly centred
images or images with a quality scan score of < 8
Optical coherence tomography: Cirrus OCT, software version 3.0 (Carl Zeiss Meditec, Inc.). Test
was performed through undilated pupils using a fast RNFL thickness acquisition protocol on the
same day by the same examiner. The average of 2 measurements was used for the analysis. Images
that were obtained during eye movement or were unfocused, were poorly centred, or had signal
strength of < 7 were excluded
The authors stated no conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous optic nerve damage (defined as cup-to-disc asymmetry between
fellow eyes of greater than 0.2, rim thinning, notching, excavation, and/or RNFL defect) and
corresponding abnormal SAP result (GHT and PSD outside 95% of normal limits)
Visual field testing: Humphrey Field Analyzer, 24-2 SITA-standard strategy (Carl-Zeiss Meditec,
Inc.). VF with rate of fixation losses, false positives, and false negatives > 33% were considered
unreliable
Optic disc evaluation: dilated fundus stereoscopic examination and photography.
Flow and timing Index tests were performed on the same day, but no detail reported about reference standard’s
execution time. A total of 117 eyes were enrolled. 9 participants were not included in the control
group: 4 for quality SLP-VCC scan < 8, 3 OCT signal strength < 7, and 2 for unreliable VF. 20
glaucoma patients were not included: 9 for quality SLP-VCC scan < 8, 6 OCT signal strength < 7
and 5 for unreliable VF
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
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High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
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Study characteristics
Patient sampling Case-control study in which patients attending the glaucoma clinic and healthy volunteers were
enrolled between September 2009 and October 2010. One eye per person (randomly selected if
both eligible) was considered
Patient characteristics and set-
ting
Sample size: 205 eyes of 205participants (70 glaucoma, 65 ocular hypertension, 70 normal controls)
Age: perimetric glaucoma mean ± SD, 65.87 ± 11.90 years; controls, 56.80 ± 11.16 years
Sex: 69 men (38 glaucoma, 31 controls) and 71 women (32 glaucoma, 39 controls)
Ethnicity: not reported.
Setting: Glaucoma Service of Policlinico di Monza Hospital (University of Milan-Bicocca)
Country: Italy.
Ocular comorbidities: eyes with significant lens opacity, systemic diseases with ophthalmic involve-
ment, co-existing retinal disease, uveitis, or non-glaucomatous optic neuropathy were excluded
Spectrum of glaucoma severity: the mean ± SD mean deviation and PSD on the VF test were -6.
49 ± 6.46 and 6.39 ± 3.97 respectively, for glaucoma
Control participants: IOP of < 21 mmHg, no history of high IOP, and 2 reliable normal VFs (PSD
and GHT within normal limits)
Index tests Optical coherence tomography: RTVue (Optovue Inc.), software version 4.0.5.39. ONH and
GCC scanning protocol were used for the analysis. Only good-quality images, defined as a signal
strength index of Z50 without motion artefacts, were used for the analysis
The authors declare no conflict of interest.
Target condition and reference
standard(s)
Manifest perimetric glaucoma: glaucomatous VF damage defined as PSD outside the 95% normal
confidence limits or aGHT result outside the 99%normal confidence limits, in at least 2 consecutive
and reliable VF examinations
Visual field test: automated perimetry model 750i (Carl Zeiss Meditec Inc.), with 24-2 SITA-
algorithm. Tests were considered reliable only with fixation loss of < 30%, and false-positive and
false-negative response rates of < 20%
Flow and timing No details were reported about patients exclusion or time interval between index and reference test
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
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Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Did all patients receive a refer-
ence standard
Yes
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Borque 2008
Study characteristics
Patient sampling Patients were chosen prospectively and consecutively from the outpatient clinics from January 2006
to December 2006. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 440 patients were assessed, 417 eyes of 417 patients were included in the analysis (71
perimetric glaucoma, 68 preperimetric glaucoma, 218 OHT, 60 healthy controls)
Age: perimetric glaucoma patients mean ± SD, 64.83 ± 9.23 years; preperimetric glaucoma patients
59.57 ± 10.18 years; OHT patients 53.21 ± 12.01 years; controls 59.85 ± 10.78 years
Ethnicity: all participants were white.
Setting: “Miguel Servet” University Hospital in Zaragoza
Country: Spain.
Ocular comorbidities: no history of eye surgery or serious trauma, systemic diseases with oph-
thalmic repercussions; BCVA ≥ 20/30, spherical refraction > ±5 D, cylinder refraction > ±3 D,
transparent optic media
Spectrumof glaucoma severity:mean ± SDMDon theVF test were -6.10 ± 5.43 dB, for perimetric
glaucoma eyes, -0.43 ± 1.30 dB, for preperimetric glaucoma; -0.26 ± 1.06 dB for OHT
Control participants: normal eye exam, IOP < 21 mmHg, normal morphology of the optic nerve
and normal VF result
Index tests Scanning laser polarimetry: GDx-VCC, (version 5.4.1.35, Laser Diagnostic Technologies, Inc.,
San Diego, CA, USA). Images were taken under midriasis by experienced technicians. Tests were
accepted only if of high quality (> 7), centred on the optic nerve, with images perfectly and uniformly
focused and lighted with no movement artefacts
No details about author’s conflict of interest were reported
Target condition and reference
standard(s)
Manifest perimetric glaucoma: glaucomatous optic nerve appearance (defined as neuroretinal
rim thinning, focal or diffuse with an increase of the cup, the presence of notches, or both) and
glaucomatous VF defects (defined as the presence of a group of at least 3 altered points with a P <
5% or a group(not near the blind spot) with at least 2 altered points with a P < 1% and/or SD from
the mean with a P < 5% and/or GHT outside normal limits
Preperimetric glaucoma: IOP≥ 21 mmHg, papillary morphology compatible with glaucoma and
normal VF result
Ocular hypertensive: IOP ≥ 21 mmHg, normal papillary morphology and normal VF result
Visual field testing: Humphrey Field Analyzer, model 750, 24-2 SITA standard programme (Zeiss-
Humphrey, Dublin, CA, USA). VF reliability criteria (false positives, false negatives and loss of
focus) were considered to accept each test but the cut-off values considered were not specified
Optic disc evaluation: papillary stereophotographs by 2 glaucoma specialists unaware of the pa-
tient’s medical history
Flow and timing 11 patients were excluded due to poor-quality images, 5 did not sign the informed consent form and
7 did not attend all the appointments to complete the examination protocol.Therefore 23 patients
(< 10%) were not included in the final analysis
The time interval between reference standard and index test was not reported
Comparative
Notes None.
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Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Bowd 2005
Study characteristics
Patient sampling Participants were enrolled in the University of California, San Diego, Diagnostic Innovations in
Glaucoma Study (DIGS). One randomly-selected eye from each patient was included in this ob-
servational cross-sectional study
Patient characteristics and set-
ting
Sample size: 164 eyes of 164 patients (92 glaucoma and 72 healthy controls)
Age: glaucoma patients mean ± SD, 66.9 ± 8.9 years; controls 64.3 ± 8.8 years
Country: USA.
Ocular comorbidities: no co-existing retinal disease, BCVA < 20/40, spherical refraction > ±5 D,
cylinder refraction > ± 3D, uveitis, or non-glaucomatous optic neuropathy
Setting: University of California, San Diego.
Spectrum of glaucoma severity:mean ± SDMD on the VF test was -5.32 ± 4.0 dB (range, -20.14
dB to -0.26 dB). According to Hodapp et al. grading scale, 54 patient had early, 24 had moderate
and 14 had severe glaucoma
Control participants: healthy-appearing ONH on clinical examination, SAP results (MD, PSD,
GHT) within normal limits, and no history of IOP > 22 mmHg
Index tests Scanning laser polarimetry: GDxVCC, software version 5.01 (Laser Diagnostic Technologies, San
Diego, CA., USA). 2 machine learning classifiers were tested: the support vector machine and the
relevance vector machine. Only well-focused, evenly illuminated, and centred scans with residual
anterior segment retardation < 15.0 nm and atypical scan scores < 25, determined by GDx VCC
software, were included
One author had financial disclosure.
Target condition and reference
standard(s)
Manifest glaucoma: repeatable (2 consecutive) SAP results outside normal limits by PSD (P < 5%)
or GHT
Visual field testing: Humphrey Field Analyzer, model II, 24-2 SITA-standard strategy (Carl Zeiss
Meditec, Dublin, CA, USA)
Optic disc appearance was not part of the reference standard
Flow and timing The first abnormal SAP was on or before the imaging date but no other information about time
delay between tests was reported
No patients were excluded from the analysis.
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Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
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Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Bozkurt 2010
Study characteristics
Patient sampling Healthy and glaucomapatientswere enrolled prospectively.Normal eyeswere consecutively recruited
from patients referred for refraction who underwent routine examination or from hospital staff. No
further details about glaucoma patients enrolment. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 342 participants were enrolled (158 glaucoma and 184 healthy controls)
Age: glaucoma patients mean ± SD, 63.0 ± 10.7 years, controls 59.6 ± 9.7 years
Sex: 121 men (60 glaucoma, 61 controls) and 221 women (98 glaucoma, 123 controls)
Ethnicity: Turkish.
Country: Turkey.
Ocular comorbidities: BCVA≥ 20/40, refractive error of < 5 spherical dioptres and 2D of cylinder
and transparent ocular media. No parapapillary atrophy, tilted discs or indistinct disc borders
Setting: Hacettepe University School of Medicine.
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -6.97 ± 4.98 dB
and 4.28 ± 3.33 dB, respectively
Control participants: IOP < 20mmHg, ONH appearance no suspicious for glaucoma and normal
SAP
Index tests Confocal scanning laser ophthalmoscopy:Heidelberg Retina Tomograph (HRT; Heidelberg En-
gineering GmbH, Heidelberg, Germany). ONH topography (through undilated pupils) and con-
tour line drawing were performed by the same experienced operator using HRT II, with HRT III
software version 3.0. Good image quality was defined as follows: acquisition sensitivity < 90%;
topography SD < 35 mm; > 75% of the disc within the target circle; minimal movement during
the acquisition movie; no floaters over the disc
No details about authors’ conflict of interest were reported
Target condition and reference
standard(s)
Manifest perimetric glaucoma: ONH or RNFL structural abnormalities (diffuse thinning, focal
narrowing or notching of the optic disc rim; documented progression of cupping of the optic
disc; diffuse or localised abnormalities of the peripapillary RNFL; disc rim or peripapillary RNFL
haemorrhages; neural rim asymmetry between the 2 eyes consistent with loss of neural tissue) and/
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or VF result abnormalities (defined as a cluster of 3 points with P < 5%, a cluster of 2 points with P
< 1% on pattern deviation probability plots, or a PSD with P < 5% or GHT outside normal limits
Visual field testing: Humphrey Field Analyzer II, 30-2 SITA standard programme (Carl Zeiss-
Humphrey, Dublin, CA, USA). VF reliability criteria included fixation losses rates, false-positive
and false-negative rates < 25%
Optic disc evaluation: no details reported.
Flow and timing No patients were reported by the authors as excluded from the analysis
All tests and imaging were carried out within a 2-week period
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Brusini 2005
Study characteristics
Patient sampling Consecutive patients with early-to-moderate primary open-angle glaucoma and controls were con-
sidered. One eye per person was selected
Patient characteristics and set-
ting
Sample size: 80 eyes of 80 patients (40 glaucoma and 40 healthy controls)
Age: glaucoma patients mean ± SD, 65.8.9 ± 8.5 years; controls 57 ± 7.8 years
Country: not specified.
Ocular comorbidities: no ocular pathologies other than glaucoma, BCVA < 32/40, SE > ±5 D,
mild nuclear sclerosis, drusen, large peripapillary atrophy, previous intraocular surgery, diabetes
mellitus, or neurologic disorders
Setting: not specified.
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -3.1 ± 1.6 dB and
3.1 ± 0.9 dB. Patient with SAP test result having a MD > -9 dB and a PSD < 8 dB were included
Control participants: normal IOP and normal SAP results.
Index tests Scanning laser polarimetry: GDx-FCC (Nerve Fibre Analyzer, version 2.0.09, Laser Diagnostic
Technologies, Inc., San Diego, CA, USA) and GDx-VCC (software version 5.1.0, Laser Diagnostic
Technologies, Inc. SanDiego, CA, USA). According to the GDx-normative database, values labelled
as outside normal limits and the Number > 70 were considered abnormal. A new cut-off point was
determined for each GDx parameter. The inclusion criteria included a good SLP image quality. No
details about authors’ conflict of interest were reported
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Target condition and reference
standard(s)
Manifest glaucoma: IOP>21mmHgbefore treatment and reproducible SAP glaucomatous defects
(defined as at least 1 of the following: a cluster of > 3 points in the pattern deviation probability
plot, located in areas that are typical of glaucoma, having a probability level of < 5%, with at least
1 point having a probability level of < 1%; PSD probability level of < 5%; GHT outside normal
limits)
Visual field testing: Humphrey Field Analyzer, model II 750, 30-2 SITA-standard strategy (Carl
Zeiss Meditec Inc., Dublin, CA, USA). Reliable criteria for VF tests included false-positive and
false-negative responses of < 33% and fixation losses of < 20%
Optic disc appearance was not part of the reference standard
Flow and timing Reference standard and index test were performed within 3 months
All patients were included in the analysis.
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Unclear
Low
DOMAIN 3: Reference Standard
56Optic nerve head and fibre layer imaging for diagnosing glaucoma (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Brusini 2005 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Brusini 2006a
Study characteristics
Patient sampling Glaucoma patients were recruited from those under the care of the Glaucoma Service of theDepart-
ment of Ophthalmology. Normal participants were recruited from staff members and volunteers.
One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 157 eyes of 157 participants (95 glaucoma and 62 healthy controls)
Age: glaucoma patients mean ± SD, 71 ± 10 years; controls 66 ± 9.9
Country: Italy.
Ocular comorbidities: no ocular pathologies other than glaucoma, BCVA < 0.7, SE > ±5 D, pap-
illary anomalies, large peripapillary atrophy, previous intraocular surgery, diabetes, or neurological
disorders
Setting: Glaucoma Service, Department of Ophthalmology at the Santa Maria della Misericordia
Hospital, Udine
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -3.7 ±3 dB and 4.
5 ± 2.7 dB. According to the GSS, 45 eyes as stage 1 (Md > -5.0 dB) and 41 as stage 2 (MD range
-5.0 to -9.0)
Control participants: normal IOP, normal ONH/RNFL appearance (no diffuse or focal rim thin-
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ning, cupping, optic disc haemorrhage or RNFL defects), and normal SAP results (MD and PSD
within 95% CI, and a GHT within normal limits)
Index tests Scanning laser polarimetry: GDx-VCC, software version 5.1.0 (Laser Diagnostic Technologies,
Inc. San Diego, CA, USA).The mean of 3 measurements was used. All images with quality score
gradings < 8 were excluded
No details about authors’ conflict of interest were reported
Target condition and reference
standard(s)
Manifest glaucoma: IOP>21mmHgbefore treatment and reproducible SAP glaucomatous defects
(defined as at least 1 of the following: a cluster of > 3 points in the pattern deviation probability
plot, located in areas that are typical of glaucoma, having a probability level of < 5%, with at least
1 point having a probability level of < 1%; PSD probability level of < 5%; GHT outside normal
limits)
Visual field testing: Humphrey Field Analyzer, model II 750, 30-2 SITA-standard strategy (Carl
Zeiss Meditec Inc., Dublin, CA, USA). Reliable criteria for VF tests included false-positive and
false-negative responses of < 33% and fixation losses of < 20%
Optic disc appearance was not part of the reference standard
Flow and timing Reference standard and index test were conducted within a period of 3 months
All patients were included in the analysis.
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
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Were any conflict of interest
avoided
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Calvo 2014
Study characteristics
Patient sampling Case-control study, in which patients with glaucoma were recruited consecutively from an ongo-
ing longitudinal follow-up study at the Miguel Servet University Hospital, and normal eyes were
consecutively recruited from patients referred for refraction that underwent routine examination,
hospital staff, and relatives of patients. One eye per person was randomly selected
Patient characteristics and set-
ting
ample size: 338 eyes of 338 participants (156 glaucoma and 182 controls)
Age: glaucoma mean ± SD, 61.05 ± 9.4 years; controls, 59.55 ± 9.7 years
Sex: 125 men (68 glaucoma, 57 controls) and 213 women (88 glaucoma, 125 controls)
Ethnicity: white.
Clinical Setting: Miguel Servet University Hospital, Zaragoza.
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Country: Spain.
Ocular comorbidities: patient with previous intraocular surgery, diabetes or other systemic diseases,
history of ocular or neurologic disease, or current use of a medication that could affect VF sensitivity
were excluded
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were -6.64 ± 6.0
and 6.03 ± 3.8 respectively, for glaucomatous eyes
Control participants: no specific details reported.
Index tests Optical coherence tomography: Cirrus SD-OCT (Carl Zeiss Meditec Inc., Dublin, CA, USA),
software version 6.2. Optic disc cube 200 x 200 scan protocol was used for the analysis. All images
had to have a quality > 6
Confocal scanning laser ophthalmoscopy: HRT III (Heidelberg Engineering, Heidelberg, Ger-
many). The margin of the optic disc was manually traced by the same glaucoma specialist, masked
to the patients’ identity and clinical history. All scans had to have an interscan SD < 30 µm
No conflict of interest were reported
Target condition and reference
standard(s)
Manifest glaucoma: IOP measurements > 21 mmHg and a glaucomatous VF defect, defined as a
PSD with P < 0.5% and GHt outside normal limits. No details about ophthalmic characteristics of
controls
Visual field test: Humphrey Field Analyzer model 750i (Carl Zeiss Meditec, Dublin, CA, USA);
24-2 SITA-standard strategy
Flow and timing 12patients (< 10%)were excluded from the analysis: 4with no reliable standard automated perimetry
after 3 attempts and 8 which did not complete the visits included in the study protocol
All exams were performed within 6 weeks of the person’s date of enrolment into the study
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
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If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Chen 2007
Study characteristics
Patient sampling Healthy controls, early glaucoma patients and glaucoma suspects were prospectively enrolled. Con-
trol participants were volunteers from the staff or their family members at the China Medical Uni-
versity Hospital. No details to assess the number of eyes for each person
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Patient characteristics and set-
ting
Sample size: 210 eyes were enrolled, 189 actually included in the analysis (82 early glaucoma, 45
glaucoma suspects and 62 controls)
Age: early glaucoma patients mean ± SD, 48.55 ± 15.36 years, glaucoma suspects 44.2 ± 15.97,
controls 44.7 ± 12.55 years
Sex: 89 men (41 glaucoma, 19 suspects, 29 controls) and 100 women (41 glaucoma, 26 suspects,
33 controls)
Ethnicity: Taiwan Chinese population.
Country: Taiwan.
Ocular comorbidities: BCVA < 20/40, a spherical equivalent outside ±5.0 D, and a cylinder
correction > 3.0 D were excluded
Setting: China Medical University Hospital (Taiwan).
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -3.32 ± 2.2 dB
and 3.09 ± 2.2 dB, respectively for early glaucoma patients; -2.43 ± 2.16 dB and 2.45 ± 1.6 dB,
respectively for glaucoma suspects
Control participants: IOP < 21 mmHg, open angle on gonioscopy, normal optic disc appearance
and normal VF result (GHT and CPSD within normal limits)
Index tests Scanning Laser polarimetry:GDx-VCC, software 5.5.0 (Carl Zeiss Meditec inc.) The exams were
performed by the same experienced technician, through undilated pupils. All images had to be well
focused, with centred optic disc, without any motion artefact and a minimum score of 8
No details about authors’ conflict of interest were reported
Target condition and reference
standard(s)
Manifest perimetric glaucoma: glaucomatous optic nerve appearance (defined as notching or
thinning of the neuroretinal rim) and glaucomatous corresponding VF defects (defined by 2 or
more contiguous points with a pattern deviation sensitivity loss of P < 0.01, or 3 or more contiguous
points with sensitivity loss of P < 0.05 in the superior or inferior arcuate areas, or a 10-dB difference
across the nasal horizontal midline at 2 or more adjacent locations and an abnormal result on the
GHT), and open angle by gonioscopy. All patients had VF MD > -6 dB
Glaucoma suspects: abnormal disc consistent with glaucoma with a normal VF test
Visual field testing: Humphrey Field Analyzer, model 750 II, full-threshold automated perimetry,
30-2mode (Carl Zeiss-Humphrey, Dublin, CA, USA). VF reliability criteria included fixation losses
rates, false-positive and false-negative rates < 20%
Optic disc evaluation: stereoscopic fundus examination.
Flow and timing 21 eyes (< 10%) enrolledwere excluded from the analysis because good images could not be obtained.
All tests and imaging were carried out within 4 weeks
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Did all patients receive a refer-
ence standard
Yes
Chen 2008
Study characteristics
Patient sampling Prospective cross-sectional study including early-to-moderate glaucomatous eyes (high-tension pri-
mary open angle glaucoma and primary angle closure glaucoma) and age-matched participants.
The glaucoma patients were followed for at least 6 months between December 2004 and August
2005. Participantsts with normal eyes were volunteers from the staff or family members at the China
Medical University Hospital. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 88 eyes of 88 glaucoma patients (47 POAG and 41 PACG); 45 eyes from 45 normal
participants
Age: glaucoma patients mean ± SD, 61.7 ± 9.9 years for POAG and 61.8 ± 8.5 years for PACG;
controls 57.9 ± 9.0 years
Sex: 60 men (22 controls, 31 POAG and 7 PACG), and 71 women (21 controls, 16 POAG and 34
PACG)
Ethnicity: Taiwan Chinese.
Country: China.
Ocular comorbidities: no peripapillary atrophy, BCVA < 20/40, SE > ±5 D or secondary angle
closure, such as lens-induced glaucoma, neovascular glaucoma, or uveitis
Setting: Glaucoma Service, China Medical University Hospital.
Spectrum of glaucoma severity: mean ± SD MD on the VF test was -4.54 ± 5.43 dB for POAG
eyes and -4.62 ± 3.99 dB for PACG eyes. Patients with VF results < -15 dB were excluded
Control participants: IOP < 21 mmHg, open angle on gonioscopy, normal optic disc appearance
and normal VF result (GHT and CPSD within normal limits)
Index tests Scanning Laser polarimetry: GDx VCC (Carl Zeiss Meditec, Inc, Dublin, CA, USA; version 5.
5.0). Measurements were obtained by the same trained and experienced technician. All images had
to be of high quality, with a score > 7 , a centred optic disc, well-focused, even and just illuminated
through the images, and without any motion artefact. Each patient could undergo multiple GDx
VCC scans. Only 1 successful scan was saved into the hard disc and was printed out. All of the
print-outs were evaluated by the same doctor
None of the authors had conflict of interest.
Target condition and reference
standard(s)
Manifest primary open angle glaucoma: glaucomatous optic neuropathy (defined as either cup/
disc asymmetry between fellow eyes of > 0.2, rim thinning, notching, excavation, or RNFL defect)
, VF defects (defined as 2 or more contiguous points with a pattern deviation sensitivity loss of P <
0.01, or 3 or more contiguous points with P < 0.05 in the superior or inferior arcuate areas, or a 10-
dB difference across the nasal horizontal midline at 2 or more adjacent locations and an abnormal
GHT result), open angle on gonioscopy, and initial IOP > 21 mmHg
Primary angle closure glaucoma: glaucomatous optic neuropathy with corresponding VF loss
associated with gonioscopic finding of at least 180° of peripheral anterior synechiae, and IOP > 21
mmHg on 2 separate occasions
64Optic nerve head and fibre layer imaging for diagnosing glaucoma (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Chen 2008 (Continued)
Visual field testing: Humphrey Field Analyzer, model 750, 30-2 central full threshold strategy
(Carl Zeiss Meditec, Inc). VF reliability criteria included fixation losses and false-positive and false-
negative rates of < 20%
Optic disc evaluation: stereoscopic fundus examination.
Flow and timing Time interval between reference standard and index test was < 4 weeks. Some patients without good
GDx VCC imaging data were excluded
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
No
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Did all patients receive a refer-
ence standard
Yes
Chen 2013
Study characteristics
Patient sampling Prospective, case-control study. Glaucoma patients had received regular treatment or follow-up care
at the Glaucoma department whereas the normal controls were volunteers recruited from the staff
and their families. 1 eye per person was randomly chosen
Patient characteristics and set-
ting
Sample size: 161 eyes of 161 participants (35 POAG, 26 PACG, 27 glaucoma suspects, 21 ocular
hypertension and 52 controls)
Age: glaucoma mean ± SD, 44.71 ± 13.69 years; PACG, 64.81 ± 6.81 years; glaucoma suspects,
34.56 ± 16.46 years; ocular hypertension, 30.0 ± 13.8 years controls, 35.27 ± 15.29 years
Sex: no details reported
Ethnicity: Chinese
Clinical Setting: Glaucoma Service of the Department of Ophthalmology at China Medical Uni-
versity Hospital
Country: China
Ocular comorbidities: patients with a BCVA < 20/40, a spherical equivalent > ±5.0 D, or a cylinder
correction>3.0D, orwith co-existing retinal disease, uveitis, or non-glaucomatous optic neuropathy
were excluded
Spectrum of glaucoma severity: the mean ± SD mean deviation and PSD on the VF test were -5.
47 ± 7.99 and 4.82 ± 7.31 respectively, for POAG eyes; -4.87 ± 5.65 and 5.21 ± 3.92 respectively,
for PACG eyes; -1.85 ± 1.44 and 2.12 ± 1.18 respectively, for glaucomatous-suspected eyes
Control participants: IOP < 21 mmHg, no history of increased IOP, normal-looking optic disc
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heads, and normal VF results (MD and PSD with P > 5% and GHT within normal limits)
Index tests Optical coherence tomography: Cirrus SD-OCT (software version 3.0; Carl Zeiss Meditec Inc.).
Optic disc cube 200 x 200 scan protocol was used for the analysis. All images had to have focused
ocular fundus images, a centred circular ring around the optic disc and a signal strength > 5.
The authors declare no conflicts of interest.
Target condition and reference
standard(s)
Manifest primary open angle glaucoma: IOP > 21 mmHg, open angle on gonioscopy, glaucoma-
tous optic disc appearance (defined as > 0.2 cup/disc asymmetry between the eyes, rim thinning,
notching, excavation, or RNFL defect) and a reproducible glaucomatous VF defect (defined as ≥ 2
contiguous points with a pattern deviation with P < 0.01, ≥ 3 contiguous points with a sensitivity
loss of P < 0.05 in the superior or inferior arcuate areas, or a 10-dB difference across the nasal
horizontal midline at ≥ 2 adjacent locations and GHT outside normal limits)
Manifest primary angle closure glaucoma: a gonioscopic finding with at least 180° of peripheral
anterior synechiae, IOP > 21 mmHg and glaucomatous optic disc appearance
Glaucoma suspects: abnormal disc appearance consistent with glaucoma along with a normal VF
result
Visual field test: Humphrey Field Analyzer model 750 ( Carl Zeiss Meditec, Dublin, CA, USA);
30-2 SITA-standard strategy. All exams had fixation losses and false-positive and false-negative rates
of < 20%
Flow and timing No details about exclusion were reported.
The time interval between index and reference test was not reported
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
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Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Cho 2011
Study characteristics
Patient sampling Glaucoma patients were recruited prospectively, in a consecutive manner between August 2008
and February 2009. Age-matched healthy eyes formed the control group. One eye per person was
randomly selected
Patient characteristics and set-
ting
Sample size: 108 eyes initially enrolled, 92 actually included in the analysis (49 glaucoma, 43
healthy controls)
Age: glaucoma patients mean ± SD, 51.8 ± 14.2 years, controls 46.6 ± 16.3 years
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Ethnicity: Asian.
Country: South Korea.
Ocular comorbidities: no ophthalmic disease that could affect VF result, no history of diabetes
mellitus; BCVA ≥ 20/30, with a spherical equivalent within ± 5 D and a cylinder correction within
+3 D
Setting: Asan Medical Center (Seoul, Korea).
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -6.39 ± 6.03 dB
and 6.38 ± 4.69 dB, respectively
Control participants: IOP < 22 mmHg, no history of IOP elevation, and normal based on VF
examination
Index tests Optical coherence tomography: SD-SLO/OCT (OTI, Opkos. Toronto, Canada).
No details about author’s conflict of interest were reported
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous optic disc appearance (defined as vertical cup/disc ratio of > 0.
6, a difference in vertical cup-disc ratio of more than 0.2 between the eyes, diffuse or focal neural
rim thinning, haemorrhage, or nerve fibre layer defects) and a glaucomatous VF defect (defined as
a cluster of 3 points with P < 5% on the pattern deviation map in at least 1 hemifield, including at
least 1 point with a P < 1%; or a cluster of 2 points with a < 1% and a GHT result outside normal
limits; or a PSD outside 95% of the normal limits)
Visual field testing: Humphrey Field Analyzer, SITA standard, 24-2 programme (Carl Zeiss
Meditec, Inc., Dublin, CA, USA). VF reliability criteria included false-positive and false-negative
rates < 15%, and a fixation loss < 20%
Optic disc evaluation: stereoscopic optic nerve photography.
Flow and timing 16 subjects (> 10%) were excluded from the analysis due to poor image quality
The time interval between index and reference standard was not specified
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
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DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
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Study characteristics
Patient sampling Participants were consecutively enrolled from October 2011 to April 2012. Healthy controls were
enrolled among people undergoing routine eye examination. One eye per person was randomly
selected
Patient characteristics and set-
ting
Sample size: 207 patients examined, 181 eventually included in the analysis. The patients were
divided into 2 groups: a highly myopic group (spherical equivalent > -6.00 D and > -20.00 D)
and a non-highly myopic group (spherical equivalent > -6.00 D and < -0.25 D): 71 highly myopic
patients (49 glaucoma, 22 controls) and 110 non-highly myopic (54 glaucoma, 56 controls)
Age: glaucoma highly myopic eyes mean ± SD, 46.57 ± 11.37 years; highly myopic controls 44.
05 ± 15.14 years; glaucoma non-highly myopic eyes mean ± SD, 53.85 ± 12.52 years; non-highly
myopic controls 49.27 ± 13.42 years
Sex: 97 men (61 glaucoma, 36 controls) and 84 women (42 glaucoma, 42 controls)
Ethnicity: Korean.
Country: Korea.
Setting: Glaucoma Clinic of Seoul National University Hospital, Seoul
Ocular comorbidities: eyes with retinal pathology, diabetes, BCVA < 20/40 or non-glaucomatous
optic nerve diseases, and eyes with previous laser therapy or ocular surgery, were excluded
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were -7.44 ± 4.85
dB and 8.90 ± 4.73 dB respectively for glaucoma highly myopic eyes; were -7.31 ± 6.64 dB and 9.
00 ± 4.36 dB respectively for glaucoma non-highly myopic eyes
Control participants: IOP < 22 mmHg, normal appearance of ONH and normal VF test
Index tests Optical coherence tomography: Cirrus HD-OCT (Carl Zeiss Meditec, Dublin, CA, USA). The
Macular cube 200 x 200 and 1 optic disc cube 200 x 200 scans were acquired through dilated pupil.
Images with a signal strength < 6, visible eye motion, blinking artefacts, or algorithm segmentation
failure were excluded.
No authors had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous optic disc change (defined as a large cupping (> 0.7 vertical
cup/disc ratio), cup/disc asymmetry between the glaucomatous and normal eyes greater than 0.2,
neuroretinal rim thinning, notching, or excavation) and glaucomatous VF defects (defined as GHT
outside normal limits; a PSD with P < 0.05; a cluster of 3+ non-edge contiguous points in the
pattern deviation plot in the same hemifield with P < 0.05, including 1+ with P < 0.01)
Visual field testing: Humphrey Field Analyzer, 30-2 SITA standard programme (Carl Zeiss
Meditec). VF reliability criteria were fixation losses < 20%, and false-positive and false-negative rates
< 15%
Optic disc evaluation: stereoscopic colour disc photography, assessed by 2 glaucoma specialists in
a masked fashion without knowing clinical data or OCT results
Flow and timing The time interval between index tests and reference standard was not reported
26/207 (> 10%) eyes were excluded: 10 eyes were excluded from the study because of retinal disease,
as well as 4 eyes due to optic nerve disease. 11 eyes were excluded owing to unreliable VF, and 1 eye
due to poor OCT signal strength
Comparative
Notes None.
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Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
Da Pozzo 2005
Study characteristics
Patient sampling Patients were selected among those referred to the Glaucoma Unit at Trieste University Eye Clinic
between January and July 2004 for periodical scheduled visits. Healthy participants were recruited
among staff members, friends or spouses of patients, or normal volunteers. One eye per person was
randomly selected for inclusion
Patient characteristics and set-
ting
Sample size: 141 eyes initially enrolled, 124 eyes of 124 participants included in the analysis (59
glaucoma and 65 healthy controls)
Age: glaucoma patients mean ± SD, 67.1 ± 9.1 years; controls 64.6 ± 7.5
Country: Italy.
Ocular comorbidities: no corneal or lens opacity, BCVA < 20/40, SE > ± 4D, peripapillary atrophy
falling under ellipsemeasurement, tilted disc, uveitis, significant vitreous floaters, or diffuse/localised
retinal or macular disease
Setting: Glaucoma Unit, Trieste University Eye Clinic.
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were −7.66 ± 6.19 dB
and 7.46 ± 4.18 dB respectively
Control participants: normal VF result (MD and PSDwithin 95% confidence limits, GHTwithin
normal limit), IOP < 21 mmHg, and healthy optic disc with intact neuroretinal rim
Index tests Scanning Laser polarimetry: GDx-VCC, software 5.3.4 (Laser Diagnostic Technologies, San
Diego, California, USA). Scans with evidence of atypical pattern on the thickness map or a quality
score < 8 as automatically provided by device software, were excluded from the study
None of the authors had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous optic disc appearance(cupping, rim notching, or diffuse thin-
ning) and reproducible VF defects (defined as GHT outside normal limits or PSD with P < 5%)
Visual field testing: Humphrey Field Analyzer, 24-2 SITA-standard strategy (Humphrey Systems,
Dublin, CA,USA). VF reliability criteria included fixation losses and false-positive and false-negative
rates of < 20%
Optic disc evaluation: stereo biomicroscopy with the aid of a +90 D lens after pupil dilation
Flow and timing Time interval between reference standard and index test was within 2 months. 17 patients were
excluded for poor imaging quality: 11 presented atypical patterns on the retardation map, 4 did not
pass the 4-scan quality check or saw their RNFL readings flagged as “incompatible with normative
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database,” and 2 had poor fixation
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
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Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
Da Pozzo 2006
Study characteristics
Patient sampling Patients were selected among those referred to the Glaucoma Unit at Trieste University Eye Clinic
between January and October 2004 for periodic scheduled visit. Healthy participants were recruited
among staff members, friends or spouses of patients, or normal volunteers. One eye per person was
randomly selected
Patient characteristics and set-
ting
Sample size: 110 eyes of 110 participants (48 glaucoma and 62 healthy controls)
Age: glaucoma patients mean ± SD, 66.8 ± 8.8 years; controls 64.7 ± 6.5 years
Country: Italy.
Ocular comorbidities: no corneal or lens opacity, BCVA < 20/40, SE > ± 4D, peripapillary atrophy
falling under ellipsemeasurement, tilted disc, uveitis, significant vitreous floaters, or diffuse/localised
retinal or macular disease
Setting: Glaucoma Unit, Trieste University Eye Clinic.
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -1.74 ± 1.69 dB
and 3.56 ± 1.5 dB
Control participants: normal VF result (MD and PSDwithin 95% confidence limits, GHTwithin
normal limit), IOP < 21 mmHg, and healthy optic disc with intact neuroretinal rim
Index tests Scanning Laser polarimetry: GDx VCC (software 5.3.4; Carl Zeiss Meditec, CA, USA). The
correct positioning of ellipse on inner margin of peripapillary scleral ring was rechecked on all eyes
by a trained technician. Scans with evidence of atypical pattern on the printout retardation map or
a score < 7 on the 4-scan quality checks performed by software (alignment, fixation, refraction and
illumination) were excluded
No details about authors’ conflict of interest were reported
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous optic disc appearance(cupping, rim notching, or diffuse thin-
ning) and reproducible VF defects (defined as GHT outside normal limits or PSD with P < 5%)
Visual field testing: Humphrey Field Analyzer, 24-2 SITA-standard strategy (Humphrey Systems,
Dublin, CA,USA). VF reliability criteria included fixation losses and false-positive and false-negative
rates of < 20%
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Optic disc evaluation: stereo biomicroscopy with the aid of a +90 D lens after pupil dilation
Flow and timing Time interval between reference standard and index test was within 2 months. 14 patients were
excluded for poor imaging quality: 6 presented atypical patterns on the retardation map, 2 did not
pass the 4-scan quality check, 3 saw their RNFL readings flagged as “incompatible with normative
database” and 3 had poor fixation
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
Unclear
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of the results of the index tests?
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
De Leon-Ortega 2006
Study characteristics
Patient sampling Data were obtained from patients who had undergone optic disc imaging and visual functional
testing between January 2003 and February 2005 as part of ongoing longitudinal glaucoma studies.
Controls were obtained primarily from referrals and University of Alabama employees
One eye per person was randomly selected.
Patient characteristics and set-
ting
Sample size: 228 eyes of 228 participants (79 glaucoma and 149 healthy controls)
Age: glaucoma patients mean ± SD, 56.0 ± 13.9 years; controls 40.3 ± 11.3 years
Sex: 63 men (25 glaucoma and 38 controls) and 165 women (54 glaucoma and 111 controls)
Ethnicity: 42 of 79 in the glaucoma group and 82 of 149 in the controls were African-American
Country: USA.
Ocular comorbidities: noBCVA<20/40, SE > ± 5D, comorbid ophthalmic, or neurologic surgery/
disease
Setting: University of Alabama at Birmingham.
Spectrum of glaucoma severity: mean ± SD MD on the VF test was -3.8 ± 3.6 dB. According to
Hodapp et al. grading scale, 44 eyes had an early glaucoma, 31 moderate, and 4 severe
Control participants: IOP < 22 mmHg, bilateral normal eye examination findings and bilateral
normal VF results (defined as PSD within the 95% normal limits and a GHT result within 99%
limits)
Index tests Scanning laser polarimetry: GDxVCC (Carl ZeissMeditec, Inc., Dublin, CA, USA). Themean of
3 images was calculated. Images were considered of good quality if there was good fixation, minimal
eye movement, and good illumination on the reflectance image, with no artefacts on the retardance
image
No author had conflict of interest.
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Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous VF loss (defined as PSD outside 95% normal limits or GHT
outside 99% normal limits) confirmed with a second VF test
Visual field testing: no details about how it was conducted and which instrument was used. VF
reliability criteria included fixation losses and false-positive and false-negative rates of < 30%
Optic disc appearance was not part of the reference standard
Flow and timing Reference standard and index tests were completed within 1 to 8 weeks
45 glaucoma patients (> 10%) were excluded due to poor-quality images
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
De Leon-Ortega 2007
Study characteristics
Patient sampling Data were obtained from the University of Alabama at Birmingham Optic Nerve Imaging Center
database, which consists of functional and imaging data from glaucoma patients and controls en-
rolled in clinical studies from January 2000 to December 2004. Glaucoma patients were recruited
by chart review and referrals, while controls were university employees, or were recruited from the
general population
One eye per person was randomly selected.
Patient characteristics and set-
ting
Sample size: 374 participants were initially enrolled, 78 glaucoma (44 African-American, 34 Eu-
ropean), 89 healthy controls (51 African-American, 38 European) actually included in the analysis
Age: glaucomaAfrican-American patientsmean ± SD, 49.5 ± 9.8 years, glaucomaEuropean ancestry
49.4 ± 17.2 years, controls African-American 47.3 ± 9.5 years, controls European ancestry 47.5 ±
8.8 years
Ethnicity: African-American and European ancestry.
Country: USA.
Ocular comorbidities: no history of intraocular surgery (except uncomplicated cataract surgery),
cataracts, problems affecting colour vision other than glaucoma, use of medication or any comorbid
condition affecting visual function. BCVA ≥ 20/40, spherical refraction within ±5 D, and cylinder
correction within ± 3D
Setting: University of Alabama at Birmingham.
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -3.6 ± 3.6 dB and
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4.3 ± 3.1 dB, for glaucoma African-American; -3.3 ± 3.2 dB and 4.1 ± 3.1 dB, for glaucoma
European ancestry, respectively
Control participants: IOP < 22 mmHg, no past history of increased IOP, no family history of
glaucoma, normal VF test results, and normal optic nerve appearance
Index tests Confocal scanning laser ophthalmoscopy:Heidelberg Retina Tomography (Heidelberg Engineer-
ing, Heidelberg, Germany). An experienced operator evaluated the image quality and outlined the
disc margin, masked to the patient diagnosis. After obtaining the HRT 2 results, all scans with their
respective contour lines were exported to a personal computer with theHRT 3 software. Images were
excluded if they had: acquisition sensitivity > 89%, SD > 39, results, ONH not centred, excessive
eye movement occurred during the acquisition movie, floaters over or adjacent to the disc
One author was a consultant for Carl Zeiss Meditec.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous VF result, defined as either GHT outside the 99% normal
limits or a PSD outside the 95% normal limits, and at least 1 cluster of 3+ test points outside
95% confidence interval in the pattern deviation probability plot, without crossing the horizontal
hemifield
Visual field testing: Humphrey Field Analyzer II, SITA standard, 24-2 programme (Carl Zeiss
Meditec, Inc., Dublin, CA, USA). VF reliability criteria included a fixation loss , false-positive and
false-negative rates < 33%
Optic disc evaluation: dilated fundus examination, simultaneous stereoscopic optic disc photog-
raphy
Flow and timing Of 374 patients initially enrolled, 167 were actually included in the analysis. 31 (> 10%) were
excluded due to poor image quality, 5 patients were excluded due to poor quality in the stereopho-
tograph
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
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If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
Essock 2005
Study characteristics
Patient sampling Patients were enrolled prospectively from the outpatient clinics of glaucoma specialists. Both eyes
were selected and enrolled for some patients
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Patient characteristics and set-
ting
Sample size: 134 eyes of 134 participants (67 glaucoma and 67 control subjects)
Age: glaucoma patients mean age, 67.22 years; controls 64.61 years
Country: USA.
Ocular comorbidities: no significant ocular media opacity.
Setting: The Institute of Ophthalmology and Visual Science, University of Medicine and Dentistry
of New Jersey; New York Eye and Ear Infirmary (New York, NY); Eye Care Center (San Diego, CA,
USA)
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -6.82 ± 6.2 dB
and 6.25 ± 4.2 dB respectively
Control participants: normal IOP and normal appearance of ONH. VFs were measured in most,
but not all, cases and were normal
Index tests Scanning laser polarimetry: GDx VCC (Laser Diagnostic Technologies, Inc., San Diego, CA,
USA). The measurements were obtained in 3 different clinics and were performed by experienced
technicians. No details about scan’s quality assessment were reported
Some authors had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: patients with VF defects of GSS stage 1 or greater.
Visual field testing: Humphrey Field Analyzer, model II 30-2 or 24-2 threshold, standard or full
SITA strategy (Humphrey-Zeiss Instruments, Dublin, CA, USA). All VFs had good reliability, no
further specified
Optic disc appearance was not part of the reference standard
Flow and timing Time interval between reference standard and index test was not specified
No patients were reported as excluded from the analysis.
Comparative
Notes All healthy participants had normal IOP and had normal appearance of optic discs. VFs were
measured in most, but not all, cases
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Unclear
High
DOMAIN 2: Index Test All tests
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If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Unclear
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Fang 2010
Study characteristics
Patient sampling Consecutive outpatients were enrolled from July 2008 to March 2009. One eye per person was
selected
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Patient characteristics and set-
ting
Sample size: 90 eyes of 90 participants were enrolled. 76 eyes were actually included in the analysis
(34 glaucoma, 42 healthy controls)
Age: glaucoma patients mean ± SD, 58.4 ± 11.0 years; controls 56.3 ± 13.7 years
Sex: 27 men (15 glaucoma, 12 controls) and 49 women (19 glaucoma, 30 controls)
Country: China.
Ocular comorbidities: no co-existing retinal disease, BCVA < 20/30, SE < -6 D or > +4 D, optic
neuropathy, uveitis, trauma and past intraocular surgery, diabetes, hypertension
Setting: Department of Ophthalmology, Peking University First Hospital, Beijing
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -2.28 ± 1.8 dB
and 3.68 ± 2.14 dB
Control participants: IOP < 21 mmHg, healthy ONH/RNFL appearance and normal VF test
result
Index tests Optical coherence tomography:RTvue FD-OCT, version 3.0. (Optovue Inc., Fremont, Ca, USA)
. Each patient was scanned using 3 patterns, including RNFL 3.45 scan, NHM4 scan , and MM7
scan. Quality FD-OCT scans were defined as those with a signal-strength index > 30
No details about author’s conflict of interest were reported
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous optic disc or RNFL appearance (rim thinning, notching, exca-
vation, or haemorrhage), open angle by gonioscopy, and glaucomatous VF defects (defined as GHT
outside normal limits, PSD with P < 5%, or a cluster of ≥ 3 points in the pattern deviation plot in
a single hemifield (superior or inferior) with P < 0.05, one of which should have a P < 0.01)
Visual field testing: Humphrey Field Analyzer, model 750, 24-2 SITA fast strategy (Carl Zeiss
Meditec, Dublin, CA, USA). VF reliability criteria included fixation losses and false-positive and
false-negative rates of < 30%
Optic disc evaluation: dilated fundus examination.
Flow and timing Time interval between reference standard and index test was not reported
12 patients with early glaucoma were excluded owing to poor image quality.
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
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High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
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Study characteristics
Patient sampling Participants were prospectively pre-enrolled from January 2006 to June 2006. Glaucomatous eyes
were recruited consecutively from an ongoing longitudinal follow-up study. Normal eyes were
consecutively recruited from patients referred for refraction who underwent routine examination
without abnormal ocular findings, hospital staff, and relatives of patients in our hospital. One eye
per person was selected
Patient characteristics and set-
ting
Sample size: 201 eyes of 201 participants enrolled, 186 eyes of 186 participants included in the
analysis (115 glaucoma, 71 healthy controls)
Age: glaucoma patients mean ± SD, 61.9±7.29 years; controls 59.0 ± 9.8
Ethnicity: white.
Country: Spain.
Ocular comorbidities: no previous intraocular surgery, BCVA < 20/40, refractive spherical error
< -5 D/cylinder error > +2 D, diabetes or other systemic diseases, history of ocular or neurologic
disease
Setting: Miguel Servet University Hospital, Department of Ophthalmology, Zaragoza
Spectrum of glaucoma severity: mean ± SD of MD and PSD on the VF test were −6.49 ± 6.08
dB and 5.08 ± 3.63 dB respectively. According to Hodapp et al. grading scale, 62 eyes had early
glaucoma, 32 moderate and 21 severe
Control participants: IOP < 20 mmHg, no optic disc morphology suspicious for glaucoma, and
a normal SAP
Index tests Confocal scanning laser tomography: HRT3 (Heidelberg Engineering, Heidelberg, Germany)
with a diode laser (670 nm wavelength). Topographic images were obtained through dilated pupils
and analysed using the Advanced Glaucoma Analysis 3.0 software. Only scans with “acceptable,
” “good,” or “very good” image quality scores were included. The margin of the optic discs was
manually traced by the same glaucoma specialist with at least a 4-point contour line
No author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: IOP of > 21 mmHg (on > 3 readings on different days), open angle by
gonioscopy and SAP defects (defined as the presence of a cluster of 3 points lower than P < 5%, a
cluster of 2 points lower than P < 1% on pattern deviation probability plots, or a PSD with P < 2%
or GHT outside the normal limits)
Visual field testing: Humphrey Field Analyzer, model 745, 24-2 SITA-standard strategy (Zeiss
Humphrey Systems, Dublin, CA, USA). VF reliability criteria included fixation losses, false-positive
and false-negative rates of < 20%. The participants completed the perimetry tests before undergoing
any clinical examination or structural test
Optic disc appearance was not part of the reference standard
Flow and timing Reference standard and index test were performed within 1 month. 15 participants (< 10%) were
excluded from the analysis: 2 participants did not provide informed consent, 2 participants did
not complete all of the required tests, 3 participants were unable to perform at least 1 of the tests
expected; in 8 participants, GPS analyses produce only a global result or no results
Comparative
Notes None.
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Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
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Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Ferreras 2008a
Study characteristics
Patient sampling Participants with normal eyes were recruited from among patients referred for refraction who under-
went routine examination without abnormal ocular findings, hospital staff, and relatives of patients
in the hospital. Patients with glaucoma were recruited from an ongoing longitudinal follow-up
study, including those who underwent imaging of the optic disk with the HRT2 from September
1, 2005 through April 30, 2007. One eye per person was selected
Patient characteristics and set-
ting
Sample size: 183 eyes of 183 participants (90 glaucoma and 93 controls)
Age: glaucoma patients mean ± SD, 60.45 ± 9.08 years; controls 56.43 ± 9.87
Sex: 79 men (41 glaucoma, 38 controls) and 104 women (49 glaucoma, 55 controls)
Ethnicity: white.
Country: Spain.
Ocular comorbidities: no previous intraocular surgery, BCVA < 20/40, SE > ± 5 D, lens opacity,
diabetes, or other ocular or neurologic disease
Setting: Department of Ophthalmology of Miguel Servet University Hospital
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test for were -6.03 ± 6.33
dB and 4.01 ± 3.61 dB respectively
Control subjects: IOP < 21 mmHg (on at least 3 readings on different days) and a normal SAP
test result
Index tests Confocal scanning laser tomography: HRT 2 (Heidelberg Engineering, Heidelberg, Germany).
All scans had to have an interscan SD of < 30 µm. The margin of the optic disks was tracedmanually
by the same glaucoma specialist, who was masked to participant identity and clinical history. Scans
were analysed using first the HRT2 software and, afterward, the Advanced Glaucoma Analysis 3.0
software
No author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: IOP > 21 mmHg, open angle by gonioscopy and typical glaucomatous SAP
defects (defined as the presence of a cluster of 3 points with a P < 0.05 or a cluster of 2 points with
a P < 0.01 on the pattern deviation plot, a PSD with P < 5%, a GHT outside normal limits, or a
combination thereof )
Visual field testing: Humphrey Field Analyzer, model 750, 24-2 SITA-standard strategy (Zeiss
Humphrey Systems, Dublin, CA, USA). VF reliability criteria included fixation losses, false-positive
and false-negative rates of < 20%. The participants completed the perimetry tests before undergoing
any clinical examination or structural test
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Optic disc appearance was not part of the reference standard
Flow and timing Reference standard and index test were performed within 2 months
Patients were enrolled consecutively. No details about participants excluded from the analysis were
reported
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
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Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Did all patients receive a refer-
ence standard
Yes
Ferreras 2008b
Study characteristics
Patient sampling FromApril, 2006, throughDecember, 2006, 2 samples (one population for obtaining the LDF and a
second independent population for testing the LDF) of consecutive healthy control participants and
glaucoma patients were pre-enrolled prospectively. Normal eyes were recruited from among patients
referred for refraction who underwent routine examination without abnormal ocular findings, from
among hospital staff, and from among relatives of patients in the hospital. Patients with glaucoma
were recruited from an ongoing longitudinal follow-up study. One eye per person was randomly
selected
Patient characteristics and set-
ting
Sample size: 2 samples were enrolled. A first sample of 166 eyes (85 glaucoma/ 81 controls) to
calculate a discriminant analysis. A second sample of 435 eyes: 225 controls and 210 glaucomatous
eyes (163 POAG, 34 PEX and 13 pigmentary glaucoma)
Age: glaucoma mean ± SD, 61.10 ± 10.07 years; controls 57.46 ± 9.84 years, for the first sample.
Glaucoma mean ± SD, 61.37 ± 10.4 years; controls 57.67 ± 10.19 years, for the second sample
Ethnicity: white.
Country: Spain.
Ocular comorbidities: BCVA < 20/40, SE > ± 5 D, no previous intraocular surgery, lens opacity,
diabetes, or other ocular or neurologic disease
Setting: Department of Ophthalmology of Miguel Servet University Hospital
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -5.79 ± 5.74 dB
and 4.93 ± 3.78 dB for the first sample, -5.34 ± 4.87 dB and 4.87 ± 3.95 dB for the second sample
Control participants: IOP < 21 mmHg (on at least 3 readings on different days), and a normal SAP
test result
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Index tests Confocal scanning laser tomography: HRT 3 (Heidelberg Engineering, Heidelberg, Germany).
Topographic images were obtained through dilated pupils and were analysed using the Advanced
Glaucoma Analysis 3.0 software. All scans had to have an interscan SD of < 30 µm. The margin of
the optic disc was traced manually by the same glaucoma specialist who was masked to the patients’
identity and clinical history.
No author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: IOP > 21 mmHg and typical SAP defects (defined as a PSD with a P < 5%
and/or a GHT outside normal limits)
Visual field testing: Humphrey Field Analyzer, model 745, 24-2 SITA-standard strategy (Zeiss
Humphrey Systems, Dublin, CA, USA). VF reliability criteria included fixation losses and false-
positive and false-negative rates of < 20%. The participants completed the perimetry tests before
undergoing any clinical examination or structural test
Optic disc appearance was not part of the reference standard
Flow and timing Reference standard and index test were performed within 1 month. 21 participants (< 10%) were
excluded from the analysis: 3 participants did not provide informed consent, 11 participants did
not complete all of the required tests, and 7 participants were unable to perform at least 1 of the
tests expected
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
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Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Garas 2011
Study characteristics
Patient sampling White individuals referred for detection or exclusion of glaucoma, who underwent RNFLT, GCC,
and ONHmeasurements made with the RTVue-100 Fourier-domain OCT between 1 January and
30 November 2009, were enrolled in the study. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 286 eyes of 286 participants (111 with perimetric glaucoma, 46 with preperimetric
glaucoma, 36 with ocular hypertension and 93 healthy control participants)
Age: perimetric glaucoma patients mean ± SD, 62.2 ± 14.7 years; preperimetric glaucoma patients
57.6 ± 11.8 years; OHT patients 51.5 ± 16.5 years; controls 54.9 ± 15.9 years
Sex: 126 male, 160 women.
Ethnicity: white.
92Optic nerve head and fibre layer imaging for diagnosing glaucoma (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
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Country: Hungary.
Ocular comorbidities: no macular pathology, diabetic retinopathy, cornea degeneration, or non-
glaucomatous optic neuropathies
Setting: Glaucoma Centre of Semmelweis University in Budapest.
Spectrum of glaucoma severity: mean ± SD MD on the VF test were -0.1 ± 1.2 dB for ocular
hypertension, 0.1 ± 1.8 dB for preperimetric group and 9.8 ± 7.8 dB for perimetric group. According
to the modified Bascom Palmer staging system, the perimetric glaucoma group consists of 26 stage
1 patients, 34 at stage 2, 21 at stage 3, 24 at stage 4 and 6 at stage 5
Control participants: no ONH damages, normal VF tests (MD < 2 dB), and IOP < 21 mmHg
Index tests Optical coherence tomography:RTVue-100Fourier-domainOCT, software version 4.0 (Optovue
Inc., Froemont, CA, USA). For RNFLT, GCC and ONH measurements the standard glaucoma
protocol was used. Scans were acquired through undilated pupils. To be included in the analysis,
images had to have a signal strength index > 40
One author is an unpaid consultant of Optovue, Inc and Carl Zeiss Meditec, Inc
Target condition and reference
standard(s)
Perimetric manifest glaucoma: glaucomatous neuroretinal rim loss and VF defect typical for
glaucoma (inferior and/or superior paracentral or arcuate scotomas, nasal step, hemifield defect or
generalised depression with MD > 2 dB)
Preperimetric manifest glaucoma: glaucomatous neuroretinal rim loss (diffuse/localised neuroreti-
nal rim thinning) and normal visual field with MD < 2 dB
Ocular Hypertension: normal ONH, normal visual field with MD < 2 dB and untreated IOP
consistently > 21 mmHg
Visual field testing: Octopus field analyser, normal or dynamic G2 threshold visual field testing.
No details about reliability criteria were reported
Optic disc evaluation: stereoscopic ONH photography by a glaucoma specialist.
Flow and timing Reference standard and index test were performed within 2 months
Of the 316 referred patients 30 (< 10%) did not meet the inclusion criteria and were not enrolled
in the study
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
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High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
94Optic nerve head and fibre layer imaging for diagnosing glaucoma (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Garas 2012
Study characteristics
Patient sampling Consecutive white individuals referred for detection of glaucoma by their family doctors, op-
tometrists, or local ophthalmologists in theGlaucoma Centre who underwent OCT andGDx imag-
ing session between January 1 and October 31, 2009, and fitting eligibility criteria, were enrolled
in the study . One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 177 eyes of 177 participants enrolled (66 perimetric glaucoma, 33 preperimetric
glaucoma, 28 hypertensive, 50 healthy eyes)
Age: perimetric glaucoma patients 64.3 ± 12.9 years; preperimetric glaucoma patients 56.2 ± 12.1
years; OHT patients mean ± SD, 50.8 ± 15.6 years; controls 50.2 ± 17.3 years
Sex: 75 men (24 perimetric glaucoma, 16 preperimetric glaucoma, 13 OHT, 22 control) and 102
women (42 perimetric glaucoma, 17 preperimetric glaucoma, 15 OHT, 28 control)
Ethnicity: white.
Country: Hungary.
Setting: Glaucoma Centre of Semmelweis University in Budapest.
Ocular comorbidities: participants with refractive error ≤ ± 10 D, no sufficient central vision for
optimal fixation and clinically significant cataract, were not included
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were 0.3 ± 1.7 dB
and 9.6 ± 6.8 dB for preperimetric and perimetric glaucoma respectively
Control participants: eyes with no structural or functional damage including healthy eyes with
normal optic nerve appearance, normal VF result and IOP consistently < 21 mmHg, and hyper-
tensive participants with normal optic nerve appearance, normal VF result and IOP untreated > 21
mmHg
Index tests Optical coherence tomography: RTVue-100 Fourier-domain OCT (Optovue Inc., Fremont, CA,
USA). The ONH scan protocol was used. All images were taken by the same operator and only
images with signal strength index > 40 were used. Images with insufficient quality or with any
artefact were rejected and reacquired
Scanning laser polarimetry: GDx VCC instrument (software version 5.5.1; Carl Zeiss Meditec
Inc., Dublin, CA, USA). Both variable corneal compensation or enhanced corneal compensation
or both were used. All images were acquired by the same operator and quality score > 8 was required
to be accepted.
One author is an unpaid consultant of Carl Zeiss, inc. and Optovue, inc
Target condition and reference
standard(s)
Glaucoma group comprised:
Preperimetric glaucoma: glaucomatous neuroretinal rim loss (diffuse or localised neuroretinal rim
thinning, notching with bared circumlinear vessels and corresponding angulation of the vessels at
the disc margin) and normal visual field with MD < 2 dB
Perimetric glaucoma: glaucomatous neuroretinal rim loss and VF defect typical for glaucoma
(inferior and/or superior paracentral or arcuate scotomas, nasal step, hemifield defect) or generalised
depression with MD > 2 dB. The glaucoma groups comprised both open-angle and angle-closure
glaucoma cases
Visual field testing: Octopus Normal or Dynamic G2 threshold.
Optic disc evaluation: detailed slit-lamp evaluation and stereoscopic ONH photography evaluated
by a glaucoma specialist
Flow and timing The time interval between index tests and reference standard was not reported
No patients were reported as excluded from the analysis by the authors
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Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
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Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Garudadri 2012
Study characteristics
Patient sampling Prospective cross-sectional study including normal participants and glaucoma patients evaluated
between July 2003 and March 2005 at a tertiary eye care centre. One eye per person was randomly
selected
Patient characteristics and set-
ting
Sample size: 220 eyes of 220 participants enrolled (125 glaucoma, 95 controls)
Age: glaucoma eyes mean ± SD, 57.46 ± 9.65 years; controls 50.39 ± 10.76 years
Sex: 145 men (86 glaucoma, 59 controls) and 75 women (39 glaucoma, 36 controls)
Ethnicity: Indian.
Country: India.
Setting: LV Prasad Eye Institute, Hyderabad.
Ocular comorbidities: all eyes had to have BCVA≥ 20/40, refractive error within ±5 D sphere and
±3 D cylinder of plano. Patients with intraocular surgery or laser within past 6 months, history or
evidence of retinal or macular pathology, evidence of any systemic diseases or neurological disorders,
which could produce a field defect were excluded
Spectrum of glaucoma severity: the mean ± SD MD on the VF test were -9.55 ± 8.61 dB for
glaucoma
Control participants: IOP ≤ 22 mmHg, normal posterior segment evaluation and normal VF
result
Index tests Scanning laser polarimetry: GDx VCC (software version 5.5.1; Carl Zeiss Meditec). Only prop-
erly-focused and well-centred images of the ONH with an image score ≥ 8 in both eyes were in-
cluded in the study. Imaging was performed by 1 of 2 trained optometrists masked to the hypothesis
and diagnosis.
No conflict of interest with the device’s manufacturer were reported by the authors
Target condition and reference
standard(s)
Manifest Glaucoma: glaucomatous ONH appearance (defined as focal or diffuse neuroretinal rim
thinning, localised notching, or nerve fibre layer defects) and corresponding VF defects, defined as
2 of the following 3: the presence of a cluster of 3 points on pattern deviation probability plot with
a P < 5%, one of which had a P < 1%, or a PSD with a P < 5%, or a GHT result outside normal
limits
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Visual field testing: Humphrey Field Analyzer (Carl Zeiss Meditec, Inc, Dublin, CA, USA) using
the 30-2 or 24-2 SITa standard programme
Optic disc evaluation: indirect fundus ophthalmoscopy using a 78D or 90D lens.
Flow and timing Index tests and reference standard were performed within 3 months
No patients were reported as excluded from the analysis by the authors
Comparative
Notes Garudadri CS was supported by Allergan and Merck, Parikh RS was supported by Merck, and
Thomas R was supported by Allergan
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Gonzales de la Rosa 2013
Study characteristics
Patient sampling Case-control study including eyes with ocular hypertension considered to be at risk, with suspected
(IOP > 25 mmHg, or IOP > 21 with CCT < 500 µm or with family history of glaucoma) or
confirmed open-angle glaucoma and control eyes. One eye per person was selected
Patient characteristics and set-
ting
Sample size: 206 eyes of 206 participants (104 eyes with suspected or confirmed open-angle glau-
coma and 102 controls)
Age: not reported.
Sex: not reported.
Ethnicity: not reported.
Clinical Setting: not reported.
Country: Spain.
Ocular comorbidities: not reported
Manifest glaucoma: focal (localised notching) or diffuse neuroretinal rimnarrowingwith concentric
enlargement of the optic cup, or both, or reproducible glaucomatous VF defects (no further details
reported) or both, regardless of the IOP values
Visual field test: not reported.
Index tests Optical coherence tomography: Cirrus OCT (Carl Zeiss Meditec, Jena, Germany).
Confocal scanning laser ophthalmoscopy: Heidelberg Retinal Tomograph HRT III (Heidelberg
Engineering, Heidelberg, Germany)
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No further details reported.
Two authors had proprietary interest in one of the index test analysed
Target condition and reference
standard(s)
Manifest glaucoma: focal (localised notching) or diffuse neuroretinal rimnarrowingwith concentric
enlargement of the optic cup, or both, or reproducible glaucomatous VF defects or both (no further
details reported), regardless of the IOP values
Visual field test: no details reported.
Flow and timing No details about exclusion were reported.
The time interval between index and reference test was not reported
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Unclear
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Unclear
Were imaging test’s quality as-
sessed?
No
Were any conflict of interest
avoided
Unclear
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
Unclear
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condition?
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Harizman 2006
Study characteristics
Patient sampling Normal participants, those suspected of having glaucoma and patients with glaucoma were enrolled
One eye per person was randomly selected.
Patient characteristics and set-
ting
Sample size: 220 eyes of 220 participants enrolled, 217 eyes included in the analysis (83 glaucoma
and 134 healthy controls)
Age: glaucoma patients mean ± SD, 58.5 ± 11.8 years; controls 45.5 ± 13.6
Country: not specified.
Ethnicity: 93 white (62 control, 31 glaucoma), 124 black (72 control, 52 glaucoma)
Ocular comorbidities: no narrow angle, BCVA < 20/40, SE > ±5 D, retinal disease, ocular surface
disease, non-glaucomatous optic neuropathy or previous intraocular surgery other than uncompli-
cated cataract surgery
Spectrum of glaucoma severity: mean ± SD of MD and PSD on the VF test were −7.31 ± 6.66
dB and 6.58 ± 3.85 dB, respectively
Control participants: VFs in both eyes unremarkable (PSD with P < 5% and GHT within 97%
normal limits) and the clinical examination normal
Index tests Confocal scanning laser tomography: HRT 2, software version 1.1.1 (Heidelberg Engineering,
Germany). A mean topographic image was automatically obtained from 3 scans using HRT2 soft-
ware V.1.4.1. Good image quality was assessed (acquisition sensitivity < 90%, topography SD < 40
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micron, more than ¾ of the disc within the target circle, minimal movement during the acquisi-
tion movie, no floaters over the disc, and good imaging clarity and exposure). A trained technician
outlined the optic disc margin on the mean topographic image. HRT2 data results were exported
to the HRT3 software (V.3.0) and the appropriate racial database was selected before analysis
No author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: reproducible, at least 2 consecutive, glaucomatous VF defects (defined as a
PSD with P < 5% or GHT outside normal limits)
Visual field testing: Humphrey Field Analyzer, 24-2 SITA-standard strategy (Carl Zeiss Meditec,
Dublin, CA, USA). VF reliability criteria included fixation losses, false-positive and false-negative
rates of < 33%
Optic disc appearance was not part of the reference standard
Flow and timing Reference standard and the index test were performed within 1 month
3 participants (< 10%, 2 normal, 1 glaucoma) were excluded from the analysis because the GPS
model could not had been calculated
Patients suspected of having glaucoma were enrolled but not included in the analysis, with no
explanation reported
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
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Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Did all patients receive a refer-
ence standard
Yes
Hoesl 2013
Study characteristics
Patient sampling Healthy control participants and glaucoma patients were enrolled. Controls were recruited from the
general population, as well as from the staff and employees of the University Erlangen-Nuremberg.
Glaucoma participants were selected from those included in ’The Erlangen Glaucoma Registry’, a
clinical registry for cross-sectional and longitudinal observational study of patients with open-angle
glaucoma or glaucoma suspect. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 134 eyes of 134 participants enrolled (102 glaucoma, 32 controls). Glaucoma patients
were divided based on TSS value: 33 had TSS = 100, 31 had TSS ≥ 80 and ≤ 99, 38 had TSS < 80
Age:TSS = 100 glaucoma eyes: mean ± SD, 57.1 ± 10.3 years; 99 ≥, TSS ≥ 80 glaucoma: 60.0 ±
9.8 years; TSS < 80 glaucoma: 60.3 ± 11.1 years; controls 57.2 ± 6.1 years
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Sex: 72 men (54 glaucoma, 18 controls) and 62 women (48 glaucoma, 16 controls)
Ethnicity: not specified.
Country: Germany.
Setting: Department of Ophthalmology, University of Erlangen- Nuremberg, Erlangen
Ocular comorbidities: patients with diabetes, any eye diseases other than glaucoma, or myopic
refractive error > 7 D or equivalent sphere > D diopter of astigmatism were excluded
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were 7.3 ± 6.3
dB and 6.4 ± 2.5 dB, respectively for TSS = 100 glaucoma group; 7.4 ± 5.3 dB and 6.8 ± 2.9 dB
respectively for 99 ≥ TSS and ≥ 80 glaucoma group; 7.4 ± 5.5 dB and 6.2 ± 2.8 dB respectively
for TSS < 80 glaucoma group
Control participants: IOP ≤ 21 mmHg, normal optic disc and normal VF result
Index tests Scanning laser polarimetry:GDx VCC (software version 5.5.0; Carl Zeiss Meditec). Only images
with a centred optic disc, well-illuminated and a scan score > 8 were accepted
The authors stated no conflict of interested.
Target condition and reference
standard(s)
Manifest Glaucoma: IOP > 21 mmHg, open angle at gonioscopy, glaucomatous ONH appearance
(defined as neuroretinal rim thinning, notching, visibility of localised RNFL defects, or an unusually
small neuroretinal rim area in relation to the optic disc size and cup-to-disc ratios that were larger
vertically than horizontally) and glaucomatous VF defects (defined as the presence of 3 adjacent test
points with P < 0.05 or 2 adjacent test points with P < 0.01 in the pattern deviation map)
Visual field testing:Octopus 500 (Haag-Streit; Peridata software, version 2.2.3). Reliability criteria
were false-positive and false-negative rates < 12%
Optic disc evaluation: 15° colour photographs (Zeiss telecentric fundus camera, Germany)
Flow and timing The time interval between index tests and reference standard was not reported
No patients were reported as excluded from the analysis by the authors
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
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DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
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Hong 2007
Study characteristics
Patient sampling Primary open-angle glaucoma patients with early VF defects and healthy controls were included.
One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 120 eyes of 120 participants (72 glaucoma and 48 healthy controls)
Age: glaucoma patients mean ± SD, 37.8 ± 15.6 years; controls 38.7 ± 13.6 years
Sex: 54 men (34 glaucoma and 20 controls); 66 women (38 glaucoma and 28 controls)
Country: not specified.
Ocular comorbidities: no significant cataract, BCVA < 20/40, SE > ±5 D, ocular diseases other
than glaucoma, previous intraocular surgery, or narrow angle
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -2.9 ± 1.12 dB
and 3.26 ± 0.76 dB, respectively
Control participants: no VF loss by SAP, IOP < 21 mmHg, no ONH/RNFL changes suggestive of
glaucoma
Index tests Scanning laser polarimetry:GDxVCC (LaserDiagnostic Technologies, Inc. SanDiego, CA,USA)
No author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: optic disc damage (defined as excavation, notching, focal or diffuse atrophy
of neuroretinal rim area, vertical cup-to-disc ratio more than 0.6, cup-to-disc asymmetry between
fellow eyesmore than 0.2, disc haemorrhage, baring of circumlinear blood vessels, or localised defect
of the RNFL) and VF loss (defined as GHT outside normal limits or PSD with P < 5% or 3+
adjacent points below the 5% level on the pattern deviation plot, with at least 1 point below the
1% level)
Visual field testing: Humphrey Field Analyzer, model II, 30-2 SITA-standard strategy (Carl Zeiss
Meditec Inc., Dublin, CA, USA). VF reliability criteria were not reported
Flow and timing Reference standard and visual field were performed within 1 week
No patient was reported as excluded from the analysis.
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
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Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Unclear
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
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Huang 2010
Study characteristics
Patient sampling Glaucoma patients and healthy controls who had sought treatment at the department of ophthal-
mology, were enrolled. One eye per person was selected
Patient characteristics and set-
ting
Sample size: 165 eyes of 165 participants (79 glaucoma, 86 healthy controls)
Age: glaucoma patients mean ± SD, 44.3 ± 14.72 years; controls 40.2 ± 15.54
Sex: 82 men (42 glaucoma, 40 controls) and 83 women (37 glaucoma, 46 controls)
Ethnicity: Taiwan Chinese.
Country: China.
Ocular comorbidities: no co-existing retinal disease, BCVA < 20/40, SE > ±5 D, uveitis, or non-
glaucomatous optic neuropathy
Setting: Department of Ophthalmology, China Medical University Hospital, Taiwan
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -5.6 ± 4.23 dB
and 2.38 ± 3.15 dB respectively
Control participants: IOP < 21 mmHg, normal optic nerve appearance, and a normal VF result
(MD and PSD within 95% confidence limits, and GHT within normal limits)
Index tests Scanning laser polarimetry: GDx-VCC, software version 5.5.0 (Laser Diagnostic Technologies,
Inc. San Diego, CA, USA). All measurements were obtained by the same trained technician. The
images had to be of high quality (a well-focused, even, centred optic disc without any motion
artefact) and with a scan quality score > 7. No author had conflict of interest
Target condition and reference
standard(s)
Manifest glaucoma: repeatable (2 consecutive) glaucomatous VF defects (defined as a PSD outside
the 95% normal confidence limits, or a GHT result outside 99% normal confidence limits)
Visual field testing: Humphrey Field Analyzer, model 750, 30-2 programme (Carl Zeiss Meditec,
Dublin, CA, USA). Optic disc appearance was not part of the reference standard
Flow and timing Reference standard and index test were performed within 3 months. No patients were reported as
excluded from the analysis
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
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High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
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Huang 2011
Study characteristics
Patient sampling Glaucoma patients were retrospectively collected from the clinical database of theGlaucoma Service,
where patients received OCT imaging as part of routine management. The control group was
enrolled prospectively, between June 2008 and September 2009. One eye per person was randomly
selected
Patient characteristics and set-
ting
Sample size: 220 eyes of 220 participants (146 glaucoma and 74 healthy controls)
Age: glaucoma patients mean ± SD, 64.34 ± 8.28 years; controls 61.49 ± 9.91 years
Sex: 59 men (25 controls, 34 glaucoma), 82 women (49 controls, 33 glaucoma)
Ethnicity: 75 white (48 glaucoma, 27 controls), 22 African-American (17 glaucoma, 5 controls),
118 Asian (73 glaucoma, 35 controls) and 15 Hispanic (8 glaucoma, 7 controls)
Country: USA.
Ocular comorbidities: no retinal disorders, BCVA < 20/40, SE < -6 D or > +3 D, optic nerve
disorders other than glaucoma, previous intraocular surgery, diabetes or central nervous system
disorders
Setting: Glaucoma Service at Beckman Vision Center, University of California, San Francisco
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -3.3 ± 2.64 dB
and 4.65 ± 3.01 dB respectively
Control participants: vertical cup-to-disc ratio ≤ 0.5, IOP ≤ 21 mmHg, and a normal VF (MD >
0 dB)
Index tests Optical coherence tomography: RTVue 100 OCT, software version 3.5 (Optovue, Fremont, CA,
USA). The ganglion cells complex scan and nerve head map 4 mm scans were acquired. A single
grader was assigned to redraw the disc margin and determine the anchoring points of the retinal
pigmented epithelium layer. OCT image had signal strength > 45 for GCC scan and 30 for Nerve
Head Map 4 mm scan.
No author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous VF defects (defined as the presence of > 3 contiguous points
lower than P < 0.05 and > 1 of these points below P < 0.01) and vertical cup-to-disc ratio large >
0.5
Visual field testing: Humphrey Field Analyzer, Model II, 30-2 SITA-standard strategy (Zeiss
Meditec, Dublin, CA, USA). Severity of VF defects was graded by a masked grader. VF reliability
criteria included fixation losses, false-positive and false-negative rates of < 20%
Optic disc evaluation: vertical cup-to-disc ratiowas estimated by an experienced glaucoma specialist
Flow and timing Reference standard and index test were performedwithin 3months. 1459 eyes from 810 participants
received the reference and the index tests during enrolment period; 220 eyes of 220 participants
were finally enrolled on the basis of inclusion criteria
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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Huang 2011 (Continued)
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
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Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Hwang 2012
Study characteristics
Patient sampling Healthy control participants and glaucoma patients (matched based on age, spherical equivalent
and optic disc size) were recruited consecutively between May 2009 and September 2011. One eye
per person was randomly selected
Patient characteristics and set-
ting
Sample size: 160 eyes of 160 participants enrolled (80 glaucoma, 80 controls)
Age: glaucoma eyes mean ± SD, 53.94 ± 11.17 years; controls 55.39 ± 11.15 years
Sex: all men.
Ethnicity: Korean.
Country: Korea.
Setting: Department of Ophthalmology, Armed Forces Capital Hospital, Seongnam
Ocular comorbidities: patients with spherical equivalent > ±2 D, BCVA < 20/30, history of ocular
inflammation, trauma, previous ocular surgery or laser, presence of concurrent retinal disease or
optic nerve disease other than glaucoma, or brain disorder that could influence VF results, were
excluded
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were -6.90 ± 4.79
dB and 7.44 ± 3.73 dB, respectively for glaucoma
Control participants: IOP ≤ 21 mmHg, open angle at gonioscopy, normal ONH, no RNFL defect
on red-free fundus photography and normal VF result
Index tests Optical coherence tomography:Cirrus HD-OCT (software version 5.1.0.96; Carl Zeiss Meditec,
Dublin, CA, USA). TheOptic Disc Scan cube 200 x 200 was used. Images with poor quality ( signal
strength ≤ 6, incorrect identification of the vitreoretinal surface detection algorithm, misidentifi-
cation of Bruch’s membrane and prominent saccade during the scan) were excluded.
The authors stated no conflict of interested.
Target condition and reference
standard(s)
Manifest Glaucoma: open angle on gonioscopy, glaucomatous ONH changes (as increased cup-
disc ratio and narrowing of the neuroretinal rim), RNFL defect (defined as a dark wedge-shaped
area with its apex touching the optic disc border in the brightly striated pattern of the surrounding
RNFL or generalised loss of RNFL visibility in the upper or lower retina), glaucomatous VF defects
(defined as a cluster of 3 points with P < 5% on the pattern deviation map in at least 1 hemifield,
including at least 1 point with P < 1%, or a cluster of 2 points with a P < 1% and GHT results
outside normal limits, or a PSD outside 95% of normal limits)
Visual field testing:Humphrey FieldAnalyzer (30-2SITA standard programme,Carl ZeissMeditec,
Inc, Dublin, CA, USA). Reliability criteria were fixation losses, false-positive and false-negative rates
< 15%
Optic disc evaluation: fundus examination with a +90 D and red-free fundus photograph using a
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Zeiss FF450 fundus camera (Carl Zeiss Meditec)
Flow and timing The time interval between index tests and reference standard was not reported
No patients were reported as excluded from the analysis by the authors
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
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Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Iester 2008
Study characteristics
Patient sampling Prospective, cross-sectional study. Patients were consecutively recruited. One eye per person was
selected
Patient characteristics and set-
ting
Sample size: 214 eyes of 214 participants (95 glaucoma, 119 healthy controls)
Age: glaucoma patients mean ± SD, 68.1 ± 11.9 years; controls 63.7 ± 12.3 years
Country: Italy.
Ocular comorbidities: no ocular disease other than glaucoma, spherical refraction > ±8 D or
secondary cause for glaucoma
Setting: Clinica Oculistica, Department of Neurological Sciences, Ophthalmology, Genetic, Uni-
versity of Genoa, Italy; Division of Ophthalmology, Ospedale S. Andrea, University La Sapienza II,
Roma, Italy
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -3.33 ± 4.92 dB
and 3.82 ± 2.85 dB, respectively
Control participants: IOP < 21 mmHg, normal VF, normal ONH and RNFL on clinical examina-
tion
Index tests Confocal scanning laser tomography: HRT 3, software version 3.0 (Heidelberg Engineering,
Heidelberg, Germany). Only high-quality images with acquisition sensitivity > 80% were included
in the study. ONHs were analysed using 2 different methods: either the observer drew the contour
line around the ONH or the system analysed the shape of the ONH without any user input
No author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous VF defects (defined as 3 adjacent points being depressed by 5
dB, with 1 of the points being depressed by at least 10 dB or 2 adjacent points being depressed by 10
dB or a 10 dB difference across the nasal horizontal meridian in 2 adjacent points) and/or a typical
abnormal ONH (defined as notching, diffuse/generalised loss of optic rim tissue, vertical cup/disk
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Iester 2008 (Continued)
diameter ratio asymmetry and disc haemorrhage), open angle at gonioscopy, IOP > 21 mmHg with
no treatment
Visual field testing: Humphrey Field Analyzer, model 750, 24-2 SITA-standard strategy (HFA,
Humphrey Inc, San Leandro, CA, USA). VF reliability criteria included fixation losses of < 20%
and false-negative rates of < 30%
Flow and timing The time interval between reference standard and index test was specified. All patients enrolled were
included in the analysis
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Jeoung 2010
Study characteristics
Patient sampling Eyes with preperimetric localised RNFL defects and normal control eyes meeting the eligibility
criteria were consecutively enrolled from May 2008 to October 2008. One eye per person was
randomly selected
Patient characteristics and set-
ting
Sample size: 110 eyes of 110 participants (55 preperimetric glaucoma and 55 healthy controls)
Age: preperimetric glaucoma patients mean ± SD, 54.1 ± 10.4 years; controls 53.4 ± 10.6 years
Sex: 60 men (30 glaucoma and 30 controls) and 50 women (25 glaucoma and 25 controls)
Country: Korea.
Ethnicity: not specified.
Ocular comorbidities: no uveitis, BCVA < 20/40, SE > ±5 D, ocular surgery other than cataract
extraction, or diseases that may affect the peripapillary area
Setting: Glaucoma Clinic of Seoul National University Hospital, Korea
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test -0.74 ± 0.96 dB and 1.
85 ± 0.39 dB, respectively
Control participants: IOP ≤ 21 mmHg (with no history of increased IOP), absence of glauco-
matous disc appearance (defined as intact neuroretinal rim without peripapillary haemorrhages,
notches, or localised pallor), no visible RNFL defect according to red-free RNFL photography, and
a normal SAP result
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Index tests Optical coherence tomography: Cirrus HD-OCT, Optic Disc cube 200 x 200 programme, soft-
ware version 3.0 (Carl Zeiss Meditec, Inc.). Patients were imaged after pupil dilation. The image
quality scans were assessed by 2 experienced examiners masked to the clinical information. The
minimum acceptable signal strength score was 6 and the examiners assessed subjectively the quality
of the image evaluating the en-face image for eye movements
No author had conflict of interest.
Target condition and reference
standard(s)
Preperimetric glaucoma: localised wedge-shaped RNFL defect clearly visible by red-free fundus
photography with normal SAP results (defined as MD and PSD within 95% confidence limits and
a GHT within normal limits) and open angle by gonioscopy
Red-free fundus photography: Digital fundus camera. 60°, wide-angle views of the optic disc,
carefully focused on the retina using the built-in split-line focusingdevicewere obtained and reviewed
on an LCD monitor by 2 experienced observers. Localised RNFL defects were determined when
their width at a 1-disc diameter distance from the edge of the disc was larger than that of a major
retinal vessel, diverging in an arcuate or wedge shape and reaching the edge of the disc
Visual field testing: Humphrey Field Analyzer, model II 750, 30-2 SITA-standard strategy (Carl
Zeiss Meditec, Dublin, CA, USA)
Flow and timing Time interval between reference standard and index test was not reported
171 eyes were initially enrolled. 19 eyes were excluded due to poor quality images. Of the 96 control
eyes, only 55 eyes age- and sex-matched with glaucoma eyes, were selected for the analysis
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
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Jeoung 2010 (Continued)
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
Jeoung 2013
Study characteristics
Patient sampling Healthy controls and glaucoma patients were among participants in the Macular Ganglion Cell
Imaging Study, an ongoing prospective study of glaucoma patients and healthy individuals at the
Glaucoma Clinic of Seoul National University Hospital. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 545 eyes of 545 participants initially considered, 425 eyes eventually included in
the analysis (306 glaucoma, 119 controls). 164 eyes with early glaucoma, 142 with moderate-to-
advanced glaucoma
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Age: early glaucoma eyes mean ± SD, 58.7 ± 10.2 years; moderate-to-advanced glaucoma eyes mean
± SD, 59.2 ± 13.1 years; controls 57.1 ± 12.3 years
Sex: 213 men (160 glaucoma, 53 controls) and 212 women ( 146 glaucoma, 66 controls)
Ethnicity: not specified.
Country: Korea.
Setting: Glaucoma Clinic of Seoul National University Hospital.
Ocular comorbidities: patients with BCVA < 20/40 in the study eye, refractive > ±6 D equivalent
sphere and ±3 D astigmatism, retinal disease (diabetic retinopathy, macular degeneration, retinal
detachment, epiretinal membrane) or non-glaucomatous optic nerve diseases, treatment that might
be toxic to the retina or optic nerve, laser therapy, or ocular surgery except non-complicated cataract
surgery were excluded
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were -2.68 ± 1.76
dB and 5.47 ± 2.8 db, respectively for early glaucoma, -12.41 ± 5.92 dB and 12.20 ± 3.16 dB for
moderate-to-severe glaucoma
Control participants: IOP ≤ 21 mmHg with no history of increased IOP, normal ONH appear-
ance, no RNFL defect on red-free fundus photography and normal VF result
Index tests Optical coherence tomography: Cirrus HD-OCT (software version 6.0, Carl Zeiss Meditec,
Dublin, CA, USA). The macular cube 200 x 200 and optic disc cube 200 x 200 scanning protocols
were used.
The authors stated no conflict of interest.
Target condition and reference
standard(s)
ManifestGlaucoma: glaucomatous optic disc cupping (defined as neuroretinal rim thinning, notch-
ing, excavation, or RNFL defect) and corresponding VF defect (defined as the presence of a cluster
of 3+ non-edge points on the pattern deviation plot with a P < 5%, with 1 of these points having a
P < 1%, a PSD with P < 5% or a GHT outside normal limits)
Visual field testing: Humphrey Field Analyzer (model II 750, 30-2 SITA standard programme,
Carl Zeiss Meditec, Inc, Dublin, CA, USA). Reliability criteria were fixation losses < 20, false-
positive and false-negative rates < 33%
Optic disc and RNFL evaluation: colour disc photography, red-free RNFL photography (TRC-
50IX; Topcon Corporation, Tokyo, Japan), evaluated independently by 2 observers in a random
order and masked fashion, without knowledge of the clinical information
Flow and timing Index test and reference standard were performed within 1 month. 92 eyes were excluded because
of diabetic retinopathy (n = 36), macular degeneration (n = 28), epiretinal membrane (n = 20), and
ocular surgery history (n = 8). 28 eyes were excluded from the analysis due to poor-quality images
Comparative
Notes Supported by Grant No. A121615 from the Korea Health technology R&D Project, Ministry of
Health&Welfare, Republic of Korea, and byGrant No. 2009-0091931 from theNational Research
Foundation of Korea (NRF) funded by the Korea government (MEST)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Jeoung 2013 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
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Did all patients receive a refer-
ence standard
Yes
Jindal 2010
Study characteristics
Patient sampling Healthy participants and patients with early-to-moderate primary open-angle glaucoma were en-
rolled prospectively. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 100 eyes of 100 participants (50 glaucoma, 50 healthy controls)
Age: glaucoma patients mean ± SD, 58.78 ± 11.08 years, controls 44.74 ± 8.88 years
Country: not specified.
Ocular comorbidities: no significant media opacity (corneal, lenticular), BCVA < 20/40, SE > ±5
D or other intraocular/neurological diseases affecting the RNFL, optic disc, or VF
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -6.45 ± 2.47 dB
and 5.71 ± 3.23 dB, respectively. Patients included were early or moderate glaucoma, according to
Hodapp et al. grading scale
Control participants: IOP ≤ 21 mmHg, open angles by gonioscopy, normal clinical evaluation,
and a normal VF test
Index tests Confocal scanning laser ophthalmoscopy:HRT 3, version 3.0. All images obtained were of good
quality, defined as having a topographic SD of < 30 µm and had no floaters or opaque areas. The
contour line was drawn by a single operator
No author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: IOP > 21mmHg at diagnosis, open angle by gonioscopy, glaucomatous ONH
changes and VF glaucomatous defects (defined as 3 contiguous non-edge points depressed with P <
5%, 1 of which had P < 1%, all being not contiguous with the blind spot and GHT outside normal
limits and PSD < 5%)
Visual field testing: Humphrey Field Analyzer, model II, 30-2 SITA-standard strategy. No details
about VF reliability criteria were reported
Optic disc evaluation: stereoscopic dilated fundus examination.
Flow and timing The time interval between reference standard and index test was not reported
No patients were reported as excluded from the analysis .
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Did all patients receive a refer-
ence standard
Yes
Kanamori 2006
Study characteristics
Patient sampling Retrospective study, performed between April 2003 and November 2003. Normal, ocular hyper-
tensive, suspected/preperimetric glaucoma and manifest perimetric glaucoma eyes were enrolled.
One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 241 eyes of 201 participants (67 perimetric glaucoma, 55 preperimetric glaucoma, 26
OHT and 93 healthy controls)
Age: perimetric glaucoma patients mean ± SD, 48.9 ± 12.6 years; preperimetric glaucoma patients
mean ± SD, 48.5 ± 12.3 years; hypertensive mean ± SD 46.4 ± 11.4 years; controls 45 ± 15.5 years
Sex: 119 men (30 perimetric glaucoma, 22 preperimetric glaucoma,14 OHT, 53 controls) and 122
women (37 perimetric glaucoma, 33 preperimetric glaucoma, 12 OHT, 40 controls)
Country: Japan.
Ocular comorbidities: no previous ocular surgeries, BCVA < 20/40, cylinder refraction > ±4 D,
retinal disease, significant vitreous opacity or diabetes
Setting: Department of Ophthalmology of the Kobe University Hospital
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -3.55 ± 1.76 dB
and 6.26 ± 10.82 dB for the perimetric glaucomatous eyes; -1.14 ± 1.41 dB and 1.46 ± 0.98 dB for
the preperimetric glaucomatous eyes; -0.63 ± 1.11 dB and 1.24 ± 0.88 dB respectively for OHT
eyes
Control participants: no family history of glaucoma, normal optic disc appearance, and normal
IOP
Index tests Scanning laser polarimetry: GDx VCC, software version 5.3.2 (Laser Diagnostic Technologies,
Inc., San Diego, CA, USA). Images were taken from each eye without pupillary dilation. Images
were accepted only if the quality score was > 7
No details about authors’ conflict interest were reported.
Target condition and reference
standard(s)
Manifest perimetric glaucoma: glaucomatous optic neuropathy (vertical cup-disc asymmetry be-
tween fellow eyes of 0.2 or more and neuroretinal rim damages such as excavation, rim thinning,
and notches) and associated VF loss (2+ contiguous points with a pattern deviation sensitivity loss
of P < 0.01, or 3+ contiguous points with sensitivity loss of P < 0.05, in the superior or inferior
arcuate areas, or a 10 dB difference across the nasal horizontal midline at 2+ adjacent locations and
a GHT outside normal limits)
Manifest preperimetric glaucoma: glaucomatous optic neuropathy (vertical cup-disc asymmetry
between fellow eyes of 0.2 or more and neuroretinal rim damages such as excavation, rim thinning,
and notches) with normal VF result
Ocular hypertensive: IOP > 21 mmHg (on 2 separate occasions), normal optic disc appearance
and normal VF result
Visual field testing: Humphrey Field Analyzer, 30-2 SITA-standard strategy (Humphrey-Zeiss
Instruments, Dublin, CA, USA). VF reliability criteria included fixation losses of < 20% and false-
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negative rates of < 25%
Optic disc evaluation: stereoscopic examination with slit-lamp biomicroscopy by glaucoma expert
masked to the index test result
Flow and timing Reference standard and index tests were performed within 6 months
32 eyes (> 10%) were excluded due to poor-quality image.
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
Yes
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of the results of the index tests?
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
Kang 2012
Study characteristics
Patient sampling Healthy control participants and glaucoma patients were recruited prospectively, in a consecutive
manner, betweenMarch 2009 and February 2010. One eye per person was randomly selected. Only
people with VF loss confined to 1 side of the horizontal median were enrolled
Patient characteristics and set-
ting
Sample size: 112 eyes of 112 participants initially enrolled. 108 eyes finally included in the analysis
(54 glaucoma, 54 controls)
Age: glaucoma eyes mean ± SD, 56.4 ± 11.8 years; controls 55.1 ± 6.90 years
Sex: 56 men (28 glaucoma, 28 controls) and 49 women (23 glaucoma, 26 controls)
Ethnicity: not specified.
Country: Korea.
Setting: Glaucoma Clinic of Asan Medical Center, Seoul.
Ocular comorbidities: eyes had to have BCVA ≥ 20/30, a spherical equivalent within ±5 D and
a cylinder correction within +3 D. Patients with any ophthalmic disease other than glaucoma that
could result in an HFA defect, or with histories of intraocular surgery or diabetes mellitus were
excluded
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were -5.12 ± 3.44
dB and 6.55 ± 3.73 dB, respectively for glaucoma
Control participants: IOP < 22mmHgwith no history of increased IOP, normal ONHappearance
and normal VF result
Index tests Optical coherence tomography: Cirrus OCT (software version 3.0.0.50). Optic disc cube scan
200 x 200 mode. Images with poor quality (signal strength < 7, overt misalignment of the surface
detection algorithm, overt displacement of the measurement circle) or horizontal eye motion ob-
served within the measurement circle.
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The authors stated no conflict of interest.
Target condition and reference
standard(s)
Manifest Glaucoma: glaucomatous VF defect (defined as a GHT result outside 97% of normal
limits, a PSD outside 95% of normal limits, and a cluster of 3+ points in the pattern deviation plot
in a single hemifield (superior or inferior) with P < 0.05, 1 of which had a P < 0.01) regardless of
the ONH or RNFL appearance). Glaucomatous VF loss was confined to 1 side of the horizontal
meridian, as defined by 3+ adjacent points with P < 0.05 in a PD probability map, or 2+ adjacent
points with P < 0.02 in a superior or inferior hemifield; and the hemifield of the other side had no
clusters of 3 points with P < 0.05 and no clusters of 2 points with P < 0.02 on either total deviation
or pattern deviation probability maps
Visual field testing:Humphrey FieldAnalyzer (24-2SITA standard programme,Carl ZeissMeditec,
Inc, Dublin, CA,USA). Reliability criteria were fixation losses < 20, false-positive and false-negative
rates < 15%
Flow and timing The time interval between index test and reference standard was not reported
4 glaucoma eyes (< 10%) were excluded from the analysis: 1 eye for poor VF reliability test, 3 eyes
due to poor-quality index test result
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
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Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Kim 2011
Study characteristics
Patient sampling Glaucoma patients with or without high myopia were consecutively enrolled from January 2009 to
June 2009. Normal controls were sequentially matched. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 196 participants examined, 150 included in the analysis. The participants were divided
into 2 groups: a highly-myopic group (spherical equivalent < -6.00 D) and a non-highly myopic
group (spherical equivalent > -6.00 D): 45 highly-myopic participants (21 glaucoma, 24 controls)
and 105 non-highly myopic (56 glaucoma, 49 controls)
Age: glaucoma highly-myopic eyes mean ± SD, 42.67 ± 16.32 years; highly-myopic controls 41.
83 ± 12.44 years; glaucoma non-highly myopic eyes mean ± SD, 56.02 ± 14.90 years; non-highly
myopic controls 52.39 ± 15.55 years;
Sex: 76 men (45 glaucoma, 31 controls) and 74 women (32 glaucoma, 42 controls)
Ethnicity: Asian.
Country: Korea.
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Setting: Glaucoma-Cataract Clinic of Severance Hospital, Seoul.
Ocular comorbidities: highly-myopic eyes with any atypical non-glaucomatous field defect and
eyes with a narrow angle, media opacity, prior history of ocular surgery, diabetes mellitus, or other
diseases affecting the VF were excluded
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were -8.56 ± 5.82
dB and 7.85 ± 4.76 dB respectively, for glaucoma highly-myopic eyes; were -9.49 ± 7.41 dB and 7.
75 ± 4.16 dB, respectively for glaucoma non-highly myopic eyes
Control participants: IOP < 21 mmHg, normal appearance of ONH and normal VF test result
Index tests Optical coherence tomography: RTVue-100 (software version: 4.0.5.39, Optovue, Fremont, CA,
USA). The nerve head map 4 mm diameter (NHM4) and the MM7 scanning protocols were used.
Images with a poor quality (SSI < 35, overt misalignment of the surface detection algorithm or overt
decentration of the measurement circle location) were excluded.
No authors had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous VF defects (defined as having 3+ significant (P < 0.05) non-edge
contiguous points with at least 1 at the P < 0.01 level on the same side of the horizontal meridian
in the pattern deviation plot, classified as outside normal limits in the GHT) and glaucomatous
appearance of the ONH not otherwise described
Visual field testing: Humphrey Field Analyzer, 20-2 SITA standard programme (Carl Zeiss
Meditec). VF reliability criteria were not reported
Optic disc and RNFL evaluation: stereoscopic optic disc photography or red-free RNFL photog-
raphy
Flow and timing Index test and reference standard were performed on the same day. 46 eyes (> 10%) were excluded
from the final analysis: 36 because of poor OCT image (low signal strength (11), improper scan
decentration (14), presence of epiretinal membrane (2), erroneous RNFL or GCC profile (5) algo-
rithm of the GCC failure(4)); 3 because of unacceptable stereoscopic fundus photography, and 7
due to unreliable VF
Comparative
Notes This research was supported by the Basic Science Research Programme through the National Re-
search Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology
(No 2009-0076736)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
128Optic nerve head and fibre layer imaging for diagnosing glaucoma (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kim 2011 (Continued)
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
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Study characteristics
Patient sampling Participants were enrolled consecutively from January 2009 to June 2009. NTG were sequentially
enrolled as they presented. Primary open-angle glaucoma patients were randomly matched by age,
sex, and visual field sensitivities to those of NTG group. Healthy controls were recruited from the
hospital staff, nurses, the spouses or friends of patients, and patients referred for routine visual acuity
examination, matched by age and sex with glaucoma patients. One eye per person was randomly
selected
Patient characteristics and set-
ting
Sample size: 161 eyes of 161 participants included(52 with POAG, 51 with NTG, 58 controls)
Age: POAG eyes mean ± SD, 57.02 ± 15.74 years; NTG 55.55 ± 14.50 years; controls 55.78 ± 10.
98 years
Sex: 78 men (30 POAG, 22 NTG, 26 controls) and 83 women (22 POAG, 29 NTG, 32 controls)
Ethnicity: Asian.
Country: Korea.
Setting: Glaucoma-Cataract Clinic of Severance Hospital in the Yonsei University College of
Medicine, Seoul
Ocular comorbidities: patients with media opacity, history of ocular surgery (other than uncom-
plicated glaucoma and cataract surgery), or other diseases affecting the VF were excluded
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were -7.09 ± 5.36
db and 6.41 ± 4.31 dB respectively, for NTG, -7.70 ± 4.40 and 7.67 ± 4.43 respectively, for POAG
Control participants: IOP < 21 mmHg, normal ONH appearance and normal VF results. BCVA
≥ 20/40 and refractive error between +3 and -8 D
Index tests Optical coherence tomography: RTVue-100 Fourier-Domain OCT (software version: 4.0.5.39;
Optovue Inc, Fremont, CA, USA). NHM4 and MM7 scanning protocols were used. Images with
signal strength index < 35, overt misalignment of the surface detection algorithm or overt decen-
tration of the measurement location, were excluded.
No authors had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous VF defects (defined as having 3+ significant (P < 0.05) non-edge
contiguous points with at least 1 at the P < 0.01 level on the same side of the horizontal meridian in
the pattern deviation plot, and GHT outside normal limits) and glaucomatous ONH appearance
(defined as cup-to-disc ratio > 0.7, inter-eye cup asymmetry > 0.2 or neuroretinal rim notching,
focal thinning, disc haemorrhage, or vertical elongation of the optic cup)
Glaucoma patients were classify in 2 subgroups:
OAG: IOP before treatment > 21 mmHg based on 3 measurements on different days
NTG: untreated peak IOP < 21 mmHg on repeated 3 measurements taken at different times
Visual field testing: Humphrey Field Analyzer, 20-2 SITA standard programme (Carl Zeiss
Meditec). VF reliability criteria were fixation losses < 20% and false-positive and false-negative rates
< 15%
Optic disc evaluation: slit-lamp biomicroscopy.
Flow and timing Index test and reference standard were performed on the same day. Authors stated that “Data were
discarded if the scan quality did not satisfy the criteria described above”, but no patients were
reported as excluded from the analysis
Comparative
Notes None.
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Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
131Optic nerve head and fibre layer imaging for diagnosing glaucoma (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kim 2013a (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Did all patients receive a refer-
ence standard
Yes
Kim 2013b
Study characteristics
Patient sampling Healthy participants and patients with a RFNL defects were recruited in an observational case-
control design study. No other details were reported. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 94 participants enrolled, 90 eyes of 90 participants included in the analysis (48 with
RNFL defects, 42 controls)
Age: eyes with RNFL defects mean ± SD, 55.4 ± 11.6 years; controls 51.0 ± 12.7 years
Sex: 35 men (18 with RNFL defects, 17 controls) and 55 women (30 with RNFL defects, 25
controls)
Ethnicity: not reported.
Country: Korea.
Setting: Department of Ophthalmology, Seoul National University Hospital
Ocular comorbidities: patients with retinal abnormality, previous retinal laser or intraocular surgery
other than a cataract extraction or neurologic diseases were excluded. All patient had to have BCVA
≥ 20/40, a spherical equivalent within ±5.00 D, and an open anterior chamber angle
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were -3.1 ± 3.3 dB
and 5.3 ± 3.4 dB respectively,for eyes with a localised RNFL defect
Control participants: IOP < 21 mmHg, normal ONH appearance, normal VF results and no
RNFL defect visible on red-free RNFL photograph
Index tests Optical coherence tomography: Cirrus HD-OCT model 4000 (software version 5.1.1.6; Carl
Zeiss Meditec). The optic disc cube scan was used. To be included all images had to have a signal
strength > 6, good centring of the optic disc, and the absence of motion artefacts
Optical coherence tomography: 3D OCT-2000 (software version 7.20; TopconMedical Systems)
. The circumpapillary and macular cube scans were used. All images had to have a Q factor score >
60.
Authors’ conflicts of interest were not reported.
Target condition and reference
standard(s)
Manifest glaucoma: patients with a localised RNFL defect defined as a well-outlined, dark wedge-
shaped area in the brightly-striated pattern of the surrounding healthy RNFL with its tip touching
the optic disc border. Patients with a localised RNFL defect included those with perimetric glaucoma
with corresponding VF defects and those with preperimetric glaucoma with a normal VF
Visual field testing: Humphrey Field Analyzer II (30-2 SITA standard programme (Carl Zeiss
Meditec). Visual field reliability criteria were fixation losses <20%and false positive and false negative
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<15%
RNFL evaluation: red-free fundus photography (VX- 10; Kowa Optimed, Tokyo, Japan). Two
trained specialists evaluated the photograph independently and in a masked fashion
Flow and timing Index tests were performed on the same day but the time interval between index tests sand reference
standard was not reported. 4 participants (<10%) were excluded due to unacceptable OCT quality
scans
Comparative
Notes The work was supported by Grant number 3020110090 from the Seoul National University Hos-
pital
Research Fund donated by Mr. Bong Joo Kim.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Unclear
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Kim 2014a
Study characteristics
Patient sampling Case-control study including participants in an ongoing study of glaucoma and healthy individuals
If both eyes eligible only one eye per person was randomly chosen
Patient characteristics and set-
ting
Sample size: 184 eyes of 205 participants (92 preperimetric glaucoma, 92 normal controls)
Age: preperimetric glaucoma mean ± SD, 57.8 ± 11.4 years; controls, 57.6 ± 11.3 years
Sex: 95 men (45 preperimetric glaucoma, 50 controls) and 89 women (47 preperimetric glaucoma,
42 controls)
Ethnicity: Korean
Setting: Glaucoma Clinic of Seoul National University Hospital, Seoul
Country: South Korea.
Ocular comorbidities: eyes with history of amblyopia, uveitis, intraocular surgery (excepting un-
complicated cataract surgery), diabetes, ocular diseases possibly affecting the peripapillary area (e.g.
, large peripapillary atrophy), or macular area (e.g., epiretinal membrane), and any other ocular or
systemic diseases affecting the VF (e.g., retinal vein occlusion, ischaemic optic neuropathy), were
excluded
Spectrum of glaucoma severity: the mean ± SD mean deviation and PSD on the VF test were -0.
16 ± 1.61 and 1.99 ± 0.86 respectively, for preperimetric glaucoma
Control participants: IOP ≤ 21 mmHg with no history of increased IOP, an absence of glauco-
matous disc appearance, no visible RNFL defect on red-free fundus photography, and a normal VF
result
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Index tests Optical coherence tomography: Cirrus OCT (Carl Zeiss Meditec, Dublin, CA, USA); software
version 6.0. Only images that were well centred on the optic disc or fovea with signal strength of ≥
6 were included in the analyses. GCA and optic disc cube 200 x 200 scanning protocols were used
The authors declare no conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: 1+ localised RNFL defects associated with a glaucomatous disc appearance (e.
g. notching or thinning of neuroretinal rim), which have documented evidence of progression (e.
g. focal or diffuse narrowing of neuroretinal rim, increased excavation, increased width or depth
of RNFL defects) through stereoscopic disc photography (SDP) or red-free fundus photography
performed at least 6 months before enrolment, and normal VF result (PSD > 5% and GHT within
normal limits)
Visual field test:Humphrey Field Analyzer II (Carl ZeissMeditec, Inc.) with 30-2 SITA-algorithm.
VF exams were considered reliable when fixation loss < 20%, false-positive and false negative rates
< 33%
RNFL evaluation: red-free fundus photography (VX-10; Kowa Optimed, Tokyo, Japan). 2 glau-
coma specialists independently evaluated the red-free fundus photographs without knowledge of
the participant’s clinical information
Flow and timing 209 eyeswere initially involved (117 eyeswith glaucoma and92normal control eyes). After excluding
4 eyes for ambiguous RNFL defects and age-matching the two groups, 184 eyes of 184 subjects
(92 preperimetric glaucoma and 92 age-matched healthy control participants) were included in the
analysis
More than 10% of the enrolled eyes were excluded from the analysis
No details reported about time interval between index and reference test
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
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If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
Kim 2014b
Study characteristics
Patient sampling Retrospective case-control study including early glaucoma, preperimetric glaucoma and healthy
controls. If both eligible, one eye per person was randomly selected
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Patient characteristics and set-
ting
Sample size: 204 eyes of 204 participants (72 early glaucoma, 68 preperimetric glaucoma, 64 normal
controls)
Age: early glaucoma mean ± SD, 56.83 ± 12.73 years; preperimetric glaucoma, 53.12 ± 10.69 years;
controls, 51.77 ± 14.44 years;
Sex: not reported.
Ethnicity: not reported.
Setting: general healthcare clinic or glaucoma clinic of theGuri HanyangUniversityMedical Center
from September 2011 through May 2013
Country: South Korea.
Ocular comorbidities: patients with co-existing retinal disease, uveitis, or non-glaucomatous optic
disc neuropathy were excluded
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were -3.08 ± 1.
61 and 4.29 ± 2.64 respectively, for early glaucoma; -1.02 ± 1.29 and 1.87 ± 0.5 respectively for
preperimetric glaucoma
Control participants: first-degree relatives with glaucoma, no history or evidence of intraocular
surgery, IOP < 22 mmHg, a normal optic disc appearance and ophthalmic findings
Index tests Optical coherence tomography: Cirrus OCT (Carl Zeiss Meditec, Dublin, CA, USA); software
version 6.0. Poor-quality OCT images such as those with low signal strength (< 70), motion artefact,
or decentration were excluded. 7 x 7 mm scanning disc protocol was used to analyse RNFL and
GCC parameters
The authors declare no conflict of interest
Target condition and reference
standard(s)
Manifest perimetric glaucoma: glaucomatous VF results (defined as a cluster of 3 points with P <
5% on the pattern deviation map in at least 1 hemifield, including at least 1 point with P < 1%; or a
cluster of 2 points with P < 1%, and GHT or PSD outside normal limits) and glaucomatous ONH/
RNFL appearance (neuroretinal rim loss or notching, focal thinning of theNFL, disc haemorrhages,
or vertical elongation of the optic cup)
Manifest preperimetric glaucoma: glaucomatous ONH/RNFL appearance (neuroretinal rim loss
or notching, focal thinning of the NFL, disc haemorrhages, or vertical elongation of the optic cup)
with normal VF results
Visual field test: Humphrey Field Analyzer (Carl Zeiss Meditec, Dublin, CA, USA) 30-2 SITA
standard programme. The fixation losses < 20 %, and false-positive and false-negative errors < 15
%, were considered as reliable
Optic disc/RNFL evaluation: dilated funduscopy using a 78-D lens and stereoscopic optic disc
photography
Flow and timing No details reported about exclusion and time interval between index and reference test
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
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Did all patients receive a refer-
ence standard
Yes
Kita 2013
Study characteristics
Patient sampling Case-control study including glaucoma, and healthy controls. preperimetric glaucoma and healthy
controls. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 134 eyes of 134 participants (33 advanced glaucoma, 66 early glaucoma, 35 normal
controls)
Age: mean ± SD: advanced glaucoma 56.6 ± 10.5 years; early glaucoma 54.3 ± 10.9 years; controls,
50.7 ± 12.2 years
Sex: 52 men (12 advanced glaucoma, 23 early glaucoma, 17 controls) and 82 women (21 advanced
glaucoma, 43 early glaucoma, 18 controls)
Ethnicity: Japanese.
Setting:Department of Ophthalmology, Toho University Ohashi Medical Center, Tokyo, between
October 2009 and March 2011
Country: Japan
Ocular comorbidities: patients with diseases that affected the visual field (e.g. pituitary lesions,
demyelinating diseases, or diabetic retinopathy), retinal pathology, previous retinal laser procedures,
or if they had any previous ocular surgeries, neurological disease, or a history of diabetes, were
excluded
Spectrum of glaucoma severity: themean ± SDMDon the VF test were -10.69 ± 3.7, for advanced
glaucoma; -2.89 ± 1.74 for early glaucoma
Control participants: IOP<21mmHg, a normalONHappearance, normal open anterior chamber
angles, normal VF results for the GHT
Index tests Optical coherence tomography: RTVue-100 (software version 4.0.5.39; Optovue Inc., Fremont,
CA, USA). Images with a signal strength < 45 due to media opacity, patient positioning, or excessive
eye movement were excluded. GCC and ONH scanning protocol were used for the analysis
One authors received research support from manufacturer.
Target condition and reference
standard(s)
Manifest perimetric glaucoma: glaucomatous optic neuropathy (defined as a neuroretinal rim
narrowing of the optic disc margin with notching, excavation, or a visible RNFL defect) and VF
glaucomatous defects (defined as a cluster of 3+ contiguous points in the pattern deviation plot with
P < 5%, with at least 1 P < 1%, and GHT outside normal limits)
Visual field test:Humphrey Field Analyzer (Carl Zeiss Meditec, Dublin, CA, USA) 30-2 and 24-2
SITA standard programme. The fixation losses < 20 %, and false-positive and false-negative errors
were < 25 %, were considered as reliable
Optic disc/RNFL evaluation: stereoscopic fundus examination.
Flow and timing No details about exclusion reported.
Index test and reference standard were performed within 3 months
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Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
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Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Did all patients receive a refer-
ence standard
Yes
Koh 2014
Study characteristics
Patient sampling Case-control study in which glaucoma patients seen by a glaucoma specialist were consecutively
enrolled during the period from May 2012 to October 2012 at the glaucoma clinic at Kim’s Eye
Hospital. Healthy control were recruited from among those who visited the clinic during the
enrolment period for an annual health examination. One eye per person was included
Patient characteristics and set-
ting
Sample size: 110 eyes of 110 participants (60 glaucoma and 50 healthy controls)
Age: glaucoma mean ± SD, 60.7 ± 13.9 years; controls, 58.5 ± 14.9 years
Sex: 50 men (27 glaucoma, 23 controls) and 60 women (33 glaucoma, 27 controls)
Ethnicity: not reported.
Clinical Setting: Glaucoma clinic at Kim’s Eye Hospital, Seul.
Country: Korea.
Ocular comorbidities: patients with concurrent retinal disease (i.e. secondary to a vascular disorder,
macular degeneration), optic nerve disease other than glaucoma, or a brain disorder that could
influence VF results, or media opacity, were excluded
Spectrum of glaucoma severity: the median (1st and 3rd quartiles) MD and PSD on the VF test
were -7.64 (-10.69 to -3.84) and 6.92 (4.75 to 8.81) respectively, for glaucomatous eyes
Control participants: IOP < 21 mmHg, normal anterior chamber and open angle, a normal ONH
without glaucomatous changes; no RNFL defect on red-free fundus photography; and normal
reliable VF test results
Index tests Optical coherence tomography: Cirrus HD-OCT (Carl Zeiss Meditec, Dublin, CA, USA). Optic
disc cube 200 x 200 scan protocol was used for the analysis
Optical coherence tomography: Spectral OCT/scanning laser ophthalmoscopy (OPKO/OTI,Mi-
ami, FL, USA). Scan circle centred on the optic disc. All images had to have signal strength ≥ 6
and no motion artefacts
The authors report no conflicts of interest.
Target condition and reference
standard(s)
Manifest glaucoma: normal anterior segment on slit-lamp examination, glaucomatous ONH ap-
pearance (increased cup-disc ratio and narrowing of the neuroretinal rim), RNFL defects on red-
141Optic nerve head and fibre layer imaging for diagnosing glaucoma (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Koh 2014 (Continued)
free fundus photography(dark wedge-shaped area with its apex touching the optic disc border in
the brightly-striated pattern of the surrounding RNFL or a generalised loss of RNFL visibility in
the upper or lower retina) and glaucomatous VF defects (a cluster of 3 points with P < 5% on the
PD map in at least 1 hemifield, including at least 1 point with P < 1% or a cluster of 2 points with
P < 1%, or GHT outside normal limits, or a PSD with P < 5%)
Visual field test: Humphrey Field Analyzer (Carl Zeiss Meditec); 24-2 SITA-standard strategy. All
exams had fixation losses and false-positive and false-negative rates of < 15%
Flow and timing No details about exclusion were reported.
The index and reference test were performed on the same day
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
Yes
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condition?
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Did all patients receive a refer-
ence standard
Yes
Kook 2005
Study characteristics
Patient sampling Cases were recruited prospectively in a consecutive manner and examined between April 2003
and September 2004. The control group consisted of clinic staff, friends or spouses of patients, or
volunteers from other specialty clinics. One eye per person was selected
Patient characteristics and set-
ting
Sample size: 136 eyes of 136 participants (70 glaucoma, 66 healthy controls)
Age: glaucoma patients mean ± SD, 55.11 ± 10.49 years; controls 52.15 ± 11.81
Sex: 60 men (39 glaucoma, 21 controls) and 76 women (31 glaucoma, 45 controls)
Country: Korea.
Ocular comorbidities: no retinal pathology, BCVA < 20/30, spherical refraction > ±5 D, cylinder
refraction > ±3 D, history of laser or intraocular surgery, intracranial abnormalities, or a lesion
revealed by neurological examination
Setting: Asian Medical Center, University of Ulsan, Seoul.
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were −4.59 ± 3.25 dB
and 6.72 ± 3.08 dB, respectively
Control participants: normal VF, absence of glaucomatous ONH appearance, multiple IOPs < 21
mmHg
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Index tests Scanning laser polarimetry: GDx VCC, software version 5.3.1 (Laser Diagnostic Technologies,
Dublin, CA, USA). Only scans of high quality were used in the study (centred optic disc, well-
focused even illumination throughout the fundus image, and no motion artefacts). Only eyes with
a scan quality score of 8+ were analysed. Index tests were reviewed independently by 2 glaucoma
specialists in a blinded fashion.
No author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous optic nerve appearance (excavation, neuroretinal rim thinning
or notching, or asymmetry of the vertical cup-to-disc ratio of > 0.2), reproducible VFdefects (defined
as aGHT test result outside normal limits or as a CPSD outside 95% of normal limits) with localised
VF loss confined to 1 side of the horizontal meridian on the HFA (more than 3 adjacent points
with P < 0.05 in a pattern deviation probability map or > 2 adjacent points with P < 0.02, only in
1 side of the horizontal meridian) and normal anterior chambers on gonioscopy
Visual field testing: Humphrey Field Analyzer, 24-2 full threshold test strategy (Zeiss-Humphrey,
Dublin, CA, USA). VF reliability criteria included fixation losses rates of < 20% and false-negative
and false-positive rates of < 15%
Optic disc evaluation: simultaneous stereophotographs were assessed by 2 independent graders
Reference standard tests were review in a blind fashion.
Flow and timing The time interval between reference standard and index test was not reported
16 participants had poor-quality index or reference test results and were excluded from the analysis
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
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Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
Kotowski 2012
Study characteristics
Patient sampling Healthy, glaucoma suspect and glaucoma patients were selected among those recruited in the ’Pitts-
burgh Imaging Technology Trial study’ (a prospective longitudinal study designed to assess ocular
structure over time). No details about methods of patient selection. Right eye was selected for each
patient fitting the inclusion criteria
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Patient characteristics and set-
ting
Sample size: 166 participants evaluated, 163 eyes of 163 participants included in the analysis (63
glaucoma, 49 glaucoma suspects, 51 controls)
Age: glaucoma eyes mean 64.3 years; glaucoma suspects mean 61.6 years; controls 54.8 years
Sex: 61 men (24 glaucoma, 18 glaucoma suspects, 19 controls) and 102 women (39 glaucoma, 31
glaucoma suspects, 32 controls)
Ethnicity: not reported.
Country: USA.
Setting: University of Pittsburgh Medical Center Eye Center, Pittsburgh, PA
Ocular comorbidities: patientswith history of diabetes, anymacular pathology, conditions affecting
VF other than glaucoma, previous ocular trauma or surgery other than glaucoma interventions or
uncomplicated cataract extraction were excluded. Participants had to have visual acuity ≥ 20/40,
refractive error between −6 and +3 D, and no visually significant media opacities
Spectrum of glaucoma severity: the median (IQR) MD and PSD on the VF test were -2.21 (-6.
92 to -0,35) dB and 2.99 (1.65 to 8.84) dB respectively,for glaucoma
Control participants: normal findings on ocular exam, no history of elevated IOP and normal VF
result (defined as MD and PSD within 95% limits of the normal population, and GHT within
normal limit)
Index tests Optical coherence tomography: Cirrus HD-OCT (software version 5.0; Carl Zeiss Meditec). The
macular cube 200 x 200 and optic disc cube 200 x 200 were used. Image with signal strength < 7,
motion artefacts or with segmentation errors were excluded.
One author had potential conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous VF result (defined as a PSD outside of the 95% limits of the
normal population or GHT outside normal limits) associated with abnormal optic disc appearance
(rim notching, cup asymmetry, vertical cup to disc ratio > 0.7), RNFL defect or IOP > 21 mmHg
Visual field testing: Humphrey Field Analyzer (24-2 SITA standard programme (Carl Zeiss
Meditec, Dublin, CA, USA). VF reliability criteria were fixation losses, false-positive and false-
negative rates < 30%
Optic disc evaluation: not reported.
Flow and timing Index test and reference standard were performed at the same visit. 3 eyes (< 10%) were excluded
due to failure of the segmentation algorithm
Comparative
Notes Supported in part by the National Institute of Health grants R01-EY13178 and P30-EY08098
(Bethesda, MD), The Eye and Ear Foundation (Pittsburgh, PA) and an unrestricted grant from
Research to Prevent Blindness (New York, NY)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
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Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
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Kratz 2014
Study characteristics
Patient sampling Case-control study enrolling glaucoma and healthy participants recruited from January 2010 to
December 2010 at the Sydney Eye Hospital, Sydney, Australia. One eye from each person was
selected randomly if both eyes were eligible
Patient characteristics and set-
ting
Sample size: 173 eyes of 173 participants (85 glaucoma and 88 healthy controls)
Age: glaucoma mean ± SD, 69.96 ± 1.13 years; controls, 67.38 ± 11.97 years
Sex: 90 men (50 glaucoma, 40 controls) and 83 women (35 glaucoma, 48 controls)
Ethnicity: not reported.
Clinical Setting: Sydney Eye Hospital, Sydney.
Country: Australia.
Ocular comorbidities: patient with clinical evidence of macular disease, past refractive or retinal
surgery, neurologic pathology or diabetes were excluded
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were -7.89 ± 7.03
and 6.45 ± 3.64 respectively, for glaucomatous eyes
Control participants: normal VF, and no history of IOP > 21 mmHg.
Index tests Optical coherence tomography: Cirrus HD-OCT software (Version 5.1.0.96, Carl Zeiss Meditec,
Inc., Dublin, CA, USA). Optic disc cube 200 x 200 scan protocol was used for the analysis. Scans
with movement artefact or signal strength < 7 were excluded
Confocal scanning laser ophthalmoscopy: HRT3 (HRT; Heidelberg Engineering, GmbH,
Dossenheim, Germany) Experienced examiners outlined the optic disc margin on the mean topo-
graphic image. All participants had image quality SD < 30 µm
The authors stated no conflicts of interest.
Target condition and reference
standard(s)
Manifest perimetric glaucoma: glaucomatous VF defect, defined as GHT outside normal limits,
or PSD with P < 5% or a cluster of 3+ points in the PD plot in a single hemifield (superior or
inferior) with P < 5%, 1 needed a P < 1%
Visual field test:Humphrey Field Analyzer II (Carl Zeiss Meditec, Dublin, CA, USA); 24-2 SITA-
standard strategy. All exams had fixation losses and false-positive and false-negative rates of < 20%.
Imaging and VF tests were performed by trained technicians masked to other clinical information
at the same visit
Flow and timing The index and reference test were performed on the same day.
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
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Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Lee 2010
Study characteristics
Patient sampling Healthy and glaucomatous participants who met the eligibility criteria were recruited prospectively
between March 2008 and March 2009. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 165 eyes of 165 participants (88 glaucoma, 77 controls).
Age: glaucoma patients mean ± SD, 53.7 ± 10.8 years; controls 51.7 ± 11.4
Sex: 87 men (39 controls, 48 glaucoma), and 78 women (38 controls, 40 glaucoma)
Ethnicity: Korean.
Country: Korea.
Ocular comorbidities: no ocular pathologies other than glaucoma, BCVA < 20/30, spherical re-
fraction > ±5 D, cylinder refraction > ±3 D, diabetes or closed angle at gonioscopy
Setting: Asan Medical Center, Seoul.
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -6.33 ± 4.79 dB
and 6.7 ± 4.12 dB, respectively
Control participants: normal optic disc appearance, normal VF result, and IOP < 22 mmHg
Index tests Scanning laser polarimetry: GDx VCC (Carl Zeiss Meditec, Inc, Dublin, CA, USA). All images
were acquired by a single well-trained operator. The pupils were dilated if their diameter was < 3mm.
All poor-quality scans, defined as those with a quality score grade < 8 and an atypical retardation
pattern with a typical scan score of < 80 were excluded
Optical coherence tomography: Cirrus HD-OCT, “optic disc cube” scan (Carl Zeiss Meditec,
Inc, Dublin, CA, USA). All images were acquired by a single well-trained operator. The pupils were
dilated if their diameter was < 3 mm. Images with signal strength < 6, overt misalignment of the
surface detection algorithm on at least 15% of consecutive A-scans or 20% of cumulative A-scans
or overt decentration of the measurement circle location, were excluded
No details about authors’ conflict of interest were reported
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous VF defect (defined as a cluster of 3 points with a P < 5% on a
pattern deviation map in at least 1 hemifield, including at least 1 point with a P < 1% or a cluster
of 2 points with a probability of < 1% and a GHT or PSD outside 99% normal limits ) and a
glaucomatous ONH appearance (vertical cup disc ratio > 0.7, or a vertical cup-disc ratio asymmetry
> 0.2 between eyes, or diffuse/focal neural rim thinning or haemorrhage)
Visual field testing: Humphrey Field Analyzer, 24-2 SITA-standard strategy (Carl Zeiss Meditec,
Dublin, CA, USA). VF reliability criteria included fixation losses rates of < 20% and false-negative
and false-positive rates of < 15%
Optic disc evaluation: stereoscopic optic nerve photography.
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Flow and timing The time interval between reference standard and index tests was < 2 weeks. 19 (> 10%) eyes were
excluded due to poor SD-OCT or GDx VCC quality images
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
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DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
Leite 2011
Study characteristics
Patient sampling Participants were recruited from the longitudinal Diagnostic Innovations in Glaucoma Study and
the African Descent and Evaluation Study. Healthy participants were recruited from the general
population. No other details on methods of patient selection were reported. Both eyes of some
participants were included in the study
Patient characteristics and set-
ting
Sample size: 233 eyes (126 glaucoma, 107 controls) of 149 participants (91 glaucoma, 58 controls)
Age: glaucoma eyes mean ± SD 70 ± 10 years; controls 50 ± 19 years
Sex: 97 men (58 glaucoma, 39 controls) and 136 women (68 glaucoma, 68 controls)
Ethnicity: 76 African-American (49 glaucoma, 27 controls)
Country: USA.
Setting: Hamilton Glaucoma Center, University of California, San Diego
Ocular comorbidities: patients with co-existing retinal disease, uveitis, or non-glaucomatous optic
neuropathy were excluded. All eyes had to have BCVA ≥ 20/40, spherical refraction within ±5.0
D, cylinder correction within ±3.0 D, and open angles on gonioscopy
Spectrum of glaucoma severity: the mean (first, third quartile) MD and PSD on the VF test were
-5.85 (-7.59, -2.16) dB and 5.36 (2.15, 7.95) dB respectively, for glaucoma
Control participants: IOP < 22 mmHg with no history of elevated IOP and at least 2 reliable
normal VFs (defined as PSD within 95% confidence limits and a GHT result within normal limits)
Index tests Optical coherence tomography: Spectralis OCT (Spectralis HRA-OCT; software version 5.2.0.3)
The RNFL 3.45 mm scan was used. Only images with well-centred scan and a signal strength > 15
dB were included
Optical coherence tomography: Cirrus (software version 4.5, Carl Zeiss Meditec Inc.). The optic
disc cube scan was used. Only images with a well-centred scan, a signal strength > 6 dB and the
absence of movement artefacts were included
Optical coherence tomography: RTVue (software version 4.0.5.39). The ONH map scan was
used. Only images with a signal strength ≥ 30 were included
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Some authors had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous VF result defined as a PSD outside the 95% normal limits or a
GHT result outside the 99% normal limits. ONH appearance was not part of the reference standard
Visual field testing:Humphrey FieldAnalyzer, 24-2 SITA standard programme (Carl ZeissMeditec,
Dublin, CA, USA). All VFs were reviewed by the “visual field reading center”, in order to check for
artefacts or inappropriate fixation
Flow and timing Index tests were performed on the same day but the time interval between index tests and reference
standard was not reported. No patients were reported by the authors excluded from the analysis
Comparative
Notes Supported in part by National Eye Institute R01-EY08208 (FAM) and R01-11008 (LMZ), and
CAPES grant BEX1327/09-7 (MTL). Participant retention incentive grants in the formof glaucoma
medication at no cost (Alcon Laboratories Inc., Allergan, Pfizer Inc., and SANTEN Inc.)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
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Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Leung 2010
Study characteristics
Patient sampling Normal participants and glaucoma patients were enrolled consecutively fromAugust 2008 to Febru-
ary 2009. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 223 eyes of 223 participants (121 glaucoma, 102 healthy controls)
Age: perimetric glaucoma patients mean ± SD 54 ± 14.6 years; controls 50.3 ± 10.3 years
Ethnicity: Chinese.
Country: China.
Ocular comorbidities: no macular diseases, BCVA < 20/40, spherical refraction < -8 D or > +4 D,
refractive or retinal surgery, neurologic diseases, or diabetes
Setting: University Eye Center at the Chinese University of Hong Kong
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -8.99 ± 8.16 dB
and 6.86 ± 4.12 dB, respectively. According to the Hodapp et al. grading scale, 63 eyes had early
glaucoma, 58 moderate to advanced
Control participants: normal VF and no history of IOP > 21 mmHg.
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Index tests Optical coherence tomography: Cirrus HD-OCT, “optic disc cube” scan protocol software version
3.0 (Carl ZeissMeditec Inc.). All theOCT scans had a signal strength of > 7. Saccadic eyemovement
was detected in the line-scanning ophthalmoscope overlaid withOCT en face duringOCT imaging.
Images with motion artefact were rescanned at the same visit
Some authors had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous VF defects (defined as ≥ 3 significant (P < 0.05) non-edge
contiguous points with ≥ 1 at the P < 0.01 level on the same side of horizontal meridian in the
pattern deviation plot and confirmed with ≥ 2 consecutive examinations)
Visual field testing: Humphrey Field Analyzer, model II, 24-2 SITA-standard strategy (Carl Zeiss
Meditec, Inc., Dublin, CA). VF reliability criteria included fixation losses rates, false-negative and
false-positive rates of < 20%. Reference standard was performed by investigators masked to other
clinical information. Optic disc appearance was not part of the reference standard
Flow and timing Reference standard and index tests were performed at the same visit. A total of 223 participants
(102 normal subjects and 121 glaucoma patients) were enrolled consecutively. Authors stated that
5 subjects were excluded in the study (3 had low strength in Cirrus HD-OCT imaging and 2 had
an epiretinal membrane at the macula evident in the OCT scan) but still 223 participants were
included in the analysis
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
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Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Did all patients receive a refer-
ence standard
Yes
Lisboa 2013
Study characteristics
Patient sampling A cohort of participants suspected of having glaucoma was selected from theDiagnostic Innovations
in Glaucoma Study database, and followed for at least 5 years. A documented evidence of progressive
glaucomatous change in the appearance of the optic disc was used as reference standard. Participants
with progressive optic disc damage and no visual field loss were included in the preperimetric
glaucoma group. Patients followed untreated for about 14 years without any evidence of progressive
change in the appearance of the optic disc or visual field loss were used as the control group. Both
eyes were selected for some patients
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Patient characteristics and set-
ting
Sample size: 142 eyes (48 glaucoma, 94 controls) of 91 participants.
Age: glaucoma eyes mean ± SD 65.9 ± 9.1 years; controls 64.2 ± 11.2 years
Sex: glaucoma: male 53%; controls: male 31%
Ethnicity: 12 African-American (8 glaucoma, 4 controls).
Country: USA.
Setting: Hamilton Glaucoma Center, University of California, San Diego
Ocular comorbidities: patients with co-existing retinal disease, uveitis, or non-glaucomatous optic
neuropathy were excluded. All eyes had to have BCVA ≥ 20/40, spherical refraction within ±5.0
D, cylinder correction within ±3.0 D, and open angles on gonioscopy
Spectrum of glaucoma severity: the mean (first, third quartile) MD and PSD on the VF test were
-0.81 (-1.82, 0.12) dB and 1.75 (1.46, 1.84) dB respectively, for glaucoma
Control participants: participants followed untreated for a long period (13.6 ± 3.6 years) without
any evidence of progressive change in the appearance of the optic disc or VF loss in both eyes
Index tests Optical coherence tomography: RTVue (software version 6.1.0.4; Optovue, Inc., Fremont, CA,
USA). The ONH protocol and ganglion cell complex scanning protocols were used. Only good-
quality images, as defined by a signal strength index ≥ 28 for RNFL and ONHmeasurements, and
≥ 32 for macular measurements were included in the analysis
Some authors had potential conflict of interest
Target condition and reference
standard(s)
Manifest preperimetric glaucoma: documented evidence of progressive glaucomatous change in
the appearance of the optic disc (based on focal or diffuse thinning of the neuroretinal rim, increased
excavation, or enlargement of the RNFL defects) and normal VF result (defined as a MD and PSD
within 95% confidence limits and a GHT result within normal limits)
Visual field testing: 24-2 SITA standard programme (Carl Zeiss Meditec, Dublin, CA, USA)
Optic disc and RNFL evaluation: stereoscopic optic disc photographs (TRC-SS, Topcon Instru-
ment Corp. of America, Paramus, NJ). Stereoscopic sets of slides were examined using a stereoscopic
viewer (Asahi, Pentax, Tokyo, Japan). 2 experienced graders, masked to the participant’s identity, to
other test results, and to the chronological sequence of the photographs, evaluated the stereopho-
tographs
Flow and timing Reference standardwas performedbefore index test but time interval between index test and reference
standard was not reported. Index test different scanning protocols were performed within 6 months.
No patients were reported by the authors as excluded from the analysis
Comparative
Notes Supported in part byNational Institutes of Health/National Eye Institute Grants EY021818 (FAM),
EY11008 (LMZ), and EY14267 (LMZ); Coordena¸ca~o de Aperfei¸ coamento de Pessoal deN´ vel
Superior (CAPES) grant Bolsas no Exterior (BEX) 1066/11-0; an unrestricted grant from Research
to Prevent Blindness (New York, New York); and grants for participants’ glaucoma medications
from Alcon, Allergan, Pfizer, Merck, and Santen
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Lisboa 2013 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Did all patients receive a refer-
ence standard
Yes
Mai 2007
Study characteristics
Patient sampling Healthy controls and glaucoma patients were recruited. Controls were recruited consecutively either
from an ongoing longitudinal follow-up study or from staff members, their friends and spouses,
partners of the patients, or volunteers. No details on glaucoma patient selection method. One eye
per person was randomly selected
Patient characteristics and set-
ting
Sample size: 133 eyes of 133 participants (92 glaucoma, 41 controls).
Age: glaucoma patients mean ± SD, 65.4 ± 10.9 years; controls 61.2 ± 12.0
Sex: 73 men, 60 women.
Ethnicity: white.
Country: Netherland.
Ocular comorbidities: no ocular disease other than glaucoma, BCVA < 20/40, spherical refraction
< -7 D or > +3 D, intraocular surgery (except uncomplicated cataract surgery), diabetes mellitus or
arterial hypertension
Setting: Rotterdam Eye Hospital, Rotterdam.
Spectrum of glaucoma severity: mean ± SD of MD and PSD on the VF test for glaucoma were -
9.4 ± 7.4 dB and 8.1 ± 3.9 dB, respectively. According to Hodapp et al. grading score 59 eyes had
mild and moderate glaucoma, 33 severe
Control participants: IOP < 21 mmHg, normal VF results (MD and PSD within 95% confidence
limits and GHTwithin normal limits ) and healthy-appearingONH (no diffuse/local rim thinning,
cupping, or optic disc haemorrhages)
Index tests Scanning laser polarimetry: GDx VCC, software version 5.4.0, GDx-ECC, software version 5.5.
0.11 (Carl Zeiss Meditec, Inc., Dublin, CA, USA). Images were acquired through undilated pupils,
by 2 trained and experienced technicians following a standard protocol. Only images of high quality
(with quality scan score ≥ 7 ) were selected
Some authors had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous optic disc appearance (diffuse or local rim thinning or cupping)
, abnormal VF result (confirmed on 2 consecutive occasions and defined as 2 or more adjacent
points at a P ≤ 0.01 level, or 3+ adjacent points at a P ≤ 0.05 level in the total deviation plot, or
GHT outside normal limits) and open angle by gonioscopy
Visual field testing: Humphrey Field Analyzer, full threshold strategy (126 eyes), 24-2 SITA stan-
dard strategy (5 eyes), or 24-2 SITA-fast (2 eyes) (Carl Zeiss Meditec, Inc.). Reliability criteria
included fixation losses rates of < 25% and false-positive rates of < 20%. Acceptable false-positive
rate was < 20% and < 33% for controls and glaucoma respectively
Flow and timing The time interval between reference standard and index test was not reported. No patients were
reported by the authors as excluded from the analysis
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Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
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Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Mansoori 2011
Study characteristics
Patient sampling Cross-sectional study involving healthy and glaucoma participants. Glaucoma patients were re-
cruited from patients attending glaucoma outpatient department, healthy controls were recruited
from the staff of the same institute. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 178 eyes of 178 participants (83 glaucoma, 95 controls).
Age: glaucoma eyes mean ± SD 57.1 ± 6.1 years; controls 56.9 ± 11 years
Sex: 79 men (40 glaucoma, 39 controls) and 99 women (43 glaucoma, 56 controls)
Ethnicity: Indian.
Country: India.
Setting: Department of Glaucoma, Pushpagiri Eye Institute, Andhra Pradesh
Ocular comorbidities: patients with family history of glaucoma, uveitis, corneal, retinal or macular
pathology, neurological disease or abnormal disc appearance such as tilted disc or discs with peri-
papillary atrophy were excluded. All eyes had to have BCVA ≥ 20/30, spherical refraction within
±4.0 D, cylinder correction within ±2.0 D, clear ocular media and open angles on gonioscopy
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were -4.6 ± 0.3 and
5.2 ± 0.7 respectively,for glaucoma. All glaucoma had MD > -6 dB
Control participants: IOP ≤ 21 mmHg, no past history of Increased IOP, normal optic disc and
RNFL appearance and normal VF result (MD and PSD within 95% confidence limits and GHT
within normal limits)
Index tests Optical coherence tomography: OCT/SLO (OPKO/OTI,Miami FL,USA). TheRNFL scanning
protocol after pupil dilation was used. A good-quality image required a signal strength > 7, a clear
SLO image allowing optic disc and scan circle visibility, a dense colour saturation throughout all
retinal layers and no algorithm failure.
The authors stated no conflict of interest.
Target condition and reference
standard(s)
Manifest early glaucoma: glaucomatous optic nerve damage and consistent VF loss (defined as the
presence of a cluster of 3+ adjacent points on pattern deviation plot with a P < 5% with 1+ points
with P < 1% and GHT outside normal limits), and IOP > 21 mmHg in > 2 occasions
Visual field testing: 24-2 SITA standard programme (Carl Zeiss Meditec, Dublin, CA, USA)
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Optic disc and RNFL evaluation: dilated fundus and optic disc examination with a +78 D lens
Flow and timing The time interval between index test and reference standard was not reported
No patients were reported by the authors as excluded from the analysis
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
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Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Medeiros 2004a
Study characteristics
Patient sampling Patients’ data were selected retrospectively from a research database, containing patients included
in a prospective, longitudinal study designed to evaluate optic nerve structure and visual function
in glaucoma. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 100 eligible patients, 114 included in the analysis (42 glaucoma patients, 32 glaucoma
suspects and 40 healthy controls)
Age: glaucoma patients mean ± SD 67 ± 11 years, glaucoma suspects 61 ± 12 years, controls 65 ±
11 years
Ethnicity: not specified
Country: USA.
Ocular comorbidities: no co-existing retinal disease, uveitis, or non-glaucomatous optic neuropa-
thy. BCVA ≥ 20/40, spherical refraction within ±5.0 D, cylinder correction within ±3.0 D, and
open angles on gonioscopy
Setting: Hamilton Glaucoma Center, University of California.
Spectrum of glaucoma severity: mean MD on the VF test were -4.92 dB for glaucoma patient;
According to the Hodapp- Parrish-Anderson grading scale, 27 patients were classified as having
early defects, 9 had moderate defects and 6 had severe VF defects
Control participants: IOP ≤ 22 mmHg,with no history of increased IOP, a normal VF result and
a healthy appearance of the optic disc and RNFL
Index tests Scanning laser polarimetry:GDxVCC, software version 5.0.1 (LaserDiagnostic Technologies Inc,
San Diego, CA, USA). Good-quality image required a focused and evenly-illuminated reflectance
image with a centred optic disc. Quality assessment was evaluated by an experienced examiner
masked to the participant’s identity and results of the other tests
One author had conflict of interest.
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Target condition and reference
standard(s)
Manifest glaucoma: repeatable (2 consecutive) abnormal VF test results, defined as a PSD outside
the 95% normal GHT results outside 99% normal confidence limits, regardless of the appearance
of the optic disc
Glaucoma suspect: ocular hypertension (IOP > 22 mmHg on more than 2 separate visits) or glau-
comatous appearance of the optic disc (defined as neuroretinal rim thinning, excavation, notching,
or characteristic RNFL defects)
Visual field testing: Humphrey Field Analyzer, 24-2 full-threshold standard automated perimetry
or SITA-standard programme (Carl Zeiss Meditec, Inc., Dublin, CA, USA). VF reliability criteria
were not reported
Optic disc evaluation: stereoscopic optic disc photography.
Flow and timing 17 patients (> 10%) were not included in the final analysis due to poor-quality RNFL photograph
or SLP image. All index tests were performedwithin 3months, but no details about the time interval
between index and reference test
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
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DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
Medeiros 2004b
Study characteristics
Patient sampling Patients were included in a prospective longitudinal study designed to evaluate optic nerve structure
and visual function in glaucoma (Diagnostic Innovations in Glaucoma Study) from April 2002 to
November 2003. All patients who met the inclusion criteria were enrolled in this study. One eye
per person was randomly selected
Patient characteristics and set-
ting
Sample size: 183 eyes of 183 participants were enrolled, 141 eyes included in the analysis (75
glaucoma, 66 healthy controls)
Age: glaucoma patients mean ± SD, 68 ± 10 years; controls 65 ± 8 years
Country: USA.
Setting: Hamilton Glaucoma Center, University of California, San Diego
Ocular comorbidities: no co-existing retinal disease, close angle by gonioscopy, BCVA < 20/
40, spherical refraction > ±5 D, cylinder refraction > ±3 D, uveitis, or non-glaucomatous optic
neuropathy
Spectrum of glaucoma severity: mean ± SD MD on the VF test was −4.89 ± 3.9 dB. According
to the Hodapp et al. grading scale, 53 eyes had early glaucoma,11 moderate and 11 severe.
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Control participants: IOP ≤ 22 mmHg, normal VF result (MD and PSD within 95% confidence
limits and GHT within normal limits) and healthy ONH/RNFL appearance (no diffuse/focal rim
thinning, cupping, optic disc haemorrhage, or RNFL defects)
Index tests Scanning laser polarimetry: GDx VCC, software version 5.0.1 (Laser Diagnostic Technologies
Inc, San Diego, CA, USA). Assessment of image quality was performed by an experienced examiner
masked to the participant’s identity and results from the other tests. Good-quality images required
a focused and evenly-illuminated reflectance image with a centred optic disc, a residual anterior
segment retardation of 15 nm or less and an atypical scan score < 25
One author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: repeated (2 consecutive) glaucomatous VF loss defined as a PSD with P < 5%
or a GHT outside normal limits
Visual field testing: Humphrey Field Analyzer, 24-2 SITA-standard strategy (Carl Zeiss Meditec,
Inc). VF reliability criteria were not reported
Optic disc appearance was not part of the reference standard
Flow and timing Reference standard and index tests were performed within 6 months
42 of 183 participants(> 10%) had unacceptable-quality imaging scans and were not included in
the analysis.
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
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Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
Medeiros 2005
Study characteristics
Patient sampling Patients’ data were selected from a research database, containing patients included in a prospective,
longitudinal study designed to evaluate optic nerve structure and visual function in glaucoma.
Normal participants were recruited from the staff and employees of the University of California, as
well as from the general population. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 136 patients (41 perimetric glaucoma, 30 preperimetric glaucoma, 65 healthy controls)
Age: perimetric glaucoma patients mean ± SD, 65 ± 9 years, preperimetric glaucoma 70 ± 11 years,
controls 66 ± 11 years
Ethnicity: not specified.
Country: USA.
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Ocular comorbidities: no co-existing retinal disease, uveitis, or non-glaucomatous optic neuropa-
thy. BCVA ≥ 20/40 , spherical refraction within ±5.0 D, cylinder correction within ±3.0 D
Setting: Hamilton Glaucoma Center, University of California.
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -7.53 ± 6.58 dB
and 7.13 ± 3.60 dB for perimetric glaucoma, -2.07 ± 1.65 dB and 1.65 ± 0.3 dB for preperimetric
glaucoma, -0.59 ± 1.13 dB and 1.59 ± 0.38 dB for control group, respectively
Control participants: IOP ≤ 22 mmHg,with no history of increased IOP, a normal VF result and
a normal clinical examination
Index tests Scanning laser polarimetry: GDx VCC, software version 5.0.1 (Laser Diagnostic Technologies
Inc, San Diego, CA, USA). To be acceptable each image required a focused and evenly-illuminated
reflectance image with a centred optic disc, residual anterior segment retardation ≤ 15 nm and an
atypical scan score > 25. Quality assessment was performed by an experienced examiner masked to
the participant’s identity and results of the other tests
No details about conflict of interest were reported.
Target condition and reference
standard(s)
Manifest perimetric glaucoma: evidence of progressive glaucomatous change in the appearance of
the optic disc (as assessed by simultaneous stereoscopic optic disc photographs and defined by focal
or diffuse thinning of the neuroretinal rim, increased excavation, or enlargement of RNFL defects)
and abnormal VF result (GHT outside normal limits or a PSD with P < 5%)
Manifest preperimetric glaucoma: evidence of progressive glaucomatous change in the appearance
of the optic disc (as assessed by simultaneous stereoscopic optic disc photographs and defined by
focal or diffuse thinning of the neuroretinal rim, increased excavation, or enlargement of RNFL
defects) and normal VF result
Optic disc evaluation: stereoscopic optic disc photographs were acquired with TRC-SS (Topcon,
Paramus, New Jersey, USA) and included only if had a good quality. For each participant, the most
recent stereophotograph was compared with the oldest available (at least 1 year time interval) by
2 experienced graders masked to the participant’s identity and to the temporal sequence of the
photographs
Visual field testing: Humphrey Field Analyzer ,24-2 SITA standard (Zeiss-Humphrey, Dublin,
CA, USA)
Flow and timing No patients were reported by the authors as excluded from the analysis. The GDx VCC imaging
date was always after the date of the optic disk stereophotograph that showed progression
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
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Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
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Moreno 2011
Study characteristics
Patient sampling Healthy controls and early glaucoma patients were prospectively and consecutively enrolled
One eye per person was randomly selected.
Patient characteristics and set-
ting
Sample size: 123 eyes of 123 participants (67 glaucoma, 56 controls).
Age: glaucoma eyes mean ± SD 64.3 ± 11.8 years; controls 56.5 ± 12.9 years
Sex: 49 men (27 glaucoma, 22 controls) and 74 women (40 glaucoma, 34 controls)
Ethnicity: 65 white (36 glaucoma, 29 controls), 35 African descent (19 glaucoma, 16 controls), 23
mixed (12 glaucoma, 11 controls)
Country: Brazil.
Setting: not specified.
Ocular comorbidities: patients with previous ocular surgery or trauma, spherical equivalent > ±4.
0 D, history of using oral or topical steroids, and any ocular disease other than glaucoma including
moderate or advanced cataract, were excluded
Spectrum of glaucoma severity: the mean ± SD MD on the VF test were -2.5 ± 1.6 dB,for
glaucoma. All glaucoma patients had MD > -6 dB
Control participants: IOP < 21 mmHg, normal VF results and no glaucomatous optic neuropathy
Index tests Optical coherence tomography: RTVue-100 OCT (software version A4, Optovue, Fremont, CA,
USA). The GCC and RNFL 3.45 mm scanning protocols were used. Images with signal strength
indices < 40 or not well centred were excluded. All images were acquired by a single experienced
operator who was masked to patients’ clinical data.
The authors stated no conflict of interest.
Target condition and reference
standard(s)
Manifest early glaucoma: glaucomatous optic neuropathy (defined as a vertical cup-to-disc ratio of
≥ 0.6, asymmetry of cup-to-disc ratio ≥ 0.2 between eyes, and presence of localised RNFL defects
or neuroretinal rim defects or both) and glaucomatous VF defects (defined as 3+ points in clusters,
with a P < 5% on the pattern deviation plot (excluding those on the edge of the field or directly
above or below the blind spot), a PSD with a P < 5%, or a GHT results outside the normal limits)
Visual field testing:Humphrey FieldAnalzyer(24-2SITA standard programme (Carl ZeissMeditec,
Dublin, CA, USA). Reliability criteria were not reported
Optic disc evaluation: funduscopy and stereophotograph assessment.
Flow and timing The time interval between index test and reference standard was not reported. No patient were
reported by the authors as excluded from the analysis
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
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Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Moreno-Montañés 2008
Study characteristics
Patient sampling Healthy, ocular hypertensive and glaucoma participants were consecutively enrolled. One eye per
person was randomly selected
Patient characteristics and set-
ting
Sample size: 182 eyes of 182 participants (83 glaucoma, 40 OHT, 59 healthy controls)
Age: glaucoma patients mean (range), 68 (60 to 73) years; hypertensive 63.5 (57 to 70.5); controls
56 (47 to 67)
Sex: 87 men (45 glaucoma, 16 OHT, 26 controls) and 95 women (38 glaucoma, 24 hypertensive,
33 controls)
Ethnicity: white.
Country: Spain.
Ocular comorbidities: no corneal/retinal disease, BCVA < 20/40, spherical equivalent > ±5 D, no
substantial media opacity
Setting:Department ofOphthalmology,ClínicaUniversitaria deNavarra, Pamplona; InstitutCatalá
de la Retina, Barcelona
Spectrum of glaucoma severity: mean (range) MD/PSD on the VF test were -4.94 (-12.58 to -
2.67)/4.29 (2.15 to 8.34) dB, for glaucoma eyes; -0.99 (-2.52 to -0.29)/1.5(1.40 to 1.87) dB for
OHT eyes
Control participants: IOP ≤ 21 mmHg, normal VF, and no familiar glaucoma.
Index tests Confocal scanning laser ophthalmoscopy: HRT 3, software version 3.0 (Heidelberg Engineering,
Dossenheim, Germany). All images were acquired after pupil dilation and were of good quality,
defined as having a topographic SD of ≤ 30 µm. Contour lines were placed in the margin of the
optic disk by experienced users and were reviewed by 2 authors
No author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous defects reproducible in at least 3 reliable and consecutive VFs
(defined as at least 3 contiguous locations were outside the 95% normal limits of the pattern
deviation plot and 1 was outside the 99% normal limits), with open angle at gonioscopy
OHT: IOP > 21 mmHg on 3 different days, with 3 consecutive normal VFs
Visual field testing: Humphrey Field Analyzer, 24-2 SITA-standard strategy (Carl Zeiss Meditec,
Dublin, CA,USA). Reliability criteria included fixation losses rates, false-positive and false-negative
rates of < 30%
The optic disc appearance was not part of the reference standard
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Flow and timing Reference standard and index test were performed on the same day. A total of 182 eyes were enrolled.
Authors stated that in 7 eyes (3 normal, 1 ocular hypertensive, 3 glaucomatous) the GPS failed to
provide a sectorial classification and were excluded from the enrolled group but still 182 participants
were reported and included in the analysis
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
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Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Did all patients receive a refer-
ence standard
Yes
Moreno-Montañés 2010
Study characteristics
Patient sampling Normal eyes and eyes with glaucoma were recruited prospectively. Normal group included patients
consecutively recruited from hospital staff, nurses, relatives of patients, and patients referred for a
routine visual acuity examination without ocular diseases. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 216 eyes of 216 participants (86 glaucoma, 130 healthy controls)
Age: glaucoma patients mean ± SD, 60.12 ± 12.45 years; controls 58.22 ± 10.85 years
Sex: 109 men and 107 women.
Ethnicity: white.
Country: Spain.
Ocular comorbidities: no corneal/retinal disease, BCVA < 20/40, spherical equivalent > ±5 D or
substantial media opacity
Setting: Department of Ophthalmology, Clínica Universidad de Navarra,Pamplona
Spectrum of glaucoma severity: according to the ’glaucoma staging system’, 35 eyes had early
glaucoma (stage 1; mean ± SD MD of -3.0 ± 1.21 dB), 21 eyes had moderate (stage 2, mean ± SD
MD of -7.81 ± 2.01 dB), 14 eyes had advanced (stage 3, mean ± SD MD of -14.7 ± 1.32 dB), 16
eyes had severe (stage 4, mean ± SD MD of -26.14 ± 2.88 dB)
Control participants: IOP ≤ 21 mmHg, normal VFs, and no familiar glaucoma history
Index tests Optical coherence tomography: Cirrus HD-OCT, OCT volume scan, software version 3.0 (Carl
Zeiss Meditec, Dublin, CA, USA). The OCT examinations were performed after pupil dilation
by an experienced operator who was different from the examiner who performed the VF testing
and was masked to the other findings. Only cases with signal strength of > 6 were included in the
analysis
No author had conflict of interest.
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Target condition and reference
standard(s)
Manifest glaucoma: IOP > 21 mmHg on at least 3 different days, open-angle at gonioscopy and
defects reproducible in at least 3 reliable and consecutive VFs performed on different days (according
to the ’glaucoma staging system’)
Visual field testing: Humphrey Field Analyzer, 24-2 SITA standard strategy (Carl Zeiss Meditec,
Inc., Dublin, CA, USA). No details were reported about VF reliability criteria
Optic disc appearance was not part of the reference standard
Flow and timing The index tests were performed on the same day but the time interval between reference standard
and index test was not specified
216 participants were enrolled. 50 participants (> 10%) were excluded due to OCT scan’s signal
strength < 6 and 166 were actually included in the analysis
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
175Optic nerve head and fibre layer imaging for diagnosing glaucoma (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Moreno-Montañés 2010 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
Mwanza 2012
Study characteristics
Patient sampling Helthy controls and early glaucoma patients were recruited in this cross-sectional multicentre study
from January to March 2011. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 157 participants enrolled, 154 eyes of 154 participants included in the analysis (55
glaucoma, 99 controls)
Age: glaucoma eyes mean ± SD 64.4 ± 9.6 years; controls 62.3 ± 9.6 years
Sex: not reported.
Ethnicity: not reported.
Setting: 4 glaucoma practices were involved in this multicentre study. Bascom Palmer Eye Institute,
Miami Miller School of Medicine, University of Miami, Miami, Florida; Department of Ophthal-
mology, Stanford University, Palo Alto, California; Eye Institute of Utah, Salt Lake City, Utah;
Department of Ophthalmology, University of North Carolina at Chapel Hill, Chapel Hill, North
Carolina
Ocular comorbidities: patients in the glaucoma group with a BCVA < 20/40, spherical refrac-
tion error outside the interval < -12 D or >+8 D, cylinder correction > 3 D, previous or current
vitreoretinal diseases or surgery, active infection of the anterior or posterior segment of either eye,
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diabetic retinopathy or macular oedema, history of dementia, multiple sclerosis, or a life-threatening
or debilitating disease were excluded. No detail about control group comorbidities
Spectrum of glaucoma severity: the mean ± SD MD on the VF test were -3.2 ± 1.8 dB,for
glaucoma. All glaucoma patients had MD ≥ -6 dB
Control participants: No details were reported.
Index tests Optical coherence tomography: Cirrus HD-OCT (Carl Zeiss Meditec). The macular cube 200
x 200 and the Optic disc cube 200 x 200 scanning protocols were used to acquire the images.
Only good-quality scans (signal strength≥ 6, no RNFL discontinuity or misalignment, involuntary
saccade or blinking artefacts, and absence of algorithm segmentation failure) were used for analysis.
Some authors had conflict of interest.
Target condition and reference
standard(s)
Manifest early glaucoma: glaucomatous optic disc changes and glaucomatous VF defects, defined
as GHT outside normal limits or PSD with a P < 5%, or a cluster of > 3 points in the pattern
deviation plot in a single hemifield (superior or inferior) with a P < 5%, 1 with a P < 1%
Visual field testing: Humphrey Field Analzyer(SITA standard programme (Carl Zeiss Meditec,
Dublin, CA, USA). Reliability criteria were not reported
Optic disc evaluation: dilated fundus examination.
No details about how the reference standard was conducted and interpreted in the control group
Flow and timing The reference standard was conducted within 6 months of enrolment. 3 glaucoma patients were
excluded due to repeated segmentation failure on the index test examination
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
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Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Mwanza 2013
Study characteristics
Patient sampling Case-control study including data of participants previously enrolled in 2 earlier glaucoma SD-
OCT imaging studies and 1 ongoing study. Only one randomly selected eye per person was used
Patient characteristics and set-
ting
Sample size: 253 subjects (104 early glaucoma, 149 controls). Modelling set (69 early glaucoma,
100 controls), plus a validation set (34 early glaucoma, 49 controls)
Age: modelling set: glaucoma mean ± SD, 66.0 ± 11.85, controls 62.8 ± 9.47 years
Validation set: glaucoma mean ± SD, 67.9 ± 12.56, controls 61.7 ± 9.56 years
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Sex: not reported
Ethnicity: not specified.
Clinical setting: glaucoma clinic of the Anne Bates Leach Eye Hospital, Department of Ophthal-
mology, University of Miami Miller School of Medicine
Country: USA.
Ocular comorbidities: patients with spherical diopters or < 3 cylindrical diopters, active infection
of the anterior or posterior segment of either eye, previous or current vitreoretinal diseases or surgery
in the study eye, or evidence of diabetic retinopathy or macular oedema were excluded
Spectrum of glaucoma severity: themean ± SDMDon the VF test were -3.19 ± 1.69 for glaucoma
patients
Control participants: No details reported.
Index tests Optical coherence tomography: Cirrus HD-OCT (Carl Zeiss Meditec, Inc.). Macular cube 200 x
200 and optic disc cube 200 x 200 protocol were used for the analysis. Images with signal strength
< 6, RNFL misalignment or discontinuity, blinking or involuntary saccade artefacts, and algorithm
segmentation failure were excluded
The authors declare no conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous optic disc changes (defined as cup-to-disc ratio > 0.5 in either
eye, or cup to disc asymmetry ≥ 0.2, or focal thinning of the rim in either eye) with corresponding
VF defects (GHT outside normal limits, PSD with P < 5% or a cluster 3+ points in the pattern
deviation plot in a single hemifield with P < 5%, one having P < 1%
Visual field test: Humphrey Field Analyzer (Carl Zeiss Meditec, Dublin, CA, USA). No details
about criteria for including healthy controls
Optic disc/RNFL evauation: dilated ophthalmoscopic examination and retinal photograph eval-
uation
Flow and timing No details about exclusion and time interval between index and reference test
Controls did not undergo one of the reference tests used (VF test)
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
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High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
Unclear
Did all patients receive a refer-
ence standard
No
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Study characteristics
Patient sampling Prospective, case-control study including early glaucoma and healthy controls data of participants
previously enrolled. Only one randomly-selected eye per person was used
Patient characteristics and set-
ting
Sample size: 99 participants (50 early glaucoma, 49 controls). The diagnosis of early glaucoma was
based on a visual field MD ≥ -6 dB
Age: glaucoma mean ± SD, 63.1 ± 0.1 (range, 45.6 to 83.09, controls 66.4 ± 10.8 years (range 45.
8 to 89.3)
Sex: 40 men (22 glaucoma, 18 controls) and 59 women (28 glaucoma, 31 controls)
Ethnicity: not specified.
Clinical setting: Bascom Palmer Eye Institute in Miami, Florida; the Glaucoma Associates of Texas
in Dallas, Texas; Stanford University in Palo Alto, California
Country: USA.
Ocular comorbidities: patients with media opacities, non-glaucomatous optic neuropathy (i.e.
multiple sclerosis, trauma), past or current retinal disease (i.e. retinal detachment, diabetic or in-
fectious retinopathy, age-related macular degeneration), history of retinal surgery, laser or radiation
therapy, or systemic medication that may induce optic neuropathy, were excluded
Spectrum of glaucoma severity: themean ± SDMDon the VF test were -2.96 ± 1.93 for glaucoma
Control participants: IOP ≤ 21 mmHg, normal-looking ONH without cupping, asymmetry in
cup-to-disc ratio of < 0.2, notching, or disc haemorrhage. VF not performed
Index tests Optical coherence tomography: Cirrus HD-OCT (Carl Zeiss Meditec, Inc). Optic disc cube 200
x 200 protocol and macular cube 516 x 258 protocols, were used. Only scans with a signal strength
≥ 6 and without motion (blinking or saccades) artefacts, segmentation failure caused by algorithm
dysfunction, vitreous floaters, were used for analysis
The authors declare no conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: typical ONH cupping associated with glaucomatous VF deficits. No further
details reported
Visual field test: Humphrey Field Analyzer (Carl Zeiss Meditec, Dublin, CA, USA), 24-2 SITA
standard programme
Optic disc/RNFL evauation: ophthalmoscopy.
Flow and timing No details about exclusion and time interval between index and reference test
Controls did not undergo one of the reference tests used (VF test)
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
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Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
Unclear
Did all patients receive a refer-
ence standard
No
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Na 2013a
Study characteristics
Patient sampling Prospective, case-control study including consecutive preperimetric glaucoma and healthy controls.
One eye was randomly selected if both eyes were eligible
Patient characteristics and set-
ting
Sample size: 173 participants (105 preperimetric glaucoma, 68 controls)
Age: preperimetric glaucoma mean ± SD, 51.2 ± 10.7, controls 52.3 ± 12.6 years
Sex: 86 men (59 glaucoma, 27 controls) and 87 women (46 glaucoma, 41 controls)
Ethnicity: Asian.
Clinical setting: Asian Medical Center, Seoul, between July 2010 and February 2011
Country: South Korea.
Ocular comorbidities: patients with evidence of any intracranial or otolaryngeal lesion, a history
of massive haemorrhage or haemodynamic crisis, any other ophthalmic disease that could affect
ONH or RNFL evaluation, any condition that might bias SD-OCT measurements (peripapillary
atrophy, chorioretinal coloboma or posterior staphyloma or both), or a history of diabetes mellitus
or eye surgery/laser treatment, were excluded
Spectrum of glaucoma severity: the mean ± SD MD and pattern SD on the VF test were -0.34 ±
1.31 and 1.63 ± 0.3 respectively for preperimetric glaucoma
Control participants: IOP < 22 mmHg, no history of IOP elevation, normal VF results, intact
neuroretinal, no disc haemorrhage, notches or any localised RNFL defect
Index tests Optical coherence tomography: RTVue SD-OCT (Optovue, Inc.). Software version A4.0.5.100.
ONH and GCC scanning protocols were used for analysis. Images with signal strength index values
of the ONH or GCC maps < 45 were excluded
The authors declare no conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: localised RNFL defects (present if their width at a 1-disc diameter distance
from the edge of the disc was larger than a major retinal vessel and if they diverged in an arcuate or
wedge shape reaching the edge of the disc) and normal VF test result (defined as the absence of a
cluster of 3 points with P < 5% 5% or a cluster of 2 points with P < 1%on the pattern deviation
plot, and a GHT within normal limits)
Visual field test: Humphrey Field Analyzer (Carl Zeiss Meditec, Dublin, CA, USA), 24-2 SITa
standard programme. Reliable examinations had false-positive error < 15%, a false-negative error <
15% and a fixation loss < 20%
RNFL evaluation: digital fundus camera (TRC-50IX; Topcon, Tokyo, Japan, and MegaPlus 1.4i,
Kodak, Rochester, New York, USA)
Flow and timing 6 participants (< 10%) were excluded because of unacceptable image quality
Index and reference test were performed on the same day.
Comparative
Notes None.
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Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
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Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Na 2013b
Study characteristics
Patient sampling Case-control study enrolling consecutive glaucoma patients between September 2010 and February
2012, at the Asian Medical Center, Seoul, Korea. Control group consisted of clinic staff, friends or
spouses of patients, and volunteers from other specialty clinics. One eye per person was included in
the analysis
Patient characteristics and set-
ting
Sample size: 84 eyes of 84 participants (42 glaucoma and 42 healthy controls)
Age: glaucoma mean ± SD, 50.69 ± 10.34 years; controls, 50.76 ± 9.77 years
Sex: 40 men (21 glaucoma, 19 controls) and 44 women (21 glaucoma, 23 controls)
Ethnicity: not reported.
Clinical Setting: Asian Medical Center, Seoul.
Country: Korea.
Ocular comorbidities: patients with intracranial or otolaryngeal lesion, with a history of massive
haemorrhage or haemodynamic crisis, who presented with any other ophthalmic disease that could
result in VF defects, or with diabetes mellitus or eye surgery/laser treatment, were excluded
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were -4.19 ± 2.06
and 6.04 ± 3.45 respectively, for glaucomatous eyes
Control participants: IOP < 22 mmHg, no history of IOP elevation above 21 mmHg, absence of
ONH abnormality, and a normal VF result
Index tests Optical coherence tomography: Cirrus OCT (Carl Zeiss Meditec, Inc., Dublin, CA, USA). Optic
disc cube 200 x 200 scan protocol was used for the analysis. Scans had signal strengths > 6, and no
motion artefact
Scanning laser polarimetry: GDx VCC (Carl Zeiss Meditec, Inc., Dublin, CA, USA); software
version 5.6.0.8. Accepted images had a centred optic disc, were well focused and adequately illu-
minated over the entire image, and did not show motion artefacts. Images with TSS < 80 were
excluded
The authors stated no conflicts of interest.
Target condition and reference
standard(s)
Manifest perimetric glaucoma: localised VF loss (defined as 3+ adjacent points with P < 0.05 in a
PD probability map, or 2+ adjacent points with P < 0.02 in a superior or inferior hemifield, and the
hemifield of the other side had no clusters of 3 points with P < 0.05 and no clusters of 2 points with
P < 0.02 on either total deviation or PD probability maps) confined to one side of the horizontal
meridian, GHT outside normal limits, a PSD with P < 5%, and a cluster of 3+ points in the PD
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plot in a single hemifield (superior or inferior) with P < 0.05, one with P < 0.01, and open angle by
gonioscopy
Visual field test: Humphrey Field Analyzer (Carl Zeiss Meditec); 24-2 SITA-standard strategy. All
exams had fixation losses < 20% and false-positive and false-negative rates of < 15%
Flow and timing 6 glaucoma (< 10%) were excluded due to low-quality images.
The time interval between index and reference test was not reported
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Nakatani 2011
Study characteristics
Patient sampling Normal participants, preperimetric and perimetric primary open-angle glaucoma were enrolled.
One eye per person was selected
Patient characteristics and set-
ting
Sample size: 64 eyes of 64 participants (32 early glaucoma (13 preperimetric and 19 perimetric
glaucoma) and 32 healthy controls)
Age: glaucoma patients mean ± SD, 61.5 ± 7.7 years; controls 57.3 ± 10.9 years
Sex: 33 men (14 glaucoma, 19 controls) and 31 women (18 glaucoma, 13 controls)
Country: Japan.
Ocular comorbidities: no cataract, BCVA < 20/40, spherical refraction > ±6 D, cylinder refraction
> ±2 D, close angle by gonioscopy and ocular pathology other than glaucoma
Setting: Himi Municipal Hospital.
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -2.14 ± 1.77 dB
and 3.86 ± 2.66 dB. All glaucoma patients had MD > -6 dB
Control participants: normal ONH appearance, IOP < 21 mmHg, and normal SAP results
Index tests Optic Coherence Tomography : 3D-OCT- 1000 Mark II, 3D scan and RNFL 3.4 mm protocol
(Topcon, Tokyo, Japan). 3 consecutive scans with no obvious misalignment between the centre
of the scans and the optic disc or the fovea were acquired after pupil dilatation and by the same
operator. A mean of 3 scans was used for the analysis
The authors stated no source of support.
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Target condition and reference
standard(s)
Manifest glaucoma: comprised perimetric glaucoma eyes defined as glaucomatous optic disc ab-
normalities with a localised RNFL at areas of rim thinning and glaucomatous VF defects (defined
as a cluster of 3+ non-edge points with P < 5% and at least 1 point with P < 1% in the pattern
deviation probability plot or PSD with P < 5% or GHT outside normal limits) and preperimetric
glaucoma eyes defined as glaucomatous optic disc abnormalities with localised RNFL defect at areas
of rim thinning, without glaucomatous VF defects
Visual field testing:Humphrey Field Analyzer, 30-2 SITA strategy (Carl ZeissMeditec Inc., Dublin,
CA, USA). Reliability criteria included fixation losses rates < 20%, and false-positive and false-
negative rates of < 33%
Optic disc evaluation: dilated fundus biomicroscopy using 78-diopter lens, stereoscopic optic disc
photography
Flow and timing The reference standard and index test were performed on the same day. All participants enrolled
were included in the analysis
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
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DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Nouri-Mahdavi 2013
Study characteristics
Patient sampling Case-control study inwhich glaucoma and normal participants were prospectively recruited between
December 2010 and October 2012. Both eyes of some participants were included in the analysis
Patient characteristics and set-
ting
Sample size: 150 eyes of 99 participants (59 eyes of 47 subjects with early glaucoma, 91 eyes of 52
normal healthy controls)
Age: glaucoma mean ± SD, 66.1 ± 6.0, controls 58.6 ± 9.2 years.
Sex: 56 men (23 glaucoma, 33 controls) and 94 women (36 glaucoma, 58 controls)
Ethnicity: 75 white (36 glaucoma, 39 controls); 10 African-American (6 glaucoma, 4 controls); 5
Hispanic (2 glaucoma, 3 controls); 9 Asian (3 glaucoma, 6 controls)
Clinical setting: University of California, Los Angeles (UCLA) and Glaucoma Clinic, Jules Stein
Eye Institute, between December 2010 and October 2012
Country: USA.
Ocular comorbidities: patients with evidence of retinal or neurologic diseases or prior glaucoma
surgery were excluded
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Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were -2.5 ± 1.9 and
4.5 ± 2.2 respectively for early glaucoma. All glaucoma has MD≥ -6 dB
Control participants: normal eye examinations, including normal VFs, and not having definitive
evidence of glaucomatous damage at the level of the ONH
Index tests Optical coherence tomography: Cirrus HD-OCT, (Carl Zeiss Meditec, Dublin, CA, USA). Soft-
ware version 6.0. Optic disc cube 200 x 200 and macular cube 200 x 200 scanning protocols were
used for analysis. Images with signal strength < 7, lost data on the peripapillary ring, obvious motion
artefact, or incorrect segmentation, were excluded
The authors declare no conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous VF test results, defined as GHT outside normal limits and the
presence of ≥ 4 abnormal test locations on a pattern deviation plot, with P < 5% both confirmed
at least one
Visual field test: standard automated perimetry or short-wavelength automated perimetry. Only
eyes with reliable visual fields (false-positive rate of 15% or less) were included
Flow and timing Only eyes with reliable visual fields were included but no further details on number of exclusions
were reported
Index and reference tests were performed on the same day.
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
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Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Did all patients receive a refer-
ence standard
Yes
Oddone 2008
Study characteristics
Patient sampling A series of consecutive normal and POAG participants from the population attending the glaucoma
clinics were enrolled. Normal controls were people attending the outpatient clinics, spouses and
friends of the recruited patients, or volunteers from the hospital staff. One eye per person was
randomly selected
Patient characteristics and set-
ting
Sample size: 242 eyes of 242 participants enrolled; 236 included in the analysis (99 glaucoma,137
healthy controls)
Age: glaucoma patients mean ± SD, 62.7 ± 11 years; controls 60.9 ± 13 years
Sex: 105 men (45 glaucoma, 60 controls) and 131 women (54 glaucoma, 77 controls)
Country: Italy.
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Ocular comorbidities: no neuro-ophthalmologic/retinal diseases, BCVA < 20/40, spherical refrac-
tion > ±5 D, cylinder refraction > ±3 D, uveitis, close angle by gonioscopy, ocular surgery or laser
treatments, ocular trauma, rheumatologic systemic diseases and diabetes
Setting: University of Rome Tor Vergata, Rome; University of Milan San Paolo, Milan; University
of Genoa, Genoa
Spectrum of glaucoma severity: according to the VF defect severity: 42 eyes were at stage 1 (MD
> -6 dB), 29 eyes at stage 2 (MD < -6 dB and > -12 dB), 28 at stage 3 (MD < -12 dB). Mean ± SD
MD/CPSD on the VF test were respectively -3.74 ± 1.29 dB/4.67 ± 1.72 dB (stage 1), -8.35 ± 1.
83 dB/7.5 ± 2.41 dB (stage 2), -18.07 ± 4.93/10.4 ± 2.88 dB (stage 3)
Control participants: IOP < 22 mmHg and a normal VF test result.
Index tests Confocal scanning laser tomography: HRT 3, software version 3.0 (Heidelberg Engineering
GmbH, Dossenheim, Germany). After scanning, a contour line was manually placed around the
ONH edge by 3 experienced investigators masked to the participant’s diagnosis. Only high-quality
images with acquisition sensitivity > 90% and a SD < 40 were considered acceptable
No author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: history of IOP > 24mmHg in the hospital notes and glaucomatous VF defects
(defined as GHT outside normal limits, MD and PSD outside 95% confidence limits and a cluster
of at least 3 points with P < 0.05 in the pattern deviation plot, one of each with P < 0.01 affecting
the same hemifield)
Visual field testing: Humphrey Field Analyzer, 24-2 SITA-standard strategy (Carl Zeiss Meditec,
Inc., Dublin, CA, USA). VF reliability criteria were not specified
Optic disc appearance was not part of the reference standard
Flow and timing The time interval between reference standard and index test was not reported. 268 participants were
initially screened, 242 were enrolled. In 6 eyes (2.5%, 4 glaucoma and 2 controls) the GPS was
unable to provide a classification, and were excluded from the analysis
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
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DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
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Oddone 2011
Study characteristics
Patient sampling Healthy participants and glaucoma patients were consecutively enrolled from the population at-
tending the glaucoma clinics. Normal controls were either people attending the outpatient clinics,
spouses and friends of the recruited patients, or volunteers from the hospital staff. One eye per
person was enrolled
Patient characteristics and set-
ting
Sample size: 136 participants screened, 130 enrolled, 120 eye of 120 participants finally included
in the analysis (70 glaucoma, 50 controls)
Age: glaucoma eyes mean ± SD 66.2 ± 8.6 years; controls 64.3 ± 6.0 years
Sex: 71 men (42 glaucoma, 29 controls) and 49 women (28 glaucoma, 21 controls)
Ethnicity: not reported.
Country: Italy.
Setting: G.B. Bietti Eye Foundation, Rome, and University of Rome Tor Vergata, Rome
Ocular comorbidities: patients with history of neuro-ophthalmologic or retinal diseases, uveitis,
previous ocular surgery or laser treatments, history of ocular trauma, rheumatologic systemic diseases,
and diabetes were excluded. All eyes had to have BCVA ≥ 20/40, a spherical refraction within ±5
D, astigmatism within ±3 D, and an open angle by gonioscopy
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were -8.4 ± 6.8 dB
and 7.2 ± 4.5 dB, respectively for glaucoma
Control participants: IOP < 22 mmHg in both eyes with no history of IOP > 21 mmHg, a GHT
within normal limits and a MD and a PSD within 95% confidence limits confirmed in 2 reliable,
consecutive VF tests
Index tests Optical coherence tomography: Cirrus HD-OCT (software version 3.0). The optic disc cube 200
x 200 was used to acquire the images. All images were acquired by a single, well-trained investigator
during the same visit. Only scans with a signal strength of ≥ 6, without RNFL discontinuity or
misalignments, eye movements, or blinking artefacts were included in the analysis
Scanning laser polarimetry: GDx VCC (Carl Zeiss Meditec, Dublin, CA, USA). Only high-
quality images (well-focused and uniformly illuminated reflectance image, with a centred optic disc
and a quality score > 8) and without an atypical retardation pattern were included
Confocal scanning laser ophthalmoscopy:HRT3 (software version 3.0, Heidelberg Engineering
GmbH, Dossenheim, Germany). The contour line was manually placed around the ONH edge by
one experienced investigator masked to the subset diagnosis. Only high-quality images (acquisition
sensitivity > 90% and a SD > 30) were included in the analysis
None of the authors had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma:documentedhistory of IOP>24mmHg and glaucomatousVFdamage defined
as a GHT outside normal limits, MD and PSD outside 95% confidence limits, and a cluster of > 3
points with P < 5% in the pattern deviation plot, one with P < 1% affecting the same hemifield (the
cluster had not to be contiguous with the blind spot and had not to cross the horizontal midline)
Visual field testing: Humphrey Field Analzyer (24-2 SITA standard programme (Carl Zeiss
Meditec). VF reliability criteria were not reported
Optic nerve appearance was not part of the reference standard
Flow and timing The time interval between index tests and reference standard was not reported
10 participants (< 10%) were excluded from the analysis: 6 eyes due to atypical pattern on GDx
VCC and in 4 eyes the HRT3 GPS analysis was unable to provide a classification
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Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
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Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Pablo 2010
Study characteristics
Patient sampling Healthy and glaucoma eyes were consecutive enrolled. Normal eyes were recruited from patients
referred for refraction that underwent routine examination without abnormal ocular findings, hos-
pital staff, and relatives of hospital patients. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 118 participants enrolled, 105 eyes of 105 participants included in the analysis (43
POAG, 10 pseudo-exfoliative glaucoma, 1 pigmentary glaucoma and 51 healthy controls)
Age: glaucoma patients mean ± SD, 61.9 ± 6.8 years; controls 59.1 ± 9.6 years
Ethnicity: white.
Country: Spain
Ocular comorbidities: no previous intraocular surgery, BCVA < 20/30, spherical refraction > ±5
D, cylinder refraction > ±2 D history of ocular or neurologic disease, diabetes or other systemic
diseases
Setting: Miguel Servet University Hospital, Zaragoza.
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -2.91 ± 2.28 dB
and 3.16 ± 2.07 dB, respectively
Control participants: IOP < 21 mmHg, no history of increased IOP, and a normal SAP
Index tests Confocal scanning laser ophthalmoscopy: HRT3 (Heidelberg Engineering, Dossenheim, Ger-
many). Images were obtained through dilated pupils. All scans had to have an interscan SD < 30
mm. The margin of the optic discs was manually traced by the same glaucoma specialist, who was
masked to the patients’ identity and clinical history
No author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: IOP > 21 mmHg (on at least 3 readings on different days) and glaucomatous
VF defects (defined as PSD with P < 5% and/or a GHT outside normal limits)
Visual field testing:Humphrey Field Analyzer,model 750, 24-2 SITA-standard strategy (Carl Zeiss
Meditec, Dublin, CA, USA). Reliability criteria included fixation losses, false-positive and false-
negative rates of < 20%
Optic disc appearance was not part of the reference standard
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Flow and timing The time interval between reference standard and index tests was < 6 weeks. 13 pre-selected partic-
ipants were not included in the analysis (2 did not provide informed consent, 6 did not complete
all of the required tests and in 5 GPS analyses produced only a global result or no results)
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
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Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
Pueyo 2006
Study characteristics
Patient sampling Healthy, ocular hypertensive and glaucoma eyes were enrolled. All high-IOP patients and those
affected by glaucoma were consecutively selected amongst the patients seen in consulting rooms
and who fulfilled the inclusion criteria set for this study. One eye per person was selected
Patient characteristics and set-
ting
Sample size: 427 eyes of 427 participants (74 glaucoma, 287 ocular hypertensive and 66 healthy
controls)
Age: glaucoma patients mean ± SD, 64.79 ± 9.31 years; OHT patients 55.10 ± 11.63 years; controls
58.95 ± 11.74years
Country: Spain.
Ocular comorbidities: no retinal disease, BCVA < 32/40, spherical refraction > ±5 D, cylinder
refraction > ±3 D, angular abnormalities, history of traumatism or ocular surgery, or neuro-oph-
thalmologic disease
Setting: Ophthalmology Service, University Hospital Miguel Servet, Zaragoza, Ophthalmology
Service, San Carlos Hospital, Madrid
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -6.56 ± 6.07 dB
and 5.11 ± 3.66 dB for glaucoma eyes, -0.30 ± 1.12 dB and 0.97 ± 0.75 dB for OHT eyes
Control participants: IOP ≤ 21 mmHg, automated perimetry and optic nerve appearance com-
patible with normality
Index tests Scanning laser polarimetry: GDx VCC (Laser Diagnostic Technologies, San Diego).
No details about images quality assessment or conflict of interest were reported
Target condition and reference
standard(s)
Manifest glaucoma: IOP > 21 mmHg, glaucomatous VF defects (defined as CPSD with P <
2%, and/or group of 3+ adjoining points with a probability level < 1% and/or altered GHT) and
glaucomatous optic nerve signs (defined as focal/diffuse thinning of the neuroretinal ring, papillar
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haemorrhages, asymmetry in the proportion excavation/vertical disc above 0.2 between both eyes)
Ocular Hypertension: IOP > 21 mmHg with automated perimetry compatible with normality,
without considering papillar morphology
Visual field testing:Humphrey FieldAnalyzer,model 745, 24-2 full threshold strategy.VF reliability
criteria included fixation losses rates < 20, false-positive and false-negative rates of < 33%.
Optic disc evaluation: papilla assessment was done by a glaucoma specialist.
Flow and timing The time interval between reference standard and index tests was not reported
The authors stated that all the patients for whom it was not possible to obtain good-quality images
of all the structural analysis techniques were excluded from the study, but no other details were
specified
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Unclear
Were any conflict of interest
avoided
Unclear
Low
DOMAIN 3: Reference Standard
199Optic nerve head and fibre layer imaging for diagnosing glaucoma (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Pueyo 2006 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Did all patients receive a refer-
ence standard
Yes
Rao 2010a
Study characteristics
Patient sampling Normal and glaucoma participants seen in a tertiary eye care centre between July 2004 and February
2006 were enrolled. Consecutively-seen patients with glaucoma formed the study group, whereas
the normal participants were from among those referred for refraction without any abnormal ocular
findings, patients’ relatives, or hospital staff. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 177 eyes of 177 participants (98 glaucoma, 79 healthy controls)
Age: glaucoma patients mean ± SD, 55.2 ± 9.1 years; controls 51.9 ± 10.6 years
Sex: 111 men (62 glaucoma, 49 controls) and 66 women (36 glaucoma, 30 controls)
Ethnicity: Indian.
Country: India.
Ocular comorbidities: no intraocular surgery within the previous 6 months, BCVA < 20/40,
spherical refraction > ±5 D, cylinder refraction > ±3 D, any retinal or neurologic diseases that could
confound the results of VF examination
Setting: Eye care centre in Hyderabad, Central India, between July.
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -7.3 ± 6.7 dB and
5.33 ± 3.86 dB, respectively
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Control participants: IOP < 22 mmHg in both eyes, no history of increased IOP or family history
of glaucoma, normal VF result and optic disc appearance
Index tests Confocal scanning laser ophthalmoscopy: HRT2 (Heidelberg Engineering, Dossenheim, Ger-
many). After scan, data were exported to HRT3 to be processed without altering the location of the
contour line. A single experienced operator had acquired 3 scans and drawn the disc margin in each
scan. Only images with inter-scan SD of ≤ 50 µm were included
No author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous ONH appearance (defined as focal/diffuse neuroretinal rim
thinning, localised notching, or nerve fibre layer defects) with correlating VF defects (presence of a
cluster of 3 points on pattern deviation probability plot with P < 5%, one of which had P < 1%, or
a PSD with P < 5%, or a GHT outside normal limits)
Visual field testing: Humphrey Field Analyzer, 24-2 SITA-standard strategy (Zeiss-Humphrey
Systems, Dublin, CA, USA). Reliability criteria included fixation losses rates, false-positive and
false-negative rates of < 20%
Optic disc evaluation: dilated fundus examination by 2 glaucoma specialists.
Flow and timing The time interval between reference standard and index test was not reported
10 participants (6 glaucoma and 4 normal) were excluded due to poor-quality images (< 10%)
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
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Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Rao 2010b
Study characteristics
Patient sampling Glaucoma patients were enrolled in a prospective, longitudinal study designed to evaluate optic nerve
structure and visual function in glaucoma (Diagnostic Innovations in Glaucoma Study). Healthy
participants were recruited from the general population through advertisement, as well as from the
staff and employees of the University of California. When both eyes of participants satisfied the
inclusion criteria, both were included
Patient characteristics and set-
ting
Sample size: 74 eyes of 44 normal participants and 140 eyes of 106 glaucoma patients
Age: glaucoma patients mean ± SD, 68.34 ± 10.54 years; controls 62.34 ± 12.04 years
Ethnicity: 119 white (40 controls, 79 glaucoma); 31 African-American (4 controls, 27 glaucoma)
Country: USA.
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Ocular comorbidities: no co-existing retinal disease, close angle by gonioscopy, BCVA < 20/
40, spherical refraction > ±5 D, cylinder refraction > ±3 D, uveitis, or non-glaucomatous optic
neuropathy
Setting: Hamilton Glaucoma Center, University of California, San Diego
Spectrum of glaucoma severity: mean (with 1st and 3rd quartile values) MD and PSD on the VF
test were -3.67 (-2.05, -7.07) dB and 4.03 (2.58, 9.10) dB
Control participants: IOP < 21 mmHg, with no history of increased IOP and a normal VF result
(MD and PSD within the 95% confidence limits, and a GHT within normal limits)
Index tests Optic Coherence Tomography: RTVue-100, software version 4.0.5.39 (Optovue Inc, Fremont,
CA, USA). TheONH andGCC scan protocols were acquired. Only high-quality images, as defined
by a signal strength index > 30 were used for analysis
Some authors had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: repeatable (> 2 consecutive), glaucomatous VF result (defined as a PSD outside
the 95% confidence limits or a GHT outside normal limits, or both)
Visual field testing: Humphrey Field Analyzer, 24-2 SITA-standard strategy (Carl Zeiss Meditec
Inc.). VF reliability criteria were not specified
Optic disc appearance was not part of the reference standard
Flow and timing The time interval between reference standard and index test was < 1 year. 3 participants (2 normal
and 1 glaucoma patient, < 10%) were excluded from the analysis due to incorrect baseline disc
drawing
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
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Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Rao 2012a
Study characteristics
Patient sampling Cross-sectional study comprised consecutive early glaucoma patients and 2 cohort of healthy con-
trols. One cohort (1) recruited from people who attend a tertiary eye-care clinic for a routine eye
examination, patients’ relatives, and hospital staff. Another cohort (2) including consecutive patients
who were referred to tertiary clinic centre by general ophthalmologists as glaucoma suspects based
on optic disc morphology but confirmed by glaucoma experts to be non-glaucomatous
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Patient characteristics and set-
ting
Sample size: 260 eyes of 147 participants (65 eyes of 46 glaucoma patients, 119 eyes of 60 controls
for cohort 1 and 76 eyes of 41 controls for cohort 2)
Age: glaucoma eyes mean ± SD 51.9 ± 13.2 years; controls cohort 1, 47.1 ± 12.8 years; controls
cohort 2, 50.2 ± 14.7 years
Sex: 94men (33 glaucoma, 32 controls cohort 1, 29 controls cohort 2) and 53women (13 glaucoma,
28 controls cohort 1, 12 controls cohort 2)
Country: India.
Ethnicity: not reported.
Setting: Glaucoma Center L. V. Prasad Eye Institute, Banjara Hills, Hyderabad
Ocular comorbidities: patients with any media opacities, intraocular surgery within the previous 6
months, and any retinal or neurologic diseases other than glaucoma that could confound the results
of VF examination and structural measurements with SD-OCT were excluded. All eyes had to have
BCVA ≥ 20/40, refractive error within ±5.0 D sphere and ±3 D cylinder
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were -3.2 ± 1.5 dB
and 2.8 ± 1.8 dB, respectively for glaucoma. All glaucoma eyes had early stage of disease according
to Hodapp et al. classification
Control participants: 2 cohorts of participants were used as control group:
- Cohort 1: IOP < 22 mmHg with no history of increased IOP, no family history of glaucoma, no
optic disc morphology suspicious for glaucoma and normal visual field result
- Cohort 2: IOP < 22 mmHg with no history of increased IOP, no family history of glaucoma, and
normal visual fields. They were referred to clinical centre by general ophthalmologists as glaucoma
suspects based on optic discmorphology but their optic discs were confirmed on clinical examination
by the glaucoma experts to be non-glaucomatous, but physiological variations of normal
Index tests Optical coherence tomography: RTVue (software version 4.0.5.39; Optovue Inc., Fremont, CA,
USA). The ONH and GCC scanning protocols were used to acquire the images. Only well-centred
images with a signal strength index of ≥ 30 were included in the analysis
One author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous optic disc changes (defined as focal or diffuse neuroretinal rim
thinning, localised notching or nerve fibre layer defects) and corresponding VF defects (defined by
2 of the following criteria: the presence of a cluster of 3 points on a pattern deviation probability
plot with P < 5%, one of which had P < 1%; a PSD with P < %5; or a GHT result outside normal
limits
Visual field testing: Humphrey Field Analzyer, model 750 (24-2 SITA standard programme (Carl
Zeiss Meditec). VF reliability criteria were fixation losses, false-positive and false-negative rates <
20%
Optic disc evaluation: digital optic disc photographs (Visupac 4.2.2; Carl Zeiss Meditec Systems,
GmbH, Pirmasens, Germany). The photographs were evaluated by 2 experts who were masked to
the clinical examination and VF and OCT results of the participants
Flow and timing All participants had both protocols as well as the VF testing performed on the same day
The authors stated that “Eyes in which the segmentation algorithm failed were excluded” but no
participants were reported as excluded from the analysis
Comparative
Notes None.
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Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
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Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Did all patients receive a refer-
ence standard
Yes
Rao 2012b
Study characteristics
Patient sampling Consecutive early glaucoma patients and healthy controls were enrolled at a tertiary eye-care facility
between August 2008 and June 2009. The normal participants were recruited from among those
who came for a routine eye examination, patients’ relatives and hospital staff. Both eyes were included
for some participants
Patient characteristics and set-
ting
Sample size: 216 (91 early glaucoma, 125 control) eyes of 123 participants (59 early glaucoma, 64
control) were enrolled and included in the analysis
Age: glaucoma eyes mean ± SD 51.8 ± 13.4 years; controls 47.7 ± 13.4 years
Sex: not reported.
Ethnicity: Indian.
Country: India.
Setting: glaucoma Center L. V. Prasad Eye Institute, Banjara Hills, Hyderabad
Ocular comorbidities: patients with any media opacities, intraocular surgery within the previous 6
months, and any retinal or neurologic diseases other than glaucoma that could confound the results
of VF examination and structural measurements with SD-OCT were excluded. All eyes had to have
BCVA ≥ 20/40, refractive error within ±5.0 D sphere and ±3 D cylinder
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were -2.6 ± 1.8 dB
and 2.4 ± 1.5 dB, respectively for glaucoma. All glaucoma eyes had early stage of disease according
to Hodapp et al. classification
Control participants: IOP < 22 mmHg with no history of increased IOP, no family history of
glaucoma, no optic disc morphology suspicious for glaucoma (focal or diffuse neuroretinal rim
thinning, localised notching or nerve fibre layer defects) and normal VF result
Index tests Optical coherence tomography: RTVue (software version 4.0.5.39; Optovue Inc., Fremont, CA,
USA). The ONH and GCC scanning protocols were used to acquire the images. Only well-centred
images with a signal strength index of ≥ 30 were included in the analysis.
One author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous optic disc changes (defined as focal or diffuse neuroretinal rim
thinning, localised notching or nerve fibre layer defects) and corresponding VF defects (defined by
2 of the following criteria: the presence of a cluster of 3 points on a pattern deviation probability
plot with P < 5%, one of which had P < 1% or a PSD with P < %5 or a GHT result outside normal
limits)
207Optic nerve head and fibre layer imaging for diagnosing glaucoma (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Rao 2012b (Continued)
Visual field testing: Humphrey Field Analzyer, model 750 (24-2 SITA standard programme (Carl
Zeiss Meditec). Reliability criteria were fixation losses, false-positive and false-negative rates < 20%
Optic disc evaluation: dilated fundus examination by 2 glaucoma specialists.
Flow and timing The index test and reference standard were performed on the same day
No participants were reported by the authors as excluded from the analysis
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
Unclear
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of the results of the index tests?
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Rao 2013
Study characteristics
Patient sampling Case-control study including preperimetric glaucoma and 2 different control group (patient referred
by general ophthalmologist as glaucoma suspects for optic disc appearance and healthy controls not
suspected of having glaucoma), evaluated at a tertiary eye-care facility between January 2010 and
December 2012
One eye was randomly selected if both eyes were eligible.
Patient characteristics and set-
ting
Sample size: 166 eyes of 166 participants (34 eyes of 34 preperimetric glaucoma, 72 eyes of 72
controls with optic disc appearance suspected of having glaucoma and 60 eyes of 60 healthy controls
with no optic disc appearance suspected for glaucoma)
Age: glaucoma mean (range), 54 (41 to 61), controls group 1 52 (41 to 62) years, controls group 2
50 (38 to 57)
Sex: not reported.
Ethnicity: not reported.
Clinical setting:L. V. Prasad Eye Institute, Banjara Hills, Hyderabad, between January 2010 and
December 2012
Country: India.
Ocular comorbidities: patients with any media opacities that prevented good-quality optic disc
photographs and SDOCT imaging and any retinal (including macular) disease other than glaucoma
that could confound the evaluations, were excluded
Spectrum of glaucoma severity: the mean (range) MD and PSD on the VF test were -2.14 (-4.25
to -0.98) and 1.82 (1.44 to 2.18) respectively for preperimetric glaucoma
Control participants:
- control group 1: patient referred by general ophthalmologists, as glaucoma suspects based on the
optic disc morphology. Their optic discs were confirmed on masked evaluation of disc photographs
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by the glaucoma experts to be non-glaucomatous with large physiologic cupping. All patients had
IOP < 22 mmHg in both eyes, no past history of increased IOP, no family history of glaucoma, and
normal VF
- control group 2: no suspicious findings for glaucoma, a normal ocular examination, IOP < 22
mmHg in both eyes, no past history of increased IOP, no family history of glaucoma, and normal
VF
Index tests Optical coherence tomography: RTVue SD-OCT (Optovue, Inc., Fremont, CA, USA), software
version
5.1.0.90. ONH and GCC scanning protocols were used for analysis. Optic disc cube 200 x 200 and
macular cube 200 x 200 scanning protocols were used for analysis. Images not well centred with a
signal strength index < 30, or segmentation algorithm failed, were excluded
One of the author had conflict of interest with the manufacturer
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous optic neuropathy (neuroretinal rim thinning, notching, and/or
RNFL defects), and normal VF results (PSD with P < 5% or the GHT within normal limits)
Visual field test: Humphrey Field Analyzer, model 750 (Zeiss Humphrey Systems, Dublin, CA,
USA), 24-2 SITA standard programme. Reliable exams had fixation losses, false-positive and false-
negative response rates < 20%
Optic disc evaluation: digital optic disc photographs (450plus with VISUPAC 4.2.2; Carl Zeiss
Meditec Systems GmbH, Pirmasens, Germany). Optic disc photographs were evaluated indepen-
dently by 2 glaucoma experts who were masked to other clinical examination results
Flow and timing Quote: “Eyes in which the segmentation algorithm failed were excluded”, but no further details
about exclusion reported
Index and reference test were performed on the same day.
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
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If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Did all patients receive a refer-
ence standard
Yes
Rao 2014
Study characteristics
Patient sampling Consecutive participants referred by general ophthalmologists to a tertiary eye-care facility between
September 2010 and November 2012 for a glaucoma evaluation. The control group against which
the glaucoma cohort was evaluated consisted of people referred to the Institute from general oph-
thalmologists as glaucoma suspects based on the optic disc appearance
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Patient characteristics and set-
ting
Sample size: 215 eyes of 165 participants (106 eyes of 79 glaucoma patients and 109 eyes of 86
controls)
Age: glaucoma median (interquartile range), 53 (48, 59) years; controls, 54 (45, 62) years
Sex: not reported.
Ethnicity: not reported.
Clinical Setting: Glaucoma Center, L. V. Prasad Eye Institute, Hyderabad.
Country: India.
Ocular comorbidities: patients with any media opacities that prevented good imaging and any
retinal (including macular) or neurological diseases other than glaucoma which could confound the
VF or imaging examination were excluded
Spectrum of glaucoma severity: the median (interquartile range) MD and PSD on the VF test
were -6.86 (-12.11, -4.65) and 7.58 (3.99, 10.49) respectively, for glaucomatous eyes
Control participants: normal optic disc appearance and normal VF result.
Index tests Optical coherence tomography RTVue (software version 5.1.0.90; Optovue Inc, Fremont, CA,
USA).ONHscanning protocol used for the analysis. Only well-centred images with a signal strength
index of ≥ 30 and no segmentation algorithm failure were used for the analysis
Scanning laser polarimetry: GDxPRO(version1.1.1;Carl ZeissMeditec, Inc.).Onlywell-focused,
centred and illuminated images with a quality score of ≥ 7, a typical scan score > 80, and a residual
anterior segment retardation of < 4 were included for analysis
The authors stated no conflicts of interest.
Target condition and reference
standard(s)
Manifest perimetric glaucoma: glaucomatous optic disc appearance (based on the presence of focal
or diffuse neuroretinal rim thinning, localised notching or nerve fibre layer defects) and VF defect
(defined as PSD with P < 5% and GHT outside normal limits)
Visual field test: Humphrey Field Analyzer model 750 (Zeiss Humphrey Systems, Dublin, CA,
USA); 24-2 SITA-standard strategy. All exams had fixation losses, false-positive and false-negative
rates of < 20%
Optic disc evaluation: Digital photographs (Visupac 4.2.2; Carl Zeiss Meditec Systems GmbH,
Pirmasens, Germany). 2 experts, masked to the clinical examination results of the participants,
evaluated independently the photographs
Flow and timing 69 eyes were (> 10%) were excluded due to poor-quality imaging tests or unreliable reference
standard. 61 eyes were excluded due to the optic disc classification not correlating with visual fields
The index and reference test were performed on the same day.
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
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Was a case-control design
avoided?
Unclear
Did the study avoid inappropri-
ate exclusions?
Yes
Unclear
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
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Reus 2004
Study characteristics
Patient sampling Glaucoma patients were recruited consecutively from an ongoing longitudinal follow-up study.
Healthy participants were recruited either consecutively from an ongoing longitudinal follow-up
study or from employees of The Rotterdam Eye Hospital and their spouses and friends. One eye
per healthy participant was selected randomly. One eye per glaucoma patient was selected, choosing
the eye with the more positive MD at VF, if both were eligible
Patient characteristics and set-
ting
Sample size: 239 eyes of 239 participants were enrolled, 219 eyes were actually included in the
analysis (146 glaucoma, 73 healthy controls)
Age: glaucoma patients mean ± SD, 61 ± 10 years; controls 59 ± 11
Sex: 115 men (81 glaucoma, 34 controls) and 104 women (65 glaucoma, 39 controls)
Ethnicity: white.
Country: Netherland.
Ocular comorbidities: no history of ocular disease (as posterior segment eye disease and corneal
disease), BCVA < 20/40, previous intraocular surgery (except for uncomplicated cataract surgery),
systemic hypertension or diabetes
Setting: Rotterdam Eye Hospital.
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -8.45 ± 6.81 dB
and 8.13 ± 3.88 dB. According to the Hodapp et al. grading scale: 37 eyes had mild glaucoma, 28
moderate, 81 severe
Control participants: IOP < 21 mmHg in both eyes, normal visual fields (GHT within normal
limits and no nerve fibre bundle VF defects in the total or pattern deviation probability plots or
both) and healthy-looking ONH
Index tests Scanning laser polarimetry: GDx VCC (Laser Diagnostic Technologies, Inc., San Diego, CA,
USA). All scans were acquired through undilated pupils, and were of high quality (i.e. with a centred
optic disc, well focused, even and just illuminated throughout the field)
No author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous ONH appearance with a corresponding glaucomatous nerve
fibre bundle abnormality on the total and/or pattern deviation probability plots with SAP and open
angle by gonioscopy
Visual field testing: Humphrey Field Analyzer, 24-2 SITA-Standard strategy (Carl Zeiss Meditec,
Dublin, CA, USA). VF reliability criteria were not reported
Flow and timing The time interval between reference standard and index test was not reported. 20 (< 10%) partic-
ipants were excluded from the analysis: in 4 healthy and 12 glaucoma participants the GDx VCC
software flagged measurements as “results may not be compatible with normative database”, in 4
glaucoma patients high-quality images could not be obtained
Comparative
Notes None.
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Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Reus 2007
Study characteristics
Patient sampling Healthy participants and glaucoma patients were selected from a cohort of patients and controls
who had been originally recruited for an ongoing longitudinal glaucoma study. Healthy participants
had been recruited from spouses and friends of patients and from employees of the Rotterdam Eye
Hospital and their spouses and friends. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 94 eyes of 94 participants (48 glaucoma, 6 ocular hypertensive, 40 healthy controls)
Age: glaucoma patients mean, 61 years; controls 59.
Sex: 45 men (26 glaucoma, 19 controls) and 43 women (22 glaucoma, 21 controls)
Ethnicity: white.
Country: Netherland.
Ocular comorbidities: no co-existing ocular diseases, BCVA < 20/40, previous intraocular surgery
(except for any uncomplicated cataract surgery or, if applicable, glaucoma surgery), or diabetes
mellitus
Setting: Rotterdam Eye Hospital.
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -6.56 ± 6.32 dB
and 7.71 ± 4.03 dB, respectively
Control participants: IOP < 21 mmHg in both eyes, normal VFs (GHT within normal limits and
no nerve fibre bundle VF defects in the total or pattern deviation probability plots or both) and
healthy-looking ONH
Index tests Scanning laser polarimetry: GDx VCC, software version 5.4.0 (Carl Zeiss Meditec AG, Jena,
Germany). Only high-quality scans, i.e. with a centred ONH, well focused, evenly and justly
illuminated throughout the image, and without any motion artefacts, were accepted
Some authors had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous optic disc appearance (with notching or thinning of the neu-
roretinal rim) and a reproducible corresponding nerve fibre bundle VF defect
Visual field testing: Humphrey Field Analyzer, II (Carl Zeiss Meditec AG, Jena, Germany). The
details about reliability criteria were not specified
Flow and timing The time interval between reference standard and index tests was not reported
All participant selected were included in the analysis.
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Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
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Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Rho 2014
Study characteristics
Patient sampling Case-control study enrolling consecutive early glaucoma eyes and age-matched healthy control eyes
in 2013 at CHA Bundang Medical Center, Seongnam, Republic of Korea
One eye per person was randomly selected.
Patient characteristics and set-
ting
Sample size: 120 eyes of 120 participants (58 early glaucoma and 62 healthy controls)
Age: glaucoma mean (range), 53.31 (19 to 76) years; controls, 52.05 (20 to 70) years
Sex: 52 men (24 glaucoma, 28 controls) and 68 women (34 glaucoma, 34 controls)
Ethnicity: Korean.
Clinical Setting: CHA Bundang Medical Center, CHA University, Seongnam.
Country: Korea.
Ocular comorbidities: patients with retinal disease, neuro-ophthalmologic disease, history of re-
fractive or retinal surgery within 3 months, or closed iridocorneal angle and refractive error more
than 68.0 diopters and 63.0 diopters of cylinder were excluded
Spectrum of glaucoma severity: the mean (range) MD on the VF test were -1.60 (-5.65 to 0.50),
for glaucomatous eyes of the validation group. All glaucoma had MD > -6
Control participants: IOP < 21 mmHg, normal optic disc, or normal VF test results
Index tests Optical coherence tomography: Spectralis OCT (Heidelberg Engineering GmbH, Heidelberg,
Germany), software version 5.4.7.0. Peripapillary RNFL thicknesses scanning protocol was used for
the analysis. Only images with image quality scores > 22 were accepted
The authors had no disclosure to be declared.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous optic disc contours and a corresponding abnormal VF result
(defined as 1+ of the following criteria: GHT outside normal limits; PSD with P < 0.05; 3+ non-
edged points in a cluster decreased with P < 0.05, with 1 of these with P < 0.01) or RNFL defects
plus a corresponding abnormal VF result
Visual field test: Humphrey Field Analyzer II (Carl Zeiss Meditec, Inc., Dublin, CA, USA); 24-
2 SITA-standard strategy. Reliable VF were defined by fixation loss < 30%, and false-positive and
false-negative rates of < 20%
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RNFL evaluation: fundus photography and red-free photography with a fundus camera (VX-10i;
Kowa, Nagoya, Japan)
Flow and timing The time interval between index and reference test was not specified
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
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Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Roberti 2014
Study characteristics
Patient sampling Prospective, case-control study, conducted at the IRCCS-Fondazione G. B. Bietti, Rome. One eye
per person was included
Patient characteristics and set-
ting
Sample size: 104 eyes of 104 participants (46 glaucoma and 58 controls)
Age: glaucoma mean ± SD, 61 ± 12.9 years; controls, 58.5 ± 11.3 years
Sex: not reported.
Ethnicity: not reported.
Clinical setting: IRCCS-Fondazione G. B. Bietti, Rome.
Country: Italy.
Ocular comorbidities: patients with any active or past retinal pathologies (including diabetic
retinopathy or age-related macular degeneration), opacities of optic media, history of ocular surgery
(except for uncomplicated cataract or glaucoma surgery), were excluded
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were -7 ± 5.9 and
6.9 ± 4.6 respectively, for glaucomatous eyes
Control participants: IOP < 22mmHg, normal-appearing optic disc, and normal VF test result
Index tests Confocal scanning laser ophthalmoscopy: Heidelberg Retina Tomograph (HRT3; Heidelberg
Engineering GmbH, Heidelberg, Germany). Software version 3.0. Only images with acquisition
sensitivity of > 90% and a SD < 40, were used for the study
Optical coherence tomography: RTVue-100, software version 5.1.0.90 (Carl Zeiss Meditec Sys-
tems GmbH, Pirmasens, Germany). Only images with signal strength index >50 were accepted
The authors reported no conflict of interest.
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Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous VF defect, defined as the consistent presence of a cluster of 3+
non-edge points on the pattern deviation plot with a probability of occurring in < 5% of the normal
population with one of these points having the probability of occurring in < 1% of the normal
population, a PSD with P < 5%, or a GHT result outside normal limits
Visual field test:Humphrey Field Analyzer, SITA-standard 24-2 (Carl Zeiss Meditec, Dublin, CA)
. Reliable VF were defined by fixation loss and false-negative rate < 25%, and false-positive < 15%
Flow and timing The time interval between index and reference test was not specified
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Rolle 2011
Study characteristics
Patient sampling Glaucoma preperimetric patients consecutively enrolled and sex- and age-matched normal control
participants from normal healthy population were recruited between October 2009 and September
2010. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 178 eyes of 178 participants (126 preperimetric glaucoma, 52 healthy controls)
Age: preperimetric glaucoma eyes mean ± SD 58.1 ± 6.91 years; controls 57.8 ± 6.71 years
Sex: 76 men, 102 women.
Ethnicity: white.
Setting: EyeClinic, Section ofOphthalmology,Department of Clinical Physiopathology, University
of Turino.
Country: Italy.
Ocular comorbidities: patients with previous intraocular surgery, diabetic retinopathy or other
diseases that could cause VF loss or optic disc abnormalities were excluded. All eyes had to have
BCVA ≥ 20/40, spherical equivalent refractive error ≤ +3 D or ≥ -6 D
Spectrum of glaucoma severity: the mean ± SD MD on the VF test were 1.41 ± 0.7 dB, for
glaucoma
Control participants: IOP < 21 mmHg, normal VF test (MD and PSD within 95% limits of
the normal reference and a GHT within 97% limits), normal ONH/RNFL appearance (intact
neuroretinal rim without peripapillary haemorrhages, notches, localised pallor, or RNFL defects)
and open angle by gonioscopy
222Optic nerve head and fibre layer imaging for diagnosing glaucoma (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Rolle 2011 (Continued)
Index tests Optical coherence tomography: FD-OCT RTVue-100 (software version A4, 5, 0, 59, Optovue
Inc, Fremont, CA, USA). The ONH and GCC scanning protocols were used to acquire the images.
Images with motion artefacts, segmentation errors and signal strength index < 45 were excluded.
Authors stated no conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous optic disc changes (defined as optic rim notch or diffuse/gener-
alised loss of optic rim tissue; vertical cup/disc diameter ratio asymmetry, unexplained by side dif-
ferences in optic disc size), disc haemorrhages in conjunction with the finding of IOP > 21 mmHg
and normal VF result
Visual field testing:Humphrey Field Analzyer 24-2 SITA standard programme (Carl ZeissMeditec)
. Reliability criteria were fixation losses, false-positive and false-negative rates ≤ 25%
Optic disc evaluation: slit-lamp biomicroscopy.
Flow and timing The time interval between index test and reference standard was not reported
No patients were reported by the authors as excluded from the analysis
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
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DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Schrems 2010
Study characteristics
Patient sampling Healthy participants, ocular hypertensive and glaucoma (preperimetric and perimetric) patients
were recruited from the Erlangen Glaucoma Registry (a clinical registry for cross-sectional and
longitudinal observation study of patients with open-angle glaucoma or glaucoma suspect)
Patient characteristics and set-
ting
Sample size: 386 participants (95 perimetric glaucoma, 89 preperimetric glaucoma, 145 ocular
hypertensive, 57 controls)
Age: preperimetric glaucoma mean ± SD, 55.7 ± 11.3 years; perimetric glaucoma mean ± SD 56.4
± 11.2 years; ocular hypertensive mean ± SD 53.9 ± 12years; controls 49.9 ± 13 years
Sex: 179 men (30 preperimetric glaucoma,56 perimetric glaucoma, 76 OHT, 17 controls) and 207
women (59 preperimetric glaucoma, 39 perimetric glaucoma, 69 OHT, 40 controls)
Country: Germany.
Ocular comorbidities: no ocular diseases other than glaucoma,BCVA < 16/40, spherical refraction
> ±8 D, diabetes
Setting: Department of Ophthalmology, University of Erlangen-Nuremberg, Schwabachanlage,
224Optic nerve head and fibre layer imaging for diagnosing glaucoma (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Schrems 2010 (Continued)
Erlangen
Spectrum of glaucoma severity: mean ± SD MD/PSD on the VF test were -0.37 ± 1.3/2.48 ± 1.
72 dB, for preperimetric glaucoma; -6.26 ± 5.26/32.6 ± 28.8 dB for perimetric glaucoma; 0.44 ±
1.4/2.19 ± 1.88 dB for OHT
Control participants: normal VFs and normal clinical examination.
Index tests Scanning laser polarimetry: GDx VCC (Carl Zeiss Meditec Inc, Dublin, CA, USA). A score ≥ 7
was the minimum standard for good-quality scans in this study
No author had conflict of interest.
Target condition and reference
standard(s)
Manifest perimetric glaucoma: IOP>21mmHg, abnormal appearance of the optic disc (unusually
small neuroretinal rim area in relation to the optic disc size and cup/disc ratios being higher vertically
compared with horizontally or notching, or localised/diffuse RNFL loss) and glaucomatous VF
defects (defined by a reproducible reduction in sensitivity of at least 10 dB in a cluster of ≥ 2
contiguous locations and/or a deterioration of at least 5 dB in a cluster of ≥ 3 contiguous locations
with at least one of those with ≥ 10 dB), with open angle by gonioscopy
Manifest preperimetric glaucoma: IOP > 21mmHg, glaucomatous optic disc appearance without
any corresponding VF loss
OHT: IOP > 21 mmHg, with normal optic disc appearance and VF test result
Visual field test: No details were reported about how VF testing was conducted
Optic disc evaluation: 15° colour photographs (Zeiss telecentric fundus camera, Germany). The
analyses were independently performed by 2 glaucoma specialists
Flow and timing The time interval between reference standard and index tests was not reported
All participants recruited were included in the analysis.
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
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If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Sehi 2007
Study characteristics
Patient sampling Healthy volunteers (such as office employees and friends or family members of patients with glau-
coma) and patients with glaucoma who met the eligibility criteria were prospectively enrolled
One eye per person was randomly selected.
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Patient characteristics and set-
ting
Sample size: 158 eyes of 158 participants (63 glaucoma, 95 healthy controls) stratified into 2 groups
based on the TSS obtained with SLP-VCC
Age: glaucoma patients mean ± SD, 63.3 ± 9.0 years; controls 54.6 ± 10.5 years
Sex: 53 men (25 glaucoma, 28 normal,) and 105 women (38 glaucoma, 67 control)
Ethnicity: 137 white non-Hispanic, 11 black, 6 Asian, 2 Pacific Islander and 2 Hispanic
Country: USA.
Ocular comorbidities: no previous intraocular surgery (except for uncomplicated cataract extrac-
tion), BCVA < 20/40, SE > ±5 D, ocular disease other than glaucoma or cataract, peripapillary
atrophy, or retinal disease
Setting: Institutes involved in the AIG study: Oregon health and science university; University of
Southern California; Bascom Palmer Eye Institute, University of Miami; Eye Center, University of
Pittsburgh Clinical Center
Spectrum of glaucoma severity: mean ± SD MD and PSD on the VF test were -4.2 ± 4.3 dB and
5.4 ± 4.3 dB, respectively
Control participants: IOP ≤ 21 mmHg, normal optic disc appearance and normal VF results
(GHT within normal limits, and MD and PSD of P > 5%)
Index tests Scanning laser polarimetry: GDx-ECC andGDxVCC, software version 5.5.0 (Carl ZeissMeditec
Dublin, CA, USA). 3 consecutive scans were obtained through undilated pupils, with VCC and
ECC on the same day by the same examiner. The average of 3 measurements was used for the
analysis. Images that were obtained during eye movement were excluded, as well as unfocused,
poorly-centred images or images with a quality scan score < 8
One author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous optic nerve damage (defined as either cup-to-disc asymmetry
between fellow eyes of > 0.2, rim thinning, notching, excavation, orRNFLdefect) and corresponding
abnormal SAP result (GHT and PSD outside 95% normal limits)
Visual field testing: Humphrey Field Analyzer, 24-2 SITA-standard strategy (Carl-Zeiss Meditec,
Inc., Dublin, CA, USA). SAP reliability criteria included fixation losses rates, false-positive and
false-negative rates of < 33%
Optic disc evaluation: dilated stereoscopic examination.
Flow and timing Index tests were performed on the same day but no details about the time interval between reference
standard and index test was reported
No patients were reported as excluded from the analysis.
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
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Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
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Seong 2010
Study characteristics
Patient sampling Glaucoma patients were recruited prospectively, in a consecutive manner. The controls consisted
of hospital staff, staff family members, spouses of patients, or volunteers. One eye per person was
randomly selected
Patient characteristics and set-
ting
Sample size: 167 eyes of 167 participants (102 normal tension glaucoma, 65 healthy controls)
Age: glaucoma patients mean ± SD, 54.9 ± 11.4 years; controls 52.7 ± 12.1 years
Sex: 82 men (49 glaucoma, 33 controls) and 85 women (53 glaucoma, 32 controls)
Country: South Korea.
Ocular comorbidities: no ocular diseases other than glaucoma, BCVA < 20/30, spherical refraction
> ±5 D, cylinder refraction > ±3 D, close angle by gonioscopy, neurological diseases, or diabetes
Setting: Glaucoma clinic of the Asan Medical Center, Seoul.
Spectrum of glaucoma severity: according to the Hodapp et al. grading scale, 56 eyes had early
glaucoma, 46 eyes moderate-to-advanced. Mean ± SDMD/PSD on the VF test were -2.62 ± 1.72/
3.43 ± 2.03 dB, for early glaucoma; -12.1 ± 4.4/10.1 ± 3.55 dB for moderate to advanced glaucoma
Control participants: IOP < 22 mmHg, no history of IOP elevation and no perimetric defects
Index tests Optical coherence tomography: RTVue-100 OCT, software version 4.0.0.143 (Optovue, Inc.).
The GCC, NHM4 and RNFL 3.45 scan protocols were acquired after pupil dilation by a single
well-trained operator who was masked to the diagnosis. Images with signal strength index < 40 or
with overt misalignment of the surface detection algorithm were excluded from the analysis
No author had conflict of interest.
Target condition and reference
standard(s)
Normal Tension Glaucoma: a maximum IOP < 22 mmHg before any antiglaucoma therapy, open
angle by gonioscopy, glaucomatous VF defects (defined as a cluster of 3 points with P < 5% on the
pattern deviation map in at least 1 hemifield, including at least 1 point with P < 1%; or a cluster
of 2 points with P < 1% and a GHT result outside 99% of normal limits; or a PSD outside 95%
of normal limits), and glaucomatous optic disc appearance (increased cupping or a difference in
vertical cup-disc ratio of > 0.2 between eyes, or diffuse/focal neural rim thinning, disc haemorrhage,
or RNFL defects)
Visual field testing: Humphrey Field Analyzer, 24-2 SITA-standard strategy (Carl Zeiss Meditec,
Dublin, CA, USA). Reliability criteria included fixation losses rates < 20%, false-positive and false-
negative rates < 15%
Flow and timing All index test images were acquired during the same patient visit but no details about the time
interval between reference standard and index test was reported
12 eyes (< 10%) were excluded from the analysis due to poor image quality
Comparative
Notes None.
Methodological quality
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Seong 2010 (Continued)
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
230Optic nerve head and fibre layer imaging for diagnosing glaucoma (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Seong 2010 (Continued)
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Shah 2006
Study characteristics
Patient sampling All participants were selected among people enrolled prospectively in the longitudinal Diagnostic
Innovations in Glaucoma Study. One eye per person was randomly chosen
Patient characteristics and set-
ting
Sample size: 123 eyes of 123 participants were enrolled. 101 eyes (43 glaucoma, 58 controls) in
the first analysis (functional definition of glaucoma). 114 eyes (65 glaucoma, 49 controls) in the
second analysis (structural definition of glaucoma)
Age: glaucoma patients mean ± SD, 68.3 ± 3.5 years, controls 58.6 ± 2 years, for the first analysis;
glaucoma patients mean ± SD, 65.5 ± 3 years, controls 60.1 ± 3.5 years, for the second analysis
Sex: 44 men (22 glaucoma, 22 controls) and 57 women (21 glaucoma, 36 controls) in the first
analysis; 35 men (27 glaucoma, 18 controls) and 69 women (38 glaucoma, 31 controls) in the
second analysis
Ethnicity: 88 white (47 glaucoma, 41 controls) in the first analysis; 99 white (57 glaucoma, 42
controls) in the second analysis
Country: USA.
Ocular comorbidities: no previous intraocular surgery (except for uncomplicated cataract or glau-
coma surgery), BCVA < 20/40, spherical refraction > ±5 D, cylinder refraction > ±3 D, ocular
diseases other than glaucoma, close angle by gonioscopy, non-glaucomatous secondary causes of
elevated IOP
Setting: Hamilton Glaucoma Center, University of California, San Diego
Spectrum of glaucoma severity: no details reported
Control participants: no glaucomatous VF damage and no history of IOP > 22 mmHg.
Index tests Scanning laser polarimetry:GDxVCC,software version5.5.0.14 (Carl ZeissMeditec, Inc.,Dublin,
CA, USA). Only images of good quality as assessed by an expert examiner(focused and evenly-
illuminated reflectance image with a centred optic disc, a residual anterior segment retardation of <
15 nm, and a typical scan score of > 25) were included
Some authors had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: 2 parallel analyses were conducted on 2 sample of patients partly overlapping
(some patients were included in both analyses): the first one using a functional definition of glaucoma
(repeatable glaucomatous field loss by SAP, defined as PSDoutside the 95%normal confidence limits
or GHT outside normal limits) and the second one using a structural definition of glaucomatous
optic neuropathy based on assessment of optic disc stereophotographs (defined as focal rimnotching,
rim thinning, or RNFL abnormality)
Visual field testing: Humprheys Field Analyzer, 24-2 SITA-standard strategy (Carl Zeiss Meditec)
. Reliability criteria included fixation losses rates, false-positive and false-negative rates < 25%
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Optic disc evaluation: each stereoscopic optic disc photographs was evaluated by 2 expert graders
in a masked fashion. Adjudication by a third expert grader was completed in cases of disagreement
We extracted data only for analysis using a functional definition of the reference standard
Flow and timing The time interval between reference standard and index tests was < 6 months. Of 123 eyes, 101
were included in the SAP analysis group, and 114 were included in the stereophotograph analysis
group
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Shah 2006 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
Shin 2013
Study characteristics
Patient sampling Glaucoma patients with localised RNFL defects and normal controls who visited the glaucoma
centre from September 2010 to August 2011 were enrolled. One eye per person was randomly
selected
Patient characteristics and set-
ting
Sample size: 136 eyes of 136 participants enrolled (64 glaucoma, 72 healthy controls)
Age: not reported.
Sex: not reported.
Ethnicity: not reported.
Country: Korea.
Setting: Glaucoma Center at Hanyang University Medical Center, Seoul
Ocular comorbidities: patients with any ophthalmic or neurological disease known to affect RNFL
thickness or BCVA < 20/40, spherical equivalent refractive errors < -8.0 D or > +4.0 D, were
excluded
Spectrum of glaucoma severity: The mean ± SD MD on the VF test were -6.26 ± 4.16 dB for
glaucoma
Control participants: no history of IOP > 21 mmHg, a normal ONH and RNFL appearance on
cSLO RNFL photographs and normal VF test result
Index tests Optical coherence tomography: 3D OCT-2000 (software version 7.11; Topcon, Tokyo, Japan).
The 3D disc scanning protocol was used to acquire the images. All images had to have quality score
> 50. The authors stated no conflict of interest
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Target condition and reference
standard(s)
Manifest glaucoma: the presence of localisedRNFLdefects on cSLORNFLphotographs associated
with glaucomatous optic nerve appearance (defined as increased cupping, neuroretinal rimnotching,
optic disc haemorrhage, or cup-to-disc ratio > 0.2 between the eyes) and corresponding VF defects
Visual field testing: Humphrey Field Analzyer (Carl Zeiss Meditec).
RNFL evaluation: Wide-angle (60°) red-free RNFL photographs were obtained with a confocal
scanning laser ophthalmoscope (cSLO, F-10; Nidek, Gamagori, Japan) using the blue reflectance
imaging technique. All topographic measurements of RNFL defects were performed by 2 masked
examiners
Flow and timing The index test and reference standard were performed on the same day
No patients were reported by the authors as excluded from the analysis
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
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Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Sullivan-Mee 2013
Study characteristics
Patient sampling Glaucoma patients and normal controls were selected among those involved in a prospective, lon-
gitudinal, observational glaucoma research study. Patients fitting the inclusion criteria were selected
from the study database. “Both eyes per person were considered and the lowest of the paired eye
RNFL measurements was used for determining the ability of the measured parameters to identify
early glaucoma in a patient.”
Patient characteristics and set-
ting
Sample size: 128 fitting inclusion criteria, 100 participants finally included in the analysis (50
glaucoma, 50 healthy controls)
Age: glaucoma eyes mean ± SD 68.9 ± 9.1 years; controls 66.2 ± 9.4 years
Sex: 95 men (47 glaucoma, 48 controls) and 5 women (3 glaucoma, 2 controls)
Ethnicity: 44 white non-Hispanic (22 glaucoma, 22 controls), 48 Hispanic (22 glaucoma, 26
controls), 5 black (1 glaucoma, 4 controls) and 3 American Indian (1 glaucoma, 2 controls)
Country: USA.
Setting: New Mexico Veterans Administration Health Care System, Albuquerque, New Mexico
Ocular comorbidities: patients with corneal or scleral pathologic conditions, prior refractive,
corneal, or incisional glaucoma surgery, secondary glaucoma diagnoses, VF loss resulting from non-
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Sullivan-Mee 2013 (Continued)
glaucomatous pathologic features (including retinal, optic nerve, or visual pathway disorders), re-
fractive error > ±5 D, and astigmatism > ±3 D, were excluded
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test for glaucoma were
-0.92 ± 1.74 dB and 2.78 ± 1.30 dB respectively for the right eye, -1.29 ± 1.54 dB and 2.74 ±
1.29 dB respectively for the left eye. All eyes had early glaucoma, according to the Hodapp et al.
classification
Control participants: IOP < 22 mmHg, normal optic nerve appearance and normal VF.
Index tests Optical coherence tomography: Spectralis SD-OCT (Heidelberg Engineering, Carlsbad, CA,
USA). The RNFL 3.45 mm and the posterior pole asymmetry analysis scanning protocols were used
to acquire the images. Images with poor quality (poor centration, segmentation errors, scan quality
<15, more than 4 of 61 raster scans had significant segmentation errors, image signal prevented
accurate boundary detection for Bruch’s membrane or internal limiting membrane in all or part of
4 scans or more, significant retinal or vitreoretinal pathologic features were evident) were excluded
Authors stated no conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous optic neuropathy (defined as thinning, excavation, rim erosion,
or notch of the neuroretinal rim) and glaucomatous VF defect (defined as GHT results outside
normal limits, the presence of at least 3 contiguous test points on the pattern deviation plot with P
< 1% and at least 1 at P < 5%, not including points on the edge of the field, or both
Visual field testing: Humphrey Field Analzyer (24-2 SITA standard programme (Carl Zeiss
Meditec, Inc, Dublin, CA, USA). Reliability VF criteria were fixation losses < 33%, false positive
and false negative < 15%
Optic nerve evaluation: dilated fundus examination.
Flow and timing The time interval between index test and reference standard was not reported. 28 participants
(> 10%) were excluded from the analysis due to poor OCT scan quality or confounding retinal
abnormalities (epiretinal membrane, vitreomacular traction syndrome, or large drusen)
Comparative
Notes The work was supported by the Veterans Administration Office of Research and Development. This
support included a new investigator grant from the regional Veterans Integrated Service Network
(VISN 18)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
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High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
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Sung 2013
Study characteristics
Patient sampling Case-control study including early and preperimetric glaucoma and healthy normal controls
One eye was randomly selected if both eyes were eligible.
Patient characteristics and set-
ting
Sample size: 204 patients enrolled, 179 eyes of 179 participants included in the analysis (70 early
glaucoma, 37 preperimetric glaucoma and 72 normal controls)
Age: early glaucoma mean ± SD, 53.97 ± 12.36 years; preperimetric 54.22 ± 12.70 years, controls
group 50.68 ± 13.73 years
Sex: 99 men (41 early glaucoma, 17 preperimetric glaucoma, 41 controls) and 80 women (29 early
glaucoma, 20 preperimetric glaucoma, 31 controls)
Ethnicity: Korean.
Clinical setting: Department of Ophthalmology, Chonnam National University Medical School
and Hospital, between February 1, 2012 and July 30, 2012
Country: Korea.
Ocular comorbidities: patients with history of other eye diseases like neurological disease leading
to VF abnormality, or diabetic retinopathy or macular oedema or histories of intraocular surgery
other than uncomplicated cataract surgery, were excluded
Spectrum of glaucoma severity: the median (first and third quartile values) MD and PSD on the
VF test were -3.54 (-5.23, -2.08) and 2.83 (2.19, 4.81) respectively for early glaucoma; -0.72 (-1.
51, -0.13) and 1.8 (1.53, 2.04) respectively for preperimetric glaucoma
Control participants: no family history of glaucoma, no previous intraocular surgery, IOP ≤ 21
mmHg, non-glaucomatous optic disc appearance and normal VF
Index tests Optical coherence tomography: Cirrus HD-OCT (Carl Zeiss Meditec Inc., Dublin, CA, USA)
. Macular cube 200 x 200 protocol and optic disc cube 200 x 200 protocol scans were used for
analysis. Images with image quality factor < 6 and with eye movements or blinking artefacts or
showing an apparent segmentation error were excluded
The authors declared no conflict of interest.
Target condition and reference
standard(s)
Manifest early glaucoma: glaucomatous optic nerve damage (defined as the vertical cup-to-disc
ratio ≥ 0.7 or > 0.2 asymmetry between the vertical cup-to-disc ratio of both eyes or focal neural
rim notching or generalised loss of the neural rim) and VF loss with MD ≥ -6 (defined as having
≥ 3 non-edge, contiguous points with P < 0.05 and ≥ 1 points with P < 0.01 on the same side of
horizontal meridian in the pattern SD plot and confirmed in at least 2 consecutive examinations
Manifest preperimetric glaucoma: normal VF with progressive glaucomatous optic nerve damage.
Visual field test:Humphrey Field Analyzer (Carl Zeiss Meditec Inc.) 30-2 SITA standard. Reliable
exams had fixation losses ≥ 20%, false positive and false negative response ≥ 33%
Optic disc evaluation: disc photography and red-free RNFL photography.
Flow and timing 10 eyes were excluded for low image quality, 7 eyes for intraretinal segmentation error, and 8 eyes
for unreliable VF results (> 10%)
The time interval between index and reference test was not reported
Comparative
Notes None.
Methodological quality
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Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
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Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
Takahashi 2008
Study characteristics
Patient sampling Healthy participants and glaucoma patients were enrolled at the outpatient clinic. One eye per
person was randomly selected
Patient characteristics and set-
ting
Sample size: 170 eyes of 170 participants (47 glaucoma, 38 glaucomawith diabetes, 40with diabetes
(without glaucoma) and 45 healthy controls)
Age: glaucoma patients mean ± SD, 69.2 ± 8.3years; glaucoma patients with diabetes mean ± SD
71.3 ± 7.5years; diabetes patients mean ± SD, 66.2 ± 7.8 years ;controls 68.9 ± 5.9 years
Country: Japan.
Ocular comorbidities: no neuro-ophthalmologic disease, BCVA < 32/40, spherical refraction > ±5
D, cylinder refraction > ±3 D uveitis, macular/retinal disease, or previous refractive or intraocular
surgery
Setting: Senshokai Eye Institute in Kyoto.
Spectrum of glaucoma severity: mean ± SD MD on the VF test was 6.56 ± 1.6 dB for glaucoma
eyes (without diabetes) and 7.58 ± 2.1 dB for glaucoma with diabetes
Control participants: IOP < 22 mmHg, no history of diabetes or elevated IOP, a healthy optic
disc, and no repeatable abnormal VF results
Index tests Scanning laser polarimetry: GDx VCC, software version 5.5.1 (Carl Zeiss Meditec, Dublin, CA,
USA). Only high-quality images (defined as a well-focused and uniformly illuminated reflectance
image with a centred optic disc that had minimal residual anterior segment retardation without an
atypical retardation pattern) were included
No author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous ONH changes (defined as undermining of the cup, notching,
focal/diffuse thinning of the rim area, nasal shifting of the retinal vessels or asymmetric enlargement
of the cup (cup-to-disc asymmetries > 0.2)) and glaucomatous VF defect (defined as 3 consecutive
point depressions exceeding 5 dB more than the age-matched controls and at least one of 3 consec-
utive points with a depression > 10 dB or 2 consecutive points depressed > 10 dB and 2 adjacent
points across the nasal horizontal meridian with a difference of > 5 dB)
Visual field testing: Octopus visual field analzyer, Octopus 301, version 2.04, full-threshold (G1)
programme (Interzeag, Schlieren, Switzerland). No details about VF reliability criteria were reported
Optic disc evaluation: 45° high-quality fundus colour photography (CF-PU2; Canon Inc., Tokyo,
Japan). Two experienced graders measured each fundus colour photograph independently and were
masked to the test results of the other
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Flow and timing The time interval between reference standard and index tests was <3 months
Poor images from 36 participants were considered unacceptable and were excluded from this study
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
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DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
Weinreb 2003
Study characteristics
Patient sampling Healthy and glaucoma consecutive patients who met the diagnostic inclusion criteria were enrolled.
One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 94 eyes of 94 participants (54 glaucoma, 40 healthy controls)
Age: glaucoma patients mean ± SD, 68.7 ± 9.2 years; controls 64.0 ± 10.4
Sex: 41 men, 53 women.
Ethnicity: 79 white, 5 Hispanic, 3 African-American, 2 Asian-American, 2 Indo-European, and 3
unknown
Country: USA.
Ocular comorbidities: no co-existing retinal disease, BCVA < 20/40, uveitis, or non-glaucomatous
optic neuropathy
Clinical setting: Hamilton Glaucoma Center, University of California, San Diego
Spectrum of glaucoma severity: mean ± SD MD on the VF test for glaucoma was -6.49 ± 4.94
dB
Control participants: no history of increased IOP, healthy appearance of the ONH/RNFL (no
diffuse/focal rim thinning, cupping, or RNFL defects), and normal SAP results (MD and CPSD
within 95% confidence limits, GHT within normal limits)
Index tests Scanning laser polarimetry: GDx Nerve Fibre Analyzer, version 2.0.01 modified with a VCC
(Laser Diagnostic Technologies, San Diego, CA, USA). No details about quality images assessment
were reported
One author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: repeatable (2 consecutive) glaucomatous VF test results (defined as a CPSD
outside the 95% normal limits or a GHT outside the normal limits)
Visual field testing:Humphrey FieldAnalyzer, 24-2 SITA-standard or full-threshold strategy (Zeiss-
Humphrey Systems, Dublin, CA, USA). No details about VF reliability criteria were reported
242Optic nerve head and fibre layer imaging for diagnosing glaucoma (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Weinreb 2003 (Continued)
Optic disc evaluation: dilated stereoscopic fundus examination.
Flow and timing The time interval between reference standard and index test was not specified
No patients were reported as excluded from the analysis.
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Unclear
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
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Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Wu 2012
Study characteristics
Patient sampling Glaucoma patients and normal controls were prospectively recruited between January 2009 and July
2009. Nomore details about methods of selection were reported. One eye per person was randomly
selected
Patient characteristics and set-
ting
Sample size: 146 eyes of 146 participants (61 glaucoma, 85 healthy controls)
Age: glaucoma eyes mean ± SD 69.2 ± 13.0 years; controls 63.5 ± 14.0years
Sex: 65 men (25 glaucoma, 40 controls) and 81 women (36 glaucoma, 45 controls)
Ethnicity: 104 white (41 glaucoma, 63 controls).
Country: USA.
Setting: Glaucoma Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology,
Harvard Medical School, Boston, Massachusetts
Ocular comorbidities: patients with congenital anomalies of the anterior chamber, corneal scarring
or opacities, diabetic proliferative or severe nonproliferative retinopathy, visual field loss due to a non-
glaucoma condition, were excluded. All eyes had to have BCVA ≥ 20/40 and spherical equivalent
within ±5 D
Spectrum of glaucoma severity: the mean ± SD MD and PSD on the VF test were -9.61 ± 8.76
dB and 6.14 ± 3.43 dB respectively, for glaucoma
Control participants: no ocular disease, except for mild cataracts, and normal VF test results, as
defined by PSD > 5% and GHT results within normal limits
Index tests Optical coherence tomography: Spectralis OCT (software version, 4.0, Heidelberg Engineering,
Inc, Heidelberg, Germany). The circular RNFl 3.45 mm was used to acquire the images. All the
images without good quality (signal strength < 15, a clear fundus image with good optic disc and
scan circle visibility, RNFL visible and without interruptions, and a continuous scan pattern without
missing or blank areas) were excluded from the analysis.
One author had conflict of interest.
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Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous optic nerve changes and corresponding glaucomatousVFdefect,
defined as 3+ contiguous test locations in the PSD plot with P < 5%, with at least 1 with P < 1%
on the same side of the horizontal meridian
Visual field testing: Humphrey Field Analzyer 750 (24-2 SITA standard programme ((Carl Zeiss
Meditec, Inc, Dublin, CA, USA). Reliability criteria were fixation losses < 33%, false positive and
false negative < 20%
Optic nerve evaluation: dilated ophthalmoscopy.
Flow and timing Index test and reference standard were performed on the same day
No patients were reported by the authors as excluded from the analysis
Comparative
Notes Supported in part by grant R01 EY14975-01 from the National Institutes of Health, Bethesda,
Maryland
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
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Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Yamada 2014
Study characteristics
Patient sampling Retrospective case-control study comprised patients (preperimetric glaucoma, perimetric glaucoma
and controls) who were screened for glaucoma at the Kyoto University Hospital from March 7,
2011, through November 19, 2012. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 122 eyes of 122 participants (31 advanced glaucoma, 31 early glaucoma, 30 preperi-
metric glaucoma and 30 healthy controls)
Age: advanced glaucoma ± SD, 63.0 ± 14.4 years; early glaucoma, 61.8 ± 11.5 years; preperimetric
glaucoma, 56.9 ± 14.7 years; controls, 56.9 ± 17.3 years
Sex: 69 men (32 perimetric glaucoma, 17 preperimetric glaucoma, 20 controls) and 53 women (30
perimetric glaucoma, 13 preperimetric glaucoma, 10 controls)
Ethnicity: not specified.
Clinical Setting: Kyoto University Hospital, Kyoto.
Country: Japan.
Ocular comorbidities: patients with opaque media, diabetic retinopathy or another ophthalmic
disease that could cause VF defects or fundus abnormalities, or a history of eye trauma or intraocular
surgery, as well as patients with a history of systemic or neurologic disease that could affect the visual
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field, were excluded
Spectrumof glaucoma severity: themean ± SDMDon theVF test were -0.7 ± 1.0 for preperimetric
glaucoma, -2.1 ± 1.5 for early perimetric glaucoma, -15.7 ± 7.8, fro advanced perimetric glaucoma.
Early glaucoma had MD > -6, advanced MD < -6
Control participants: IOP of ≤ 21 mmHg, a normal-appearing optic disc, and normal VF test
results
Index tests Optical coherence tomography: Spectralis HRA+OCT system (Heidelberg Engineering, Heidel-
berg, Germany). Macular scanning protocol was used for the analysis
The authors reported no conflict of interest.
Target condition and reference
standard(s)
Manifest perimetric glaucoma: glaucomatous optic disc appearance (defined as the presence of
localised or diffuse neuroretinal rim thinning) and/or RNFL defects (classified as glaucomatous
when its width at a 1-disc-diameter distance from the edge of the disc was larger than that of a
major retinal vessel, it diverged from the edge of the optic disc in an arcuate or wedge shape) and
typical reproducible VF defects (defined as the presence of GHT outside normal limits and a PSD
with P < 5%; or a cluster of 3+ adjacent non-edge points in typical glaucomatous locations that did
not cross the horizontal meridian, all of which were depressed on the PD plot with P < 5%, and 1
of which was depressed with P < 1%, on at least 2 consecutive examinations)
Manifest preperimetric glaucoma: glaucomatous optic disc appearance and normal VF results.
Visual field test: Humphrey Field Analyzer (Carl Zeiss Meditec); 24-2 SITA-standard strategy.
Reliable VF were defined by fixation loss, and false-positive and false-negative rates of < 15%
Optic disc evaluation: Stereo disc photograph (3-Dx simultaneous stereo disc camera; Nidek,
Gamagori, Japan)
RNFL evaluation: Red-free fundus photograph (Heidelberg Retina Angiography 2 [HRA2]; Hei-
delberg Engineering, Heidelberg, Germany)
Flow and timing 38 eyes (> 10%) were excluded on the basis of ocular or systemic disease history or because OCT
images were of poor quality
The time interval between index and reference test was not specified
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
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High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
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Yang 2014
Study characteristics
Patient sampling Case-control study included participants in the Diagnostic Innovations in Glaucoma Study (a
prospective longitudinal study designed to evaluate optic nerve structure and visual function in
glaucoma). Healthy participants were recruited from the general population through advertisements
or from the staff and employees at the University of California, San Diego. Both eyes were used for
some participants
Patient characteristics and set-
ting
Sample size: 210 eyes of 148 participants (144 eyes from 106 glaucoma, and 66 eyes from 42
healthy controls)
Age: glaucoma ± SD, 71.4 ± 10.2 years; controls, 60.1 ± 12.8 years
Sex: 71 men (56 glaucoma, 15 controls) and 77 women (50 glaucoma, 27 controls)
Ethnicity: not specified.
Clinical Setting: University of California, San Diego, CA.
Country: USA.
Ocular comorbidities: patients with ocular or systemic disease that could affect the optic nerve or
visual field were excluded
Spectrum of glaucoma severity: the mean ± SD MD on the VF test was -5.9 ± 6.4 for glaucoma
Control participants: IOP < 22 mmHg with no history of increased IOP and normal VF result in
both eyes
Index tests Optical coherence tomography: Swept-sourceDeepRange Imaging-OCT (DRI-OCT-1, Topcon)
. 2 Deep Range Imaging-OCT scan modes, a wide-angle scan and a 3-dimensional horizontal disc
circle grid scan, were acquired. The quality of each scan and the accuracy of the segmentation
algorithm were reviewed independently by masked reviewers
Optical coherence tomography: Spectralis SD-OCT (software v 5.3.0.7, Heidelberg Engineering,
Heidelberg, Germany) RNFL circle scan was used for the analysis. Images with the signal strength
< 15 dB, with artefacts, inverted or clipped and those that had co-existent retinal pathologic abnor-
malities, were excluded
The authors declared conflict of interest with manufacturer.
Target condition and reference
standard(s)
Manifest perimetric glaucoma: glaucomatous VF result (defined as a PSD with P < 5% or a GHT
outside normal limit, or both) or documented evidence of progressive optic disc changes on masked
grading of stereophotographs, with or without abnormal SAP results
Visual field test:Humphrey Field Analyzer II (Carl Zeiss Meditec, Dublin, CA, USA); 24-2 SITA-
standard strategy. Reliable VF were defined by fixation losses or false-negative errors < 33%, and
false-positive errors < 15%. All VFs were evaluated by the Visual Field Assessment Center
Optic disc evaluation: Stereo optic disc photograph (Kowa Nonmyd WX3D, v. VK27E, Kowa,
Tokyo Japan). Progression was assessed by experienced graders who were masked to the participants’
identities and to other test results at the Optic Disc Reading Center
Flow and timing 44 eyes (> 10%) were excluded due to image-quality scores < 50 or clipped/poorly-focused images
or images with segmentation failure and motion artefacts
The time interval between index and reference test was not specified
Comparative
Notes None.
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Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard
Yes
Yoshida 2014
Study characteristics
Patient sampling Case-control study comprised patients with open-angle glaucoma who were enrolled between Jan-
uary 2009 and March 2010 and healthy controls. If both eyes fulfilled the inclusion criteria, the eye
with a better data quality factor in the SD-OCT examination was included in the study
Patient characteristics and set-
ting
Sample size: 210 eyes of 210 participants (126 glaucoma, and 84 healthy controls)
Age: glaucoma ± SD, 60.1 ± 13.1 years; controls, 52.6 ± 15.6 years
Sex: 100 men (53 glaucoma, 47 controls) and 110 women (73 glaucoma, 37 controls)
Ethnicity: not specified.
Clinical Setting: University of Tokyo Hospital or the Tajimi Iwase eye clinic
Country: Japan.
Ocular comorbidities: patients with ocular diseases that could affect the results of SD-OCT ex-
aminations, such as diabetic retinopathy or age-related macular degeneration, were excluded
Spectrum of glaucoma severity: the mean ± SD MD on the VF test was -5.6 ± 5.2 for glaucoma
Control participants: no abnormal findings on biomicroscopy, gonioscopy and funduscopy, and
normal VF test results according to Anderson-Patella’s criteria
Index tests Optical coherence tomography: 3D OCT-1000 (Topcon Corp., Tokyo, Japan) for controls, 3D
OCT-1000 (68 eyes) or 3D OCT-2000 (Topcon Corp., Tokyo, Japan) (58 eyes) for glaucoma.
Raster scan protocol was used for analysis. Images influenced by involuntary blinking or saccade,
and those with quality factor < 60% were excluded
The OCT models used in controls and glaucoma were different.
The authors declared no conflict of interest.
Target condition and reference
standard(s)
Manifest perimetric glaucoma: glaucomatous ONH appearance (as a rim notch with a rim width
≤ 0.1, a vertical cup-to-disc ratio of > 0.7 and/or a RNFL defect (with its edge at the ONHmargin
greater than a major retinal vessel) diverging in an arcuate or wedge shape) and glaucomatous VF
defects (fulfilling at least one of Anderson- Patella’s criteria: a cluster of ≥ 3 points non-edge in the
pattern deviation plot in a single hemifield (superior/inferior) with P < 5%, one of which must have
been P < 1%, a GHT outside of normal limits, or an abnormal PSD with P < 5%)
Visual field test: Humphrey Field Analyzer (Carl Zeiss Meditec); 24-2 SITA-standard strategy for
controls; 24-2 or 30-2, for glaucoma. Reliable VF were defined by fixation losses < 25%, and false-
negative errors and false-positive errors < 15%
Optic disc evaluation: optic disc stereophotograph.
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Flow and timing The time interval between index and reference test was 3 months
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
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DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Zelefsky 2006
Study characteristics
Patient sampling Normals participants, glaucoma suspects, and glaucoma patients were enrolled. One eye per person
was randomly selected
Patient characteristics and set-
ting
Sample size: 220 eyes of 220 participants (84 glaucoma, 136 healthy controls)
Age: mean age was 51 ± 13 years for blacks (53M/71F) and 50 ± 16 years for whites (35M/61F)
Sex: 88 men (53 blacks, 35 whites) and 132 women (71 blacks, 61 whites)
Ethnicity: 96 whites (32 glaucoma, 64 controls) and 124 blacks (52 glaucoma, 72 controls)
Country: not specified.
Setting: not specified.
Ocular comorbidities: no narrow angles, BCVA < 20/40, refractive spherical refraction < ±5 D/
cylinder refraction > ±3 D, retinal disease, significant ocular surface disease, non-glaucomatous optic
neuropathy, or history of intraocular surgery other than uncomplicated cataract surgery
Spectrum of glaucoma severity: mean ± SD MD on the VF test was -7.3 ± 6.7 dB (-8.45 ± 7.21
dB for blacks, -5.45 ± 5.18 dB for white)
Control participants: normal visual fields (PSD > 5% and GHT within 97% normal limits) and
a normal clinical examination
Index tests Confocal scanning laser ophthalmoscopy:HRT2 (Heidelberg EngineeringGmbH,Dossenheim,
Germany). Data result were exported to the HRT3 software after the acquisition. Good image
quality was defined as follows: acquisition sensitivity < 90%, topography SD < 40 mm, > ¾ of the
disc within the target circle, minimal movement during the acquisition movie, no floaters over the
disc. A trained technician, relying on stereophotographs of the respective optic disc, outlined the
optic disc margin on the mean topographic image
No author had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous VF defect on 2 consecutive fields (defined as PSD < 5% or
GHT outside normal limits, or both)
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Visual field testing: Humphrey Field Analyzer, model II, 24-2 SITA-standard strategy (Carl Zeiss
Meditec, Dublin, CA, USA). Reliability criteria included fixation losses rates, false-positive and
false-negative rates < 33%
Optic disc appearance was not part of the reference standard
Flow and timing Reference standard and index tests were performed within 1 month
No patients were reported by the authors as excluded from the analysis
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Zeppieri 2010
Study characteristics
Patient sampling Healthy, ocular hypertensive and glaucoma patients were recruited consecutively. Normal partici-
pants were recruited from staff members and volunteers. One eye per person was randomly selected
Patient characteristics and set-
ting
Sample size: 319 eyes of 319 participants (75 perimetric glaucoma, 67 preperimetric glaucoma, 87
ocular hypertensive and 90 healthy controls)
Age: glaucoma perimetric patients mean ± SD, 65.9 ± 11 years, glaucoma preperimetric patients
mean ± SD, 63.9 ± 9.3 years, OHT patients mean ± SD, 63.6 ± 10.3 years, controls 53.4 ± 13.2
Country: Italy, USA, Argentina.
Ocular comorbidities: no secondary causes of glaucoma, media opacity, SE > ±5 D, angle alter-
ations, large peripapillary atrophy, diabetes, neurological disorders or previous intraocular surgery
(excluding cataract surgery performed at least 6 months prior)
Setting:S.Maria dellaMisericordiaHospital,Udine, Italy;Discoveries in Sight,Devers Eye Institute,
Portland,Oregon;CentroOftalmologico Sampaolesi y FundacionArgentinaOftalmologica, Buenos
Aires, Argentina
Spectrum of glaucoma severity: mean ± SD MD/PSD on the VF test were -2.1 ± 1.5/2.7 ± 0.9
dB, for perimetric glaucoma; -0.9 ± 1.3/1.7 ± 0.5 dB , for preperimetric glaucoma, -0.3 ± 1.4/1.5
± 0.4 dB for OHT
Control participants: normal IOP, optic nerve/RNFL appearance and SAP results.
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Index tests Scanning Laser Polarimetry: GDx VCC, software version 5.1.0 (Carl Zeiss Meditec Inc.). All
images had quality scores > 8, residual anterior segment retardation < 15 nm and typical scan score
> 75
No authors had conflict of interest.
Target condition and reference
standard(s)
Manifest perimetric glaucoma: IOP > 21 mmHg before medication and reproducible glaucoma-
tous VF defects (defined by the Anderson and Patella criteria)
Manifest preperimetric glaucoma: IOP > 21 mmHg before medication, glaucomatous optic disc/
RNFL appearance (excavation or notching involving > 2 clock hours or focal/diffuse atrophy of
neural rim area involving > 2 clock hours or disc haemorrhage or focal/generalised RNFL atrophy)
and co-existing normal VF test result
Ocular hypertensive: IOP > 21 mmHg without medication, normal optic disc/RNFL appearance,
and normal VF test result
Visual field testing: Humphrey Field Analyzer, model II 750, 30-2 SITA-standard strategy (Carl
Zeiss Meditec, Dublin, CA, USA). Reliability criteria included fixation losses rates < 20%, false-
positive < 15% and false-negative rates < 33%
Optic disc evaluation: slit-lamp indirect ophthalmoscopy and a 78-D lens. The eyes were classified
on the basis of masked consensus by 2 expert graders. Adjudication by a third expert grader was
completed in cases of disagreement
Flow and timing The time interval between reference standard and index tests was < 4 months
9 participants were not included in the analysis due to poor-quality images or unreliable SAP test
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
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Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
Zhang 2014
Study characteristics
Patient sampling Case-control study of participants from the Diagnostic Innovations in Glaucoma Study at the
University of California (San Diego) including manifest glaucoma, glaucoma suspects and healthy
controls. For some participants, both eyes were enrolled
Patient characteristics and set-
ting
Sample size: 390 eyes of 224 participants (159 eyes of 93 glaucoma, 154 eyes of 89 glaucoma
suspects, 77 of 42 normal controls)
Age: glaucoma mean ± SD, 70.87 ± 12.19 years; glaucoma suspects 66.03 ± 12.48 years, controls
257Optic nerve head and fibre layer imaging for diagnosing glaucoma (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Zhang 2014 (Continued)
group 50.68 ± 13.73 years
Sex: 107 men (45 glaucoma, 45 glaucoma suspects, 17 controls) and 117 women (48 glaucoma,
44 glaucoma suspects, 25 controls)
Ethnicity: 145 European descent, 63 African-American, 16 other.
Clinical setting: University of California, San Diego (UCSD).
Country: USA.
Ocular comorbidities: patients with any other ocular or systemic disease that could affect the optic
nerve or the visual field, were excluded
Spectrum of glaucoma severity: the mean ± SD mean deviation and on the visual field test were -
5.06 ± 5.43 for glaucoma; 0.47 ± 1.73 for glaucoma suspects
Control participants: IOP of ≤ 21 mmHg, with no history of increased IOP.
Index tests Optical coherence tomography: Cirrus HD-OCT (Carl Zeiss Meditec Inc., Dublin, CA, USA)
, software version 6.5. Macular cube 200 x 200 protocol and optic disc cube 200 x 200 protocol)
scans were used for analysis. Images with image quality factor < 7, movement artefacts, segmentation
errors or not centred on the optic disc of fovea were excluded
Some of the authors had conflict of interest.
Target condition and reference
standard(s)
Manifest glaucoma: glaucomatous VF results (defined as PSD with P < 5% or a GHT outside the
normal limits) or progressive glaucomatous optic disc changes on stereo photo
Glaucoma suspects: optic disc appearance of glaucoma and normal VF results.
Visual field test: Humphrey Field Analyzer (Carl Zeiss Meditec Inc.) 30-2 SITA standard pro-
gramme. Reliable exams had fixation losses ≥ 33%, false-positive and false-negative response ≥
15%
Optic disc evaluation: optic disc stereophotography.
Flow and timing No details about exclusion.
The time interval between Index and reference test was 6 months
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
Did the study avoid inappropri-
ate exclusions?
Yes
High
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DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Yes
Were any conflict of interest
avoided
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Did all patients receive a refer-
ence standard
Yes
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Zheng 2008
Study characteristics
Patient sampling Glaucoma patients and healthy controls were enrolled from June 2005 to June 2006. Both eyes per
each participant were included in the study
Patient characteristics and set-
ting
Sample size: 300 eyes of 190 participant (220 glaucoma, 80 healthy controls)
Age: perimetric glaucoma patients mean ± SD, 57.4 ± 9.33 years, controls 53.35 ± 11.38 years
Ethnicity: not specified.
Country: China.
Ocular comorbidities: No history of ocular disease, no history of diabetes.
Setting: Beijing Hospital.
Spectrum of glaucoma severity: mean ± SD MD on the VF test were 1.76 ± 1.71 dB for early
glaucoma group, 12.38 ± 6.05 dB for advanced glaucoma group
Control participants: IOP < 21 mmHg, normal VF result, no abnormalities for routine eye checks
the optimal vision correction ≥ 1.0 and diopter range ±6.00
Index tests Scanning laser polarimetry:GDxVCC, (LaserDiagnostic Technologies Inc, SanDiego, CA,USA)
Target condition and reference
standard(s)
Primary open angle glaucoma: IOP > 21 mmHg, characteristic VF defects for glaucoma (such as
paracentral scotoma, nasal step, arcuate scotoma), specific changes under ophthalmo-fundoscope
such as damages to the optic disc, and focal and diffusive RNFL defects, and wide angle of anterior
chamber
Primary angle closure glaucoma: eye-anatomical changes for angle-closure glaucoma, history of
acute increase of IOP or repetitive mild-to-moderate increase of IOP with or without symptoms,
narrow angle of anterior chamber, closed angle when IOP increases, and changes of discus opticus
and visual field
Visual field testing:Octopus 101 (Interzeag Inc., Switzerland) A type III light cursor was used, the
persistence time was 100 ms, and the background lightness was 4 apostilbs. The programmes G2
or tG2 were used to measure 59 - 72 testing sites within the centre of 30°
Flow and timing The time interval between index and reference test was not reported.
No patient were reported by the authors as excluded from the analysis
Comparative
Notes None.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
No
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Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were imaging test’s quality as-
sessed?
Unclear
Were any conflict of interest
avoided
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard
Yes
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BCVA: best corrected visual acuity
CPSD: corrected pattern standard deviation
IOP: intraocular pressure
GHT: glaucoma hemifield test
MD: mean deviation
NS: not specified
NTG: normal tension glaucoma
ONH: optic nerve head
POAG: primary open angle glaucoma
PACG: primary angle closure glaucoma
PSD: pattern standard deviation
RNFL: retinal nerve fibre layer
SAP: standard automated perimetry
VF: visual field
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D A T A
Presented below are all the data for all of the tests entered into the review.
Tests. Data tables by test
Test
No. of
studies
No. of
participants
1 GDx: Inferior average 30 6788
2 GDx: NFI 35 7193
3 GDx: Superior average 30 6788
4 GDx: TSNIT average 30 6535
5 OCT: RNFL average 57 13153
6 OCT: RNFL inferior quadrant 45 10599
7 OCT: RNFL nasal quadrant 30 6836
8 OCT: RNFL superior quadrant 43 10372
9 OCT: RNFL temporal quadrant 30 6836
10 HRT: Bathija function 1 214
11 HRT: Cup area 7 1882
12 HRT: C/D area ratio 9 2905
13 HRT: vertical C/D ratio 8 2622
14 HRT: Cup shape measure 6 1778
15 HRT: Cup volume 9 2905
16 HRT: FSM discriminant
function o Mikelberg function
6 1650
17 HRT: MRA 8 1395
18 HRT: Rim area 9 2904
19 HRT: RB discriminant
function
6 1642
20 HRT: Rim Volume 7 1882
21 OCT: GCC RTVue average
thickness
19 5314
22 OCT: GCC RTVue superior
thickness
16 4772
23 OCT: GCC RTVue inferior
thickness
16 4772
24 OCT: GCC RTVue FLV 13 3899
25 OCT: GCC RTVue GLV 12 3695
26 OCT: GCC 3DTopcon average
thickness
4 656
27 OCT: GCC 3DTopcon
superior thickness
3 494
28 OCT: GCC 3DTopcon inferior
thickness
3 494
29 OCT: GCIPL Cirrus average
thickness
11 2433
30 OCT: GCIPL Cirrus minimum
thickness
9 1739
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31 OCT: GCIPL Cirrus superior
thickness
8 1571
32 OCT: GCIPL Cirrus inferior
thickness
8 1571
33 OCT: ONH Disc area 7 1913
34 OCT: ONH Cup area 9 2562
35 OCT: ONH Rim area 17 4648
36 OCT: ONH Rim volume 6 1743
37 OCT: ONH Nerve head
volume
4 1451
38 OCT: ONH Cup volume 9 3013
39 OCT: ONH C/D area ratio 17 4648
40 OCT: ONH horizontal C/D
ratio
6 1971
41 OCT: ONH vertical C/D ratio 15 4085
42 OCT: GCIPL Cirrus
Inferonasal quadrant
8 1571
43 OCT: GCIPL Cirrus
Inferotemporal quadrant
8 1571
44 OCT: GCIPL Cirrus
Superonasal quadrant
8 1571
45 OCT: GCIPL Cirrus
Superotemporal quadrant
8 1571
47 Direct comparison: GDx NFI 8 1090
48 Direct comparison: OCT
RNFL average
8 1090
A D D I T I O N A L T A B L E S
Table 1. Accuracy of all parameters for each test
Test (parameter) Number of studies
(Number of patients)
Sensitivity1 Specificity1
GDx
Inferior sector 30 (4199) 0.61 (0.55 to 0.66) 0.92 (0.90 to 0.94)
Nerve fibre indicator (NFI) 35 (4958) 0.76 (0.70 to 0.81) 0.92 (0.90 to 0.94)
Superior sector 30 (4199) 0.61 (0.56 to 0.66) 0.93 (0.91 to 0.94)
Temporal superior nasal infe-
rior temporal (TSNIT) average
30 (4104) 0.61 (0.57 to 0.66) 0.93 (0.92 to 0.95)
HRT
Cup disc area ratio 9 (1959) 0.57 (0.46 to 0.68) 0.95 (0.93 to 0.96)
Cup area 7 (1447) 0.43 (0.31 to 0.56) 0.94 (0.92 to 0.96)
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Table 1. Accuracy of all parameters for each test (Continued)
Cup shape measure 6 (1343) 0.41 (0.31 to 0.52) 0.94 (0.91 to 0.95)
Cup volume 9 (1959) 0.32 (0.23 to 0.43) 0.95 (0.93 to 0.96)
Frederick S. Mikelberg (FSM)
discriminant function
6 (1215) 0.58 (0.36 to 0.77) 0.94 (0.90 to 0.96)
Moorfields regression analy-
sis (MRA)
8 (1271) 0.69 (0.56 to 0.79) 0.89 (0.84 to 0.93)
Reinhard O.W. Burk (RB) dis-
criminant function
6 (1207) 0.53 (0.42 to 0.63) 0.95 (0.93 to 0.96)
Rim volume 6 (1207) 0.53 (0.42 to 0.63) 0.95 (0.93 to 0.96)
Rim area 9 (1958) 0.45 (0.34 to 0.56) 0.95 (0.93 to 0.96)
Vertical cup/disc ratio 8 (1849) 0.67 (0.55 to 0.77) 0.94 (0.92 to 0.95)
OCT ONH
Cup/disc area ratio 17 (2863) 0.64 (0.54 to 0.73) 0.93 (0.90 to 0.95)
Horizontal cup/disc ratio 6 (1009) 0.41 (0.26 to 0.58) 0.94 (0.90 to 0.96)
Vertical cup/disc ratio 15 (2389) 0.72 (0.60 to 0.81) 0.94 (0.92 to 0.95)
Cup area 9 (1600) 0.45 (0.26 to 0.67) 0.92 (0.87 to 0.95)
Cup volume 9 (1582) 0.30 (0.16 to 0.49) 0.94 (0.92 to 0.96)
Disc area 7 (1032) 0.16 (0.09 to 0.27) 0.93 (0.88 to 0.96)
Nerve head volume 4 (749) 0.44 (0.28 to 0.62) 0.93 (0.87 to 0.96)
Rim area 17 (2863) 0.63 (0.54 to 0.70) 0.93 (0.91 to 0.95)
Rim volume 6 (947) 0.49 (0.35 to 0.62) 0.95 (0.92 to 0.96)
OCT RNFL
Average 57 (8223) 0.69 (0.63 to 0.73) 0.94 (0.93 to 0.95)
Inferior sector 45 (6542) 0.72 (0.65 to 0.77) 0.93 (0.92 to 0.95)
Nasal sector 30 (4395) 0.29 (0.23 to 0.37) 0.93 (0.91 to 0.95)
Superior sector 43 (6395) 0.59 (0.51 to 0.66) 0.94 (0.92 to 0.95)
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Table 1. Accuracy of all parameters for each test (Continued)
Temporal sector 30 (4395) 0.30 (0.22 to 0.39) 0.93 (0.91 to 0.95)
1Summary sensitivity and specificity pairs of all parameters of each test. Parameters with the highest sensitivity are presented in bold
character.
ONH: optic nerve head
RNFL: retinal nerve fibre layer
Table 2. Relative accuracy of all parameters for each test
Test (parameter) Sensitivity Specificity Relative DOR P value
GDx
Inferior sector 0.62 (0.57 to 0.67) 0.92 (0.90 to 0.94) 0.57 (0.440.74) < 0.0001
Nerve fibre indica-r
(NFI)
0.74 (0.69 to 0.78) 0.92 (0.91 to 0.94) Reference 34.21 (26.50 to
44.15)
Reference
Superior sector 0.63 (0.57 to 0.68) 0.93 (0.91 to 0.95) 0.66 (0.51 to 0.86) 0.0022
Temporal superior nasal
inferior temporal
(TSNIT) average
0.63 (0.57 to 0.68) 0.94 (0.92 to 0.95) 0.73 (0.56 to 0.95) 0.0213
HRT
Cup/disc area ratio 0.56 (0.46 to 0.66) 0.95 (0.93 to 0.96) 0.84 (0.55 to 1.30) 0.4326
Cup area 0.44 (0.35 to 0.55) 0.94 (0.93 to 0.96) 0.50 (0.32 to 0.79) 0.0032
Cup shape measure 0.37 (0.28 to 0.47) 0.94 (0.92 to 0.96) 0.37 (0.23 to 0.60) < 0.0001
Cup volume 0.31 (0.23 to 0.41) 0.94 (0.92 to 0.96) 0.30 (0.20 to 0.47) < 0.0001
Frederick
S. Mikelberg (FSM) dis-
criminant function
0.54 (0.44 to 0.64) 0.94 (0.91 to 0.96) 0.67 (0.41 to 1.10) 0.1092
Moorfields regression
analysis (MRA)
0.74 (0.64 to 0.81) 0.88 (0.84 to 0.91) 0.77 (0.45 to 1.33) 0.3476
Reinhard O.W. Burk
(RB) discriminant func-
tion
0.52 (0.41 to 0.62) 0.95 (0.92 to 0.97) 0.70 (0.41 to 1.17) 0.1722
Rim volume 0.48 (0.37 to 0.58) 0.94 (0.92 to 0.96) 0.57 (0.36 to 0.90) 0.0164
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Table 2. Relative accuracy of all parameters for each test (Continued)
Rim area 0.45 (0.35 to 0.55) 0.95 (0.93 to 0.96) 0.53 (0.34 to 0.81) 0.0038
Vertical cup/disc ratio 0.60 (0.50 to 0.69) 0.95 (0.93 to 0.96) Reference 26.81 (17.41 to
41.28)
Reference
OCT ONH
Cup/disc area ratio 0.66 (0.56 to 0.74) 0.93 (0.90 to 0.95) 0.82 (0.57 to 1.19) 0.2963
Horizontal cup/disc ra-
tio
0.56 (0.45 to 0.66) 0.93 (0.88 to 0.95) 0.49 (0.29 to 0.82) 0.0062
Vertical cup/disc ratio 0.68 (0.58 to 0.76) 0.94 (0.91 to 0.96) Reference 31.63 (18.90 to
52.93)
Reference
Cup area 0.57 (0.46 to 0.67) 0.93 (0.90 to 0.95) 0.57 (0.37 to 0.88) 0.0116
Cup volume 0.44 (0.34 to 0.55) 0.93 (0.90 to 0.96) 0.35 (0.22 to 0.56) < 0.0001
Disc area 0.31 (0.22 to 0.41) 0.92 (0.87 to 0.95) 0.15 (0.09 to 0.25) < 0.0001
Nerve head volume 0.59 (0.48 to 0.69) 0.92 (0.88 to 0.96) 0.55 (0.31 to 0.98) 0.0415
Rim area 0.65 (0.55 to 0.73) 0.94 (0.91 to 0.96) 0.90 (0.62 to 1.30) 0.5759
Rim volume 0.57 (0.46 to 0.68) 0.94 (0.91 to 0.97) 0.73 (0.41 to 1.27) 0.2647
OCT RNFL
Average 0.69 (0.64 to 0.73) 0.95 (0.93 to 0.95) Reference 37.84 (29.66 to
48.29)
Reference
Inferior sector 0.70 (0.66 to 0.75) 0.93 (0.92 to 0.95) 0.90 (0.73 to 1.13) 0.3734
Nasal sector 0.30 (0.25 to 0.35) 0.93 (0.91 to 0.94) 0.15 (0.12 to 0.19) < 0.0001
Superior sector 0.59 (0.54 to 0.64) 0.94 (0.92 to 0.95) 0.58 (0.46 to 0.72) < 0.0001
Temporal sector 0.31 (0.26 to 0.36) 0.93 (0.92 to 0.95) 0.17 (0.13 to 0.21) < 0.0001
DOR: diagnostic odds ratio
ONH: optic nerve head
RNFL: retinal nerve fibre layer
267Optic nerve head and fibre layer imaging for diagnosing glaucoma (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 3. Accuracy of macular parameters
OCT macular parameters
(models)
Number of studies (Number
of patients)
Sensitivity Specificity
Average (GCC 3D-Topcon ,
GCC RTVue, GCIPL Cirrus)
32 (5010) 0.63 (0.57 to 0.70) 0.93 (0.91 to 0.94)
Inferior sector(GCC 3D-Top-
con ,GCCRTVue,GCIPLCir-
rus)
27 (4241) 0.63 (0.56 to 0.70) 0.93 (0.01 to 0.94)
Superior sector (GCC 3D-Top-
con ,GCCRTVue,GCIPLCir-
rus)
27 (4241) 0.49 (0.43 to 0.56) 0.93 (0.91 to 0.95)
Focal loss volume (GCC
RTVue)
13 (2143) 0.66 (0.50 to 0.78) 0.93 (0.90 to 0.95)
Global loss volume (GCC
RTVue)
12 (1939) 0.64 (0.46 to 0.79) 0.93 (0.89 to 0.96)
Minimum sector (GCIPL Cir-
rus)
9 (1361) 0.76 (0.65 to 0.84) 0.91 (0.87 to 0.93)
Inferonasal sector (GCIPL Cir-
rus)
8 (1277) 0.48 (0.38 to 0.58) 0.88 (0.84 to 0.91)
Inferotemporal sector (GCIPL
Cirrus)
8 (1277) 0.75 (0.65 to 0.82) 0.90 (0.87 to 0.93)
Superonasal sector (GCIPL
Cirrus)
8 (1277) 0.43 (0.31 to 0.57) 0.89 (0.83 to 0.93)
Superotemporal sector (GCIPL
Cirrus)
8 (1277) 0.61 (0.49 to 0.71) 0.86 (0.81 to 0.90)
Table 4. Accuracy of all parameters: data extracted at the lowest specificity
Test (parameter) Sensitivity1 Specificity1
GDx
Inferior sector 0.70 (0.65 to 0.74) 0.85 (0.21 to 0.87)
Nerve fibre indicator (NFI) 0.81 (0.77 to 0.85) 0.87 (0.84 to 0.90)
Superior sector 0.70 (0.65 to 0.73) 0.86 (0.83 to 0.88)
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Table 4. Accuracy of all parameters: data extracted at the lowest specificity (Continued)
Temporal superior nasal inferior temporal
(TSNIT) average
0.69 (0.64 to 0.74) 0.87 (0.84 to 0.90)
HRT
Cup Disk area ratio 0.65 (0.55 to 0.74) 0.91 (0.87 to 0.94)
Cup area 0.44 (0.31 to 0.58) 0.93 (0.89 to 0.95)
Cup shape measure 0.47 (0.37 to 0.57) 0.92 (0.88 to 0.95)
Cup volume 0.41 (0.29 to 0.54) 0.91 (0.87 to 0.94)
Frederick S. Mikelberg (FSM) discrimi-
nant function
0.60 (0.38 to 0.79) 0.92 (0.87 to 0.95)
Moorfields regression analysis (MRA) 0.68 (0.55 to 0.78) 0.88 (0.83 to 0.92)
Reinhard O.W. Burk (RB) discriminant
function
0.56 (0.44 to 0.67) 0.93 (0.89 to 0.96)
Rim Volume 0.49 (0.38 to 0.60) 0.92 (0.89 to 0.95)
Rim area 0.54 (0.43 to 0.65) 0.91 (0.87 to 0.94)
Vertical cup disk ratio 0.71 (0.56 to 0.82) 0.92 (0.88 to 0.94)
OCT ONH
Cup disk area ratio 0.74 (0.64 to 0.81) 0.84 (0.81 to 0.87)
Cup disk horizontal ratio 0.67 (0.56 to 0.78) 0.81 (0.77 to 0.84)
Cup disk vertical ratio 0.80 (0.73 to 0.85) 0.86 (0.82 to 0.89)
Cup area 0.56 (0.32 to 0.77) 0.83 (0.79 to 0.87)
Cup volume 0.57 (0.38 to 0.73) 0.83 (0.80 to 0.86)
Disc area 0.32 (0.22 to 0.43) 0.83 (0.77 to 0.87)
Nerve head volume 0.66 (0.57 to 0.73) 0.81 (0.76 to 0.85)
Rim area 0.76 (0.67 to 0.82) 0.85 (0.81 to 0.88)
Rim volume 0.67 (0.59 to 0.74) 0.85 (0.79 to 0.90)
OCT RNFL
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Table 4. Accuracy of all parameters: data extracted at the lowest specificity (Continued)
Average 0.78 (0.74 to 0.82) 0.89 (0.86 to 0.91)
Inferior sector 0.79 (0.75 to 0.82) 0.87 (0.84 to 0.89)
Nasal sector 0.43 (0.36 to 0.50) 0.86 (0.83 to 0.89)
Superior sector 0.71 (0.66 to 0.75) 0.87 (0.85 to 0.90)
Temporal sector 0.41 (0.33 to 0.50) 0.86 (0.83 to 0.89)
1Summary sensitivity and specificity pairs of all parameters of each test. Parameters with the highest sensitivity are presented in bold
character.
ONH: optic nerve head
RNFL: retinal nerve fibre layer
Table 5. Relative accuracy of the best parameter of each test
Test (parameter) Sensitivity Specificity Relative DOR1 P value
GDx:Nerve fibre indica-
tor (NFI)
0.70 (0.65 to 0.74) 0.92 (0.91 to 0.94) 0.70 (0.37 to 1.33) 0.2797
HRT: Vertical cup/disc
ratio
0.72 (0.61 to 0.80) 0.94 (0.91 to 0.96) Reference 40.24 (22.65 to
71.50)
Reference
OCT ONH: Vertical
cup/disc ratio
0.72 (0.66 to 0.75) 0.94 (0.92 to 0.95) 0.98 (0.52 to 1.85) 0.9515
OCT RNFL: Average 0.71 (0.67 to 0.75) 0.94 (0.92 to 0.95) 0.99 (0.54 to 1.82) 0.9910
1Relative DORs are obtained from HSROC curves assuming parallelism of summary ROC curves by covariate levels, i.e. assuming
curves with the same shape.
ONH: optic nerve head
RNFL: retinal nerve fibre layer
Table 6. Heterogeneity investigation1
Covariate Number of stud-
ies (Number of pa-
tients)
Sensitivity Specificity Relative DOR2 P value
Reference
Standard
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Table 6. Heterogeneity investigation1 (Continued)
Visual field (VF)
alone
27 (4230) 0.71 (0.64 to 0.78) 0.93 (0.91 to 0.95) Reference 34.15
(23.59 to 49.44)
Reference
Optic nerve head
(ONH) alone
15 (2508) 0.73 (0.68 to 0.77) 0.94 (0.93 to 0.95) 0.56 (0.29 to 1.09) 0.0888
VF + ONH 73 (10681) 0.55 (0.43 to 0.67) 0.94 (0.91 to 0.96) 1.19 (0.77 to 1.85) 0.4278
Mean deviation
(MD)
MD < -6 (more se-
vere glaucoma)
49 (7598) 0.79 (0.74 to 0.83) 0.94 (0.93 to 0.95) Reference 57.11
(43.49 to 74.99)
Reference
MD ≥ -6 (less se-
vere glaucoma)
65 (9720) 0.64 (0.60 to 0.69) 0.93 (0.92 to 0.94) 0.45 (0.31 to 0.64) < 0.0001
Could the conduct
or in-
terpretation of the
index test have in-
troduced bias?
Low 68 (9938) 0.70 (0.65 to 0.75) 0.94 (0.92 to 0.95) Reference 33.93
(26.44 to 43.54)
Reference
High 33 (5390) 0.70 (0.63 to 0.77) 0.95 (0.94 to 0.96) 1.29 (0.83 to 2.00) 0.2642
Unclear 14 (2091) 0.74 (0.63 to 0.81) 0.91 (0.88 to 0.94) 0.86 (0.49 to 1.51) 0.6003
Could the patient
flow have intro-
duced bias?
Low risk 12 (2155) 0.67 (0.55 to 0.77) 0.61 (0.55 to 0.66) Reference 23.42
(13.76 to 39.86)
Reference
High risk 56 (8532) 0.69 (0.64 to 0.74) 0.94 (0.93 to 0.95) 1.48 (0.81 to 2.69) 0.1893
Unclear risk 47 (6732) 0.73 (0.68 to 0.78) 0.92 (0.89 to 0.95) 1.81 (0.99 to 3.34) 0.0553
Could the
reference standard,
its conduct, or its
interpretation have
introduced bias?
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Table 6. Heterogeneity investigation1 (Continued)
Low risk 101 (14897) 0.70 (0.66 to 0.74) 0.94 (0.93 to 0.95) Reference 35.06
(28.58 to 43.01)
Reference
High risk 1 (120) 0.43 (0.30 to 0.57) 1.00 (0.94 to 1.00) 0.9879
Unclear risk 13 (2402) 0.76 (0.64 to 0.85) 0.93 (0.93 to 0.94) 1.23 (0.65 to 2.36) 0.5221
Could
the selection of pa-
tients have intro-
duced bias?
Low risk 2 (284) 0.45 (0.14 to 0.81) 0.95 (0.84 to 0.98) Reference Reference
High risk 111 (16705) 0.71 (0.67 to 0.75) 0.94 (0.93 to 0.94) 2.43 (0.45 to 13.15) 0.3025
Unclear risk 2 (430) 0.61 (0.24 to 0.89) 0.96 (0.86 to 0.99) 2.29 (0.22 to 24.13) 0.4890
1Heterogeneity investigation is obtained including the parameter with the best diagnostic odds ratio (DOR) for each test, as found in
primary analyses including all studies.
2Relative DORs are obtained from HSROC curves assuming parallelism of summary ROC curves by covariate levels, i.e. assuming
curves with the same shape.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We adapted the original QUADAS guidance (Whiting 2003) developed in the protocol for this review to the framework of QUADAS
2, as recommended.
Originally, we planned to include in this review both cohort studies and case-control studies. A first draft was submitted to the DTA
Editorial Team based on a search conducted until 15 June 2013, which identified a large number of case-control studies. During the
revision process of the initial first draft, we decided to update the literature search (15 February 2015). The new search identified
further case-control studies that are known to be prone to methodological biases. We considered the addition of further poor-quality
case-control studies not to be worthwhile, and that they were unlikely to improve the quality of the body of evidence assessed in this
review. Future updates of this review should only consider studies where patients are enrolled consecutively based on the same set of
inclusion criteria, such as referable patients identified in primary care.
During the review process, we decided to extract OCT parameters that are not related to RNFL and ONH morphology, but rather to
macular cell layers affected by glaucoma, such as ganglion cell complex (GCC) and ganglion cell inner plexiform layer (GCIPL), as these
parameters have gained currency in recent years.However, these data were not formally analysed and used to formulate conclusions.
We deviated from the HSROC models using SAS rather than Winbugs, as originally planned. We found little variation in specificity,
as sensitivity was extracted at fixed specificity in almost all studies.
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